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ABSTRACT
Many eukaryotic cell surface proteins are attached to the plasma membrane by 
glycosylphosphatidylinositol (GPI) anchors. Trypanosomatid parasitic protozoa such 
as Leishmania and Trypanosoma brucei make extensive use of this method of protein 
surface attachment. The perceived importance of GPI-anchored proteins makes the 
GPI biosynthetic pathway a good target for anti-parasite chemotherapy. The terminal 
step in the pathway is the addition of complete pre-formed GPI anchors to the 
carboxyl-termini of proteins. This involves replacing a GPI signal sequence with a 
GPI anchor in a transamidation reaction. Two of the proteins involved in this step 
have been identified in yeast and mammals. One of these components, GPI8, has 
significant homology to a family of plant cysteine proteinases, the legumains, and 
GPI8 is therefore believed to be the catalytic subunit of the transamidase.
The work described in this thesis focussed on the cloning of the GPI8 gene from 
Leishmania mexicana and its characterisation. The predicted protein shares 31% 
identity with yeast and human homologues. The nucleotide sequence of a fragment of 
the T. brucei GPI8 gene has also been obtained. Targeted gene replacement of the 
single copy L. mexicana GPI8 produced GPI8 null mutants. The loss of GPI8 was 
confirmed by Southern blotting. The phenotype of the GPI8 null mutants was 
analysed with the following findings: (1) Mutant promastigotes grow well in culture. 
(2) GP63 is not detected on the promastigote surface and is greatly reduced in 
promastigote lysates. (3) Episomal re-expression of GPI8 restored GP63 to the cell 
surface. (4) GPI8 null mutants are able to infect macrophages in vitro to 
approximately wild type levels, and replicate within macrophages. (5) GPI8 null
mutants are capable of forming lesions in mice. These data show that GPI-anchored 
proteins of L. mexicana are not essential for growth of promastigotes, invasion of 
macrophages by promastigotes, or infection of mice. It remains to be established if 
GPI-anchored proteins are required for survival in the sandfly.
Sequence comparison of L. mexicana, yeast and human GPI8 proteins identified two 
potential active site cysteine residues. Mutation in which Cys216 was converted to a 
glycine led to loss of GPI8 activity, as assessed by GP63 surface expression, 
indicating that this may be the active site cysteine.
Recombinant GPI8 was produced in E. coli and used to inoculate rabbits for the 
production of anti-serum. These antibodies detected recombinant protein but failed 
to detect protein in L. mexicana cell lysates. Antibodies raised against a peptide of 
GPI8 also recognised recombinant GPI8, but not GPI8 in L. mexicana lysates. A 
protein of 38-40 kDa, however, was detected in cell lysates of T. brucei with the anti­
recombinant GPI8 antibodies. This antiserum gave a similar immunofluorescence 
pattern in T. brucei to those of an epitope-tagged ribosomal protein, QM. There is 
some overlap in fluorescence patterns between tagged QM and the endoplasmic 
reticulum marker protein BiP. This suggests that GPI8 is located in the ER of T. 
brucei, the same subcellular location that has been identified in yeast. A fusion 
protein of GPI8 and GFP was expressed in L. mexicana to attempt to localise GPI8 in 
this organism. The fusion protein, however, was unable to restore GPI8 function in 
the null mutant, therefore data on its localisation cannot be inferred.
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Molecular Parasitology (WCMP) numbers and these are listed in an Appendix (page 
230).
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CHAPTER 1
GENERAL INTRODUCTION
1.1 The trypanosomatids
Several species of the trypanosomatid protozoa are the causative agent of parasitic 
diseases of mammals, including humans. These organisms have been the subject of 
extensive research for many years, not only because of the implications of the range 
of diseases they cause, both in terms of medical and economic issues, but also 
because they have some significant differences from other eukaryotic species. The 
nature of the often very hostile conditions that these species must endure to survive 
and proliferate has resulted in the evolution of some unusual features that are of 
considerable interest to eukaryote biology. Many of these features, because they are 
not present or are used less extensively in higher eukaryotes such as humans, may 
serve as potential targets for anti-parasitic chemotherapy. Current drugs used for the 
treatment of Leishmaniasis and human African trypanosomiasis, such as the 
antimonial-based Pentostam® and the arsenic-based melarsoprol (Mel B®) are far 
from ideal with the associated side effects and the ever-increasing problem of parasite 
drug-resistance (Croft et al., 1997). Thus, new targets for anti-parasite 
chemotherapy are always being sought because the medical and economical 
implications are the most important reason for study from a humanitarian standpoint.
1.1.1 Parasitic trypanosomatids
This section will introduce two of the most important species of trypanosomatid 
pathogens.
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(I) An African trypanosome:
Trypanosoma brucei has a number of subspecies. Trypanosoma brucei brucei 
infects a variety of mammals including cattle, horses and camels causing a 
serious wasting disease known as nagana. Trypanosoma brucei gambiense is 
the causative agent of the chronic form of the human disease known as 
African sleeping sickness (African trypanosomiasis) and is distributed 
throughout Central and West Africa. Trypanosoma brucei rhodesiense 
causes the acute form of this disease and is found mainly in East and Southern 
Africa. The parasites invade the central nervous system of the host causing 
symptoms of severe headache, drowsiness and weakness that, if left untreated 
often results in death. The parasites are spread by the tsetse fly {Glossina) 
and are transmitted by the bite of this insect. Collectively, the African 
trypanosomes are endemic in 36 countries and as many as 55 million people 
are at risk of infection (Molyneux, 1997)
(II) Leishmania species: There are as many as 20 known species of Leishmania 
and these are loosely grouped into old world (Africa, Asia and Europe) and 
new world (the Americas) species according to their distribution. The 
spectrum of diseases caused by these organisms are called the leishmaniases 
and these can be grouped into three main classes:
(A) Cutaneous leishmaniasis: production of skin ulcers on the 
exposed parts of the body (face, arms and legs). Up to 200 lesions can
2
form on the host causing permanent scarring and sometimes severe 
disability. Species: Leishmania mexicana, L. major and L. tropica.
(B) Mucocutaneous leishmaniasis: usually begins with skin ulcers 
but can lead to extensive damage to the mucous membranes of the 
nose and throat causing often horrific disfigurement. Species: L. 
braziliensis, L. peruviana
(C) Visceral leishmaniasis: also known as kala azar, this is the most 
serious form of the disease producing symptoms such as fever, 
significant weight loss, enlargement of the liver and spleen and other 
secondary effects such as diarrhoea and anaemia. The World Health 
Organisation (WHO) reports that the fatality rate can be as high as 
100% if this disease is not treated (WHO Division of Control of 
Tropical Diseases). Species: L. donovani, L. infantum.
Leishmania species are found in 88 countries throughout Africa, Asia, the 
Americas and Southern European countries. This is the most widespread of 
the trypanosomatids and as many as 350 million people are at risk of infection 
with as many as 119 million currently infected (Molyneux, 1997).
1.1.2 Trypanosomatid life cycles
Both Leishmania and trypanosomes have a digenetic life cycle; that is, the life cycle 
requires two hosts: an insect host and a mammalian host and the parasites are 
transmitted from one host to the next undergoing specific morphological alterations at
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each stage. The life cycle of the African trypanosome involves transmission of the 
mammalian-infective (metacyclic) form of the parasite from the salivary glands of the 
tsetse fly (Glossina). When the infected fly takes a blood meal, the metacyclics are 
passed directly into the bloodstream of the mammalian host where they differentiate 
into the proliferative long slender form. As the infection progresses, the parasite 
becomes a short stumpy form that is non-dividing. These parasites are then 
consumed by another tsetse fly during a blood meal and, because the short stumpy 
form is preadapted for survival within the insect, the parasite rapidly becomes the 
procyclic form, once again capable of cell division. These procyclics migrate forward 
through the insect midgut to the salivary glands ready for mammalian infection once 
more.
Leishmania is passed directly into the bloodstream of the mammalian host by the bite 
of the female sandfly (Figure 1.1). The non-dividing metacyclic parasites are taken up 
by macrophages via phagocytosis where they differentiate to the non-motile 
amastigote form, which begin to undergo cell division once more. Amastigotes 
survive and replicate within the parasitophorous vacuole, essentially a distended 
lysosome. As the number of amastigotes within a macrophage increases, the 
macrophage eventually dies releasing the amastigotes, which then go on to infect 
other macrophages. This proceeds until infected macrophages are taken up in the 
blood meal of another feeding sandfly. In the gut of the sandfly, the amastigotes 
emerge from macrophages and differentiate to the flagellated procyclic promastigotes. 
These parasites migrate forward through the insect gut to reach the mouthparts, 
where they are passed onto a fresh mammalian host when the sandfly next feeds.
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Within the mammalian host Leishmania survives intracellularly. By contrast T. brucei 
are free living within the bloodstream of the host. Conditions within the insect host 
are strikingly different to those of the mammalian host explaining the need for the 
complex developmental changes observed at each life cycle stage.
1.2 Survival strategies in mammalian host
Leishmania species exist intracellularly in the mammalian host. Uptake by host cells 
occurs soon after infection thus minimising the time of exposure to the host immune 
response. By contrast, T. brucei is free-living within the bloodstream of the host and 
is thus subject to antibody-mediated responses. To cope with this, bloodstream form 
African trypanosomes possess an electron-dense surface coat of the variant surface 
glycoprotein (VSG), first visualised by electron microscopy by Professor Keith 
Vickerman. After some time in the bloodstream, antibodies against the VSG are 
produced and many of the parasites are killed. A small number survive because they 
have begun to express a different VSG protein to which antibodies are not available 
and thus escape the antibody response. These parasites proliferate until yet more 
antibodies are produced when the VSG again is replaced on the surface of a few 
parasites, and so the process known as antigenic variation continues (Barry, 1997).
Leishmania metacyclic promastigotes are taken up by host macrophages via 
phagocytosis. Survival of the promastigotes in the bloodstream prior to macrophage 
entry and macrophage itself is thought to be mediated by the cell surface molecules 
(Mauel, 1996), which include the major surface metalloproteinase GP63, 
glycoinositolphospholipids (GIPLs) and lipophosphoglycans (LPGs) and these are
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described in more detail in Section 1.4.2. The phagocytotic vesicle containing the 
promastigote fuses with lysosomes and parasites differentiate to the amastigote forms 
(Figure 1.1). The amastigotes proliferate despite the harsh conditions within the 
parasitophorous vacuole (Alexander and Vickerman, 1975) and the reasons for this 
are still not clearly defined (Mauel, 1996). It could be partly due to the nature of the 
cell surface molecules, predominantly GIPLs, as mutant L. amazonensis deficient in 
particular amastigote-specific GIPLs exhibit arrested growth following differentiation 
to amastigotes during in vitro macrophage infections (Mensa-Wilmot et al., 1999).
The individual roles of the cell surface molecules of Leishmania in parasite invasion 
and survival in both mammalian and insect hosts are described in more detail in 
Section 1.4.2.
1.3 The proteinases of trypanosomatids
As previously mentioned, much of the study of parasitic protozoa is designed to 
identify and characterise potential anti-parasite drug targets. One group of enzymes 
that have been identified as potential targets are the proteinases (North et al., 1990b; 
McKerrow, 1989). Generally, proteinases are enzymes capable of breaking down 
proteins through the hydrolytic cleavage of peptide bonds. Proteolytic enzymes can 
be divided into two categories: endopeptidases and exopeptidases (North, 1991). 
The former, cleave peptide bonds within the polypeptide chains of proteins whereas 
exopeptidases cleave peptide bonds at the ends of polypeptide chains thereby 
liberating single amino acids. Exopeptidases may be further sub-divided according to 
whether they cleave at the N or the C terminus of polypeptides. Proteinases are 
divided into four classes: cysteine, serine and aspartic proteinases, so-called because
6
of the nature of their active site residue, and metalloproteinases, which require the co­
ordination of a metal ion (usually zinc) for activity. Cysteine and metallo- proteinases 
have received the greatest attention in trypanosomatids to date. In addition to the 
cysteine proteinase active site residue, cysteine, a histidine residue is also required, 
making up the so-called catalytic dyad. Serine and aspartic proteinases of protozoa 
will not be considered further.
A classification scheme for cysteine proteinases has been proposed (Barrett and 
Rawlings, 1996). The cysteine proteinases are grouped into families (named Cl, C2, 
C3, etc.) based on primary sequence similarities. The families are further separated 
into clans based on tertiary structure (where known). Thus, to date, 35 families have 
been identified, most of which are divided into four clans (named CA, CB, CC, and so 
on) (Barrett and Rawlings, 1996). Where tertiary structure information is 
unavailable, the order in which the two residues that make up the catalytic dyad 
appear in the primary sequence, can be utilised to allow clan assignation. The Cl 
family is the largest with the representative cysteine proteinase called papain and 
includes the mammalian cathepsins L and B and the major lysosomal proteinases of 
trypanosomatids (Barrett and Rawlings, 1996). It is these enzymes that have received 
considerable interest within this and other laboratories, however the identification of 
cysteine proteinases of other families in trypanosomatids has led to the work 
presented in this thesis. The asparaginyl endopeptidases, which belong to the 
unclaimed C13 family of cysteine proteinases (Barrett and Rawlings, 1996) include 
the legumains of plants, implicated in the maturation of seed proteins (Hara- 
Nishimura et al., 1995) and the “haemoglobinase”, SM32, of Schistosoma mansoni, 
which also may be involved in protein maturation rather than direct haemoglobin
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degradation (Dalton et al., 1995a). These endopeptidases exhibit a preference for 
cleavage of peptide bonds carboxyl to asparagine residues, hence the title 
“asparaginyl endopeptidases”. Such processing enzymes have yet to be identified in 
trypanosomatids but may be required for the maturation one or more of the lysosomal 
cysteine proteinases described in the next section.
1.3.1 Cysteine proteinases of trypanosomatids
Mammalian cathepsin L and cathepsin B are produced as pre-pro-proteins, where the 
nascent polypeptide is considerably larger than the mature enzyme (Mason, 1991). 
The short pre-domain, which is involved in targeting the newly synthesised pre-pro- 
proteinase to the endoplasmic reticulum (ER), is cleaved by a signal peptidase in the 
ER. The pro-region, which is immediately carboxyl to the pre- domain, is removed 
during trafficking (possibly by autoproteolysis) yielding the mature proteinase 
(Mason, 1991). The pro-region is thought to remain associated with the enzyme 
during trafficking, behaving as an inhibitor to prevent unwanted proteolysis (Carmona 
et a l, 1996).
The cysteine proteinases identified in L. mexiccma, which are also synthesised as 
preproproteins are lysosomal and can be placed in one of three groups depending on 
their structure and activity (Coombs and Mottram, 1997).
Type I cysteine proteinases are cathepsin L-like and are characterised by long C- 
terminal extensions of unknown function that are post-translationally removed (Souza 
et al., 1992; Mottram et a l, 1996a). Type I cysteine proteinases of L. mexicana are 
encoded by a tandemly arranged array of CPB genes with 19 copies. The various
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members of the array encode isoforms of CPB with subtly different substrate 
preferences and differential expression during L. mexiccma life cycle (Mottram et al., 
1997). Equivalent enzymes from T. brucei (Mottram et al., 1989) and the South 
American trypanosome, T. cruzi (Eakin et al., 1992) have also been identified and 
characterised.
The Type II CP of L. mexicana is encoded by a single copy gene, CPA, and is also a 
cathepsin L-like enzyme (Mottram et al., 1992). CPA has a short C terminal 
extension.
Type III CP is also encoded by a single copy gene, CPC (Bart et al., 1995). CPC is 
more closely related to mammalian cathepsin B than cathepsin L and shows marked 
differences in substrate preferences to CPB (Bart et al., 1995; Robertson and 
Coombs, 1993).
Trypanosome homologues of type II have not been identified but type III has been 
identified in T. cruzi (Nobrega et al., 1998).
The genes encoding the leishmanial cysteine proteinases have been knocked out by 
targeted gene disruption. The CPA null mutant has no obvious phenotypical 
difference to wild type cells (Souza et al., 1994), however, the CPC null mutant, 
whilst still able to infect mice, the survival rate within macrophages is lower (Bart et 
al., 1997). Disruption of the entire CPB gene array has produced interesting results 
(Mottram et al., 1996a). The CPB null mutants were still infective to mice albeit at 
greatly reduced levels and in vitro macrophage infectivity of these mutants is
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significantly less than wild type, implicating the Type I Cysteine proteinases as 
virulence factors (Mottram eta l., 1996a).
1.3.2 Metalloproteinases of trypanosomatids
GP63 is the major promastigote surface metalloproteinase of Leishmcmia and is also 
present in an intracellular form in amastigotes (Frommel et al., 1990). Like CPB, 
GP63 is encoded by multi copy genes located in a tandem array in L. major (Button 
et al., 1989). The L. mexicana promastigote enzyme is attached to the cell surface by 
a glycosylphosphatidylinositol anchor (see (Medina-Acosta et al., 1989) and Section 
1.4). The role of this enzyme is not clear although it has been implicated in the 
avoidance of complement-mediated lysis by promastigotes first exposed to the 
mammalian host (Brittingham et al., 1995; Joshi et al., 1998). It has also been 
suggested to have a role in macrophage entry, via the complement pathway by 
cleavage of a complement component to facilitate uptake by complement receptors 
on the macrophage surface (Brittingham et al., 1995). However, deletion of six of 
the seven genes from L. major does not appear to alter the ability of L. major 
promastigotes to enter and survive within macrophages either in vitro or in vivo 
(Joshi et al., 1998). Expression of the seventh gene occurs in metacyclic 
promastigotes and amastigotes, so perhaps the product of this gene alone is fulfilling 
the role of GP63 in macrophage entry. The abundance of GP63 on the promastigote 
surface suggests a role in interaction with the insect host (Coombs and Mottram, 
1997) however the L. major mutants lacking GP63 encoded by genes 1-6 were 
capable of infecting and developing within the sandfly (Phlebotomus argentipes) 
(Joshi etal., 1998).
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Homologues of GP63 have also been identified in African trypanosomes (El-Sayed 
and Donelson, 1997). A possible role proposed for a GP63 homologue in African 
trypanosomes, which do not exist intracellularly in their mammalian host is also in 
avoidance of complement-mediated lysis. Because, these cells exist in the blood of 
the host, exposure to the components of the complement pathway will be constant.
1.4 The glycosylphosphatidylinositols (GPIs)
Many cell surface proteins of eukaryotes are attached to the plasma membrane by 
way of a glycosylphosphatidylinositol (GPI) anchor. This method of attachment is 
used extensively by many species of parasitic protozoa including the trypanosomatids 
(McConville and Ferguson, 1993). The major surface metalloproteinase, GP63 of 
Leishmania and the variant surface glycoprotein (VSG) of African trypanosomes are 
GPI-anchored (described above). Many of the enzymes involved in GPI biosynthesis 
in mammals and yeast have been identified to date and some potentially exploitable 
differences have already been identified.
1.4.1 Protein-GPI biosynthesis in mammals, Saccharomyces cerevisiae and 
trypanosomes
The biosynthesis of GPI-protein anchors has received considerable attention over the 
last decade (Englund, 1993; McConville and Ferguson, 1993; Kinoshita et al., 1997; 
Stevens, 1995). The anchors are produced in the endoplasmic reticulum (ER), 
initially on the cytoplasmic face and then on the lumenal face of the ER membrane, in 
a series of enzyme catalysed reactions, before being transferred en bloc to protein 
precursors (Vidugiriene and Menon, 1993). Although the pathways are somewhat
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conserved between protozoa, yeast and humans, fundamental differences have, and 
continue to be discovered supporting the long-held belief that the GPI biosynthetic 
pathway will provide excellent anti-fungal and anti-protozoal drug targets 
(McConville and Ferguson, 1993). In this section, yeast, human and Trypanosoma 
brucei protein GPI anchor biosynthesis is considered. T brucei is included as a 
representative of the protozoan pathway, owing to the volume of research carried out 
with this organism, but reference is made to Leishmania where relevant. The process 
is summarised in Figure 1.2.
1.4.1.1 Addition of N-acetylglucosamine to phosphatidylinositol, the first step of 
GPI anchor biosynthesis
The first step in the biosynthetic pathway involves the addition of N- 
acetylglucosamine (GlcNAc) from a UDP-GlcNAc donor, to phosphatidylinositol 
(PI) (Doerring et al., 1989; Hirose et al., 1991). This has been studied in cell-free 
systems using radiolabelled GlcNAc together with mammalian cell lysates and purified 
microsomes as well as with yeast membranes (see (Stevens, 1995)). GlcNAc is 
soluble in aqueous solution until it becomes complexed with PI. Interestingly, this 
simple step requires four proteins in mammals and at least three in yeast (Watanabe et 
al., 1998; Tiede et al., 1998; Inoue et al., 1996). The human proteins initially 
identified are known as PIG-A, PIG-C, PIG-H, so-called because of the name given 
to classes of human mutant cell lines defective in GPI-anchoring ability and all three 
classes were found to be defective in GlcNAc transferase activity (Stevens and Raetz, 
1991; Sugiyama et al.y 1991) and GPI1.
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The human PIG-A gene was cloned by complementation of the mutant phenotype by 
a stretch of cDNA including the gene leading to the restoration of GPI-anchored 
proteins (Miyata et al., 1993). The human disease known as paroxysmal nocturnal 
haemoglobinuria, which is attributed to defects in GPI-anchor biosynthesis is caused 
by a mutation in the PIG-A gene (Takeda et a l, 1993). A homologue of this gene, 
GPI3, has been identified in S. cerevisiae by complementation of a temperature- 
sensitive mutant defective in GlcNAc transferase activity (Vossen et al., 1995; 
Leidich et al., 1995). These cells were unable to incorporate [3H]inositol into 
proteins at non-permissive temperatures. The yeast mutant lacked in vitro GlcNAc 
transferase activity (Leidich et al., 1995). Characterisation of GPI3 revealed 
significant homology of the predicted product to PIG-A (44% identity). Homology 
to a bacterial GlcNAc transferase (RFAK) was identified also (Vossen et al., 1995) 
leading to the proposal that PIG-A is the catalytic subunit of the multi-protein 
complex. PIG-A is a 484 amino acid (54kDa) ER-membrane protein with a large 
cytoplasmic domain (Watanabe etal., 1996), a short ER-transmembrane domain and 
a lumenal domain at the carboxyl-terminus. This domain is required for activity of the 
protein, probably because of its role in targeting the protein to the rough ER 
membrane (Watanabe et al., 1996).
The second protein component of the GlcNAc transferase machinery is PIG-C and 
the yeast homologue is Gpi2p, sharing about 20% identity with one another (Leidich 
et al., 1995; Inoue et al., 1996). This protein is also an ER-membrane protein, 
lacking the ER-signal peptide and is extremely hydrophobic, possessing 6 or 7 
potential transmembrane domains. One of the features of in vitro mammalian 
biosynthesis is that the source of PI is important for the activity of the GlcNAc
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transferase complex (Watanabe et al., 1998). For example, bovine PI was found to 
be a 100 fold more efficient substrate than soybean PI and the lyso form of bovine PI 
was a poor substrate. This suggests that the GlcNAc transferase complex is capable 
of recognising PI fatty acyl chains and the hydrophobic nature of PIG-C/Gpi2p means 
that this protein could be involved in this (Watanabe et a l, 1998).
PIG-H is the third component of the mammalian GlcNAc transferase, and 
interestingly, a yeast homologue for this protein has not been identified, despite the 
fact that sequencing of the S. cerevisiae genome is now complete (see Nature 
supplement, 29 May 1997). The human gene was cloned by complementation of the 
mutant class H with a cDNA encoding a 188 amino acid cytosolic protein (Kamitani 
et al., 1993). This protein was found to interact with PIG-A by the co-purification of 
tagged PIG-A and PIG-H that were coexpressed (Watanabe et al., 1996). 
Association of the protein with the cytoplasmic face of the ER was demonstrated by 
copurification with microsomes and sensitivity to proteinase K treatment. The role of 
PIG-H is not clear because it has no significant homology to any known protein.
A third GlcNAc-defective yeast mutant, gpil, was identified (Leidich et al., 1994) 
and complementation of this mutant by a S. cerevisiae genomic library led to the 
isolation of the GPI1 gene (Leidich and Orlean, 1996). The sequence predicted a 609 
amino acid, membrane protein with 5 potential transmembrane domains and, as with 
Gpi2p and Gpi3p, the protein lacks an ER-signal peptide. Disruption of this gene was 
found to block [3H]inositol incorporation into proteins at non-permissive 
temperatures (37°C) but that at permissive temperature, incorporation was 
approximately 40% that of wild type (Leidich and Orlean, 1996). Overexpression of
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GPI2 in the gpiJ mutant partially rescued the temperature-sensitive phenotype 
suggesting that excess Gpi2p was, in some way, partially fulfilling the role of Gpilp 
(Leidich et al., 1995). More recently, the human and mouse genes have been cloned 
(Watanabe et al., 1998; Tiede et al., 1998). Both the human and mouse proteins 
have 581 amino acids and share 24% identity with S. cerevisiae Gpilp (and 85% with 
one another). Tiede and co-workers (1998) demonstrated that overexpression of the 
human gene in the yeast gpil mutant allowed the cells to grow at 30°C but not 37°C 
and marginal GlcNAc transferase activity was detected. By contrast, overexpression 
of the mouse gene resulted in greater recovery of the temperature-sensitive 
phenotype, probably because mouse GPU has a higher level of sequence identity to 
yeast Gpilp than human GPU. 50% GlcNAc transferase activity was detected when 
the mouse gene was overexpressed.
Watanabe and co-workers investigated interactions of the human homologue of GPI1 
with the other GlcNAc transferase components in a mammalian system (Watanabe et 
al., 1998). It was earlier demonstrated that tagged versions of PIG-A and PIG-H, 
when coexpressed interacted with one another, albeit weakly (Watanabe et al., 1996). 
GST-tagged hGPIl was coexpressed with FLAG-tagged PIG-A and precipitated with 
anti-GST antibodies. PIG-A was coprecipitated with hGPIl. This was repeated for 
PIG-H and PIG-C and in each case, a direct interaction with GPU was observed. A 
direct association of PIG-C with either PIG-A or PIG-H could not be demonstrated. 
When combinations of GPI1, PIG-A and PIG-H and PIG-C (all GST-tagged) were 
coexpressed with FLAG-tagged PIG-C, all four proteins were co-precipitated with 
anti-FLAG antibodies. Further, they precipitated in approximately 1:1 ratios. Cells 
were transfected with GST-tagged versions of PIG-A, PIG-C, PIG-H and hGPIl
individually and complexes were collected on glutathione beads. All four tagged 
proteins yielded purified complexes with GlcNAc transferase activity. These results 
provided evidence that these proteins form the GlcNAc transferase complex. The 
role of GPU in the complex has become slightly clearer with the finding that 
disruption of mouse GPI1 caused the PIG-A, PIG-C and PIG-H complex to become 
virtually undetectable (Hong et al., 1999). PIG-A and PIG-H complexes were readily 
detected but complexes of PIG-C and PIG-H were not. Therefore, GPU appears to 
have a role in stabilising the complex by keeping PIG-C associated with PIG-A and 
PIG-H (Watanabe et al., 1998).
It remains a possibility that there are other, as yet, unidentified components of the 
GlcNAc transferase complex, but the fact that this relatively simple step requires four 
proteins (three in yeast) seems to be a feature of much of the GPI anchor biosynthetic 
machinery.
These findings are in agreement with the previously predicted topology of the early 
stages of GPI-anchor biosynthesis (Vidugiriene and Menon, 1993). When 
permeabilised cells that had incorporated UDP-[3H]G1cNAc were treated with PI 
specific-phospholipase C (a bacterial enzyme that cleaves the phosphate-lipid bond 
between inositol and the lipid component of GPI anchors), the radiolabelled GlcNAc- 
PI was cleaved. This shows that the newly synthesised GlcNAc-PI is located on the 
cytoplasmic face of the ER. A similar result was obtained with purified microsomes. 
It was concluded that the early steps of GPI-anchor biosynthesis occur on the 
cytoplasmic side of the ER membrane (Vidugiriene and Menon, 1993).
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Although none of the genes involved in GPI-anchor biosynthesis have been identified 
in Trypanosoma brucei to date, it was in this species that the structure of a GPI 
anchor was first elucidated (Ferguson et al., 1985; Ferguson et al., 1988). 
Furthermore, it was with African trypanosomes that the biosynthetic pathway of GPI 
anchors was first solved (Mayor et al., 1990a; Mayor et al., 1990b; Masterson et al.,
1989). A cell-free system was used with radiolabelled substrates leading to the 
identification of several of the GPI intermediates. As with mammals and yeast, the 
first step of African trypanosome GPI biosynthesis is the addition of GlcNAc to PI 
(Doering et al., 1989). This step has also been observed using a Leishmania major 
cell free system (Smith et al., 1997).
1.4.1.2 The second step of GPI biosynthesis is the rapid deacetylation of 
GlcNAc-PI
The acetyl group attached to glucosamine is removed after its addition to PI, a step 
that is common to mammals, yeast and protozoa. Mammalian cell lines deficient in 
the deacetylation step have been described (Mohney et al., 1994; Stevens et al.,
1996). Another mutant cell line (Chinese hamster ovary (CHO) cells), designated 
class L, was found to accumulate GlcNAc-PI but no GlcN-PI (Nakamura et al.,
1997). This phenotype was complemented by expression of a rat cDNA in the 
mutant CHO cells; [3H]G1cNAc incorporation allowed detection of GlcN-PI 
synthesis. Furthermore, overexpression of this cDNA led to a higher degree of 
deacetylation than that observed in wild type cells (Nakamura et al., 1997). The 
cDNA encodes a predicted 252 amino acid protein, designated PIG-L, with a 
hydrophobic domain at the N-terminus. This domain is retained by the mature
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protein, which is localised to the cytoplasmic side of the ER membrane, as determined 
by sensitivity of the protein to proteinase K treatment of purified microsomes, 
indicating that the domain probably serves as an ER transmembrane region 
(Nakamura et al., 1997). This is, once again, in agreement with the predicted 
topology of this step in the biosynthetic pathway (Vidugiriene and Menon, 1993). A 
304 amino acid S. cerevisiae homologue, Gpil2p, has been identified based on 
sequence similarity, sharing 24% identity to rat PIG-L (Nakamura et al., 1997; 
Watanabe et al., 1999). Expression of this protein in the class L mutant restored the 
surface expression of the GPI-anchored protein CD59, demonstrating the inter­
species conservation of GPI-anchor biosynthesis. A DNA fragment of the human 
homologue had been identified by sequencing of expressed sequence tags (ESTs), 
leading to the production of a full length ORF by PCR (Watanabe et al., 1999). This 
was also demonstrated to be able to rescue the class L mutant phenotype, restoring 
CD59 surface expression. The ORF predicted a 252 amino acid protein with 77% 
identity to rat PIG-L (Watanabe et al., 1999). In vitro GlcNAc-PI de-N-acetylase 
activity was shown for both Gpil2p and hPIG-L, confirming complementation. 
Disruption of S. cerevisiae GPI12 is lethal.
Deacetylation of GlcNAc-PI also occurs in T. brucei (Doering et al., 1989) and L. 
major (Smith et al., 1997). The T. brucei homologue of PIG-L/GPI12 was partially 
purified by liquid chromatography (Milne et al., 1994). Differences between the 
substrate specificity of the human and T. brucei enzymes have been determined 
suggesting that this enzyme could be exploited as an anti-trypanosomal drug target 
(Sharma et al., 1999b).
18
There is no evidence for a physical interaction between PIG-L and the complex 
containing PIG-A, PIG-C, PIG-H and GPU suggesting that the GlcNAc-PI de-N- 
acetylase machinery of mammals is distinct from the GlcNAc transferase complex 
catalysing the first step of GPI biosynthesis (Watanabe et al., 1998). At the time of 
writing, the PIG-L protein is the only protein identified as being involved in the 
second step of GPI biosynthesis. If the de-N-acetylase is a complex then the other 
components have yet to be identified.
1.4.1.3 Inositol acylation is the third step of mammalian and yeast GPI 
biosynthesis but is not obligatory in trypanosomes
The next step in mammalian and yeast biosynthesis involves the acylation of the 
GlcN-PI precursor. The addition of palmitic acid (palmitoylation) to the inositol 
component of the GPI-anchor has been reported to precede the addition of the 
mannose residues in both yeast and mammals (Costello and Orlean, 1992; Urakaze et 
al., 1992). Blockage of mannosylation, the fourth step of biosynthesis, leads to a 
buildup of GlcN-acyl-PI, the inositol-acylated form of GlcN-PI. The mannosylation 
of non-acylated GlcN-PI could be observed in vitro in both yeast and human but at 
lower efficiency than the acylated precursor (Doerrler et al., 1996). Deacylation of 
the anchors is observed after addition to protein (Chen et al., 1998a). The GlcN-PI 
acyl transferase has yet to be identified.
Palmitoylation also occurs in T. brucei with the VSG anchors (Krakow et al., 1989; 
Mayor et al., 1990b) eventually yielding a completed precursor designated glycolipid 
C. Glycolipid A is the non-acylated form of glycolipid C. The first major divergence
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between the biosynthetic pathways of mammals/yeast and trypanosomes is evident at 
this stage. Where the acylation of GlcN-PI is necessary for biosynthesis to proceed in 
mammals and yeast, it does not appear to be a requirement in T. brucei (Guther et al., 
1994). Rather, the acylated and non-acylated forms appear to be in dynamic 
equilibrium with one another. The acylation/deacylation of the GPI precursor appears 
also to be stage regulated (Field et al., 1991; Field et al., 1992). The major GPI- 
linked glycoprotein of insect stage T. brucei is procyclic acidic repetitive protein 
(PARP) and the mature GPI-anchor attached to PARP is resistant to PI-PLC 
indicating inositol acylation (Field et al., 1991). By contrast the VSG anchor is PI- 
PLC-sensitive and lacks such acylation of the mature GPI anchor (Mayor et al., 
1990a; Mayor et al., 1990b). It has been proposed that inositol acylation and 
deacylation are important for later steps of GPI biosynthesis, namely ethanolamine 
addition and remodelling of the GPI-lipids respectively (Guther and Ferguson, 1995). 
Inhibition of the, as yet, unidentified inositol deacylase with 
diisopropylfluorophosphate (DFP) leads to a buildup of glycolipid C', an immature 
precursor to the completed GPI that has yet to complete fatty acid remodelling (see 
below). The inositol acyltransferase, which is sensitive to phenylmethylsulphonyl 
fluoride (PMSF) prevents addition of ethanolamine but does not affect fatty acid 
remodelling (Guther et al., 1994).
To date, inositol acylated precursors have not been detected in Leishmania (Smith et 
al., 1997).
1.4.1.4 The sequential addition of three mannose residues encompasses the 
fourth, fifth and sixth steps of GPI anchor biosynthesis
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The mannose donor to GPI biosynthesis, dolichol phosphate mannose or Dol-P-man 
is produced by the transfer of mannose from GDP-Man to Dol-P by the enzyme 
dolichol phosphate mannose synthase or DPMS (Orlean, 1990). S. cerevisiae 
DPMS1 has been cloned (Orlean et al., 1988) and a human homologue has also been 
identified (Colussi et al., 1997) although there is a fundamental difference between 
the homologues; yeast Dpmslp possesses a carboxyl terminal hydrophobic domain 
that is absent in human DPMS1.
DPMS has also been isolated and characterised from T. brucei (Mazhari-Tabrizi et 
al., 1996) and L. mexicana (Ilgoutz et al., 1999a). As with the S. cerevisiae protein, 
both TBDPMS and LMDPMS possess a carboxyl-terminal hydrophobic domain. The 
T. brucei gene was cloned by complementation of a yeast temperature-sensitive 
mutant, defective in the endogenous DPMS and TBDPMS shares nearly 50% identity 
with the yeast protein demonstrating the evolutionary conservation of the process 
(Mazhari-Tabrizi etal., 1996).
The glycosyltransferases responsible for the addition of the first and second mannose 
residues have not been identified. A candidate protein involved in the transfer of the 
third mannose residue, however, has been identified. Human PIG-B was cloned by 
complementation of class B mutant (Takahashi et al., 1996). This mutant 
accumulates a GPI precursor which contains two of the three mannose residues and 
expression of the PIG-B cDNA allows transfer of the third mannose and the 
remaining steps in biosynthesis to occur. PIG-B is a 554 amino acid ER protein. 
Proteinase K treatment revealed that most of the protein (approximately 85%) is 
contained within the lumen of the ER but that a relatively large amino-terminal
21
cytoplasmic domain (approximately 60 amino acids) is also present. This domain is 
not necessary for PIG-B activity. Interestingly, the protein appears to lack any ER- 
signal peptide and it is not clear how the protein is localised to the ER. It is not 
known if PIG-B is the GPI mannosyl transferase 3 (GMT3) itself, or if it is a subunit 
of a GMT3 complex. The yeast homologue has been cloned and was designated 
GPI 10 (Sutterlin et a l, 1998). GpilOp and PIG-B are functional homologues since 
PIG-B was able to rescue the lethal effect of GPI 10 disruption (Sutterlin et al,
1998). The yeast protein, which is highly hydrophobic has homology to another yeast 
protein, ALG9 that is required for addition of mannose in a  1-2 linkage to N-glycans 
(Canivenc-Gansel et a l, 1998).
The orientation of PIG-B would suggest that at some stage between the deacetylation 
of GlcNAc-PI and the addition of the second mannose, the GPI precursors are flipped 
to the lumenal face of the ER membrane in yeast and mammals. This is in contrast 
with findings in T. brucei where it was reported that it is probably a later GPI- 
intermediate that is translocated across the ER membrane (Vidugiriene and Menon, 
1994). Cloning of a T. brucei PIG-B homologue would help to confirm or dispute 
these findings.
Both the trypanosome and human GMT3 appear to be inhibited by mannosamine (2- 
amino-2-deoxy D-mannose (Lisanti et a l, 1991). The mannosamine (ManN) is 
utilised in GPI biosynthesis to produce ManN-Man-GlcN-PI in trypanosomes (Ralton 
et al, 1993). This confirms that blockage of the GPI biosynthetic pathway occurs 
after addition of the first two mannose residues and, since the third mannose residue
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is attached via an a  1-2 linkage, replacement of the hydroxyl on position 2 of ManN 
with an amine group means that this bond cannot be formed.
1.4.1.5 The addition of ethanolamine phosphate to Manal-2Manal-6Manal- 
4GlcN-PI
The final mammalian GPI precursor contains at least one ethanolamine phosphate 
group (Kamitani et al., 1992). Class F mutant cells are defective in the attachment of 
ethanolamine to the third mannose, however, ethanolamine is still incorporated into 
the other mannoses of the GPI precursor (Hirose et al., 1992). One protein has been 
identified as being involved in ethanolamine phosphate addition, PIG-F (Inoue et al.,
1993). The addition of extra ethanolamine groups to the other mannosyl groups is 
not confined to mammals; the yeast mutant gpilO-1 demonstrates a buildup of GPI 
precursor with the first two mannosyl groups added and has an ethanolamine 
phosphate group attached to the first mannose (Canivenc-Gansel et al., 1998).
In T. brucei it has been shown that donation of the terminal ethanolamine phosphate 
group is made by phosphatidylethanolamine (Menon et al., 1993). Another difference 
between GPI biosynthesis of mammals/yeast and trypanosomes is that the addition of 
extra ethanolamine phosphate groups to the other mannose residues does not occur in 
trypanosomes. The addition of the ethanolamine group appears to be enhanced by 
the acylation of inositol (Guther and Ferguson, 1995). The GPI precursors have to 
undergo one more step in biosynthesis at which stage they are ready for transfer to 
specific nascent polypeptides.
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1.4.1.6 Fatty acid remodelling of GPI anchors represents the final step in the 
biosynthetic pathway
This step in biosynthesis was first observed in African trypanosomes where the 
existing lipids of the PI component of the VSG anchor are replaced sequentially with 
myristic acid (Masterson et al., 1990). Myristate is donated by myristoyl-lyso- 
phosphatidylcholine (M-LPC) via myristoylCoA in an ATP-dependent reaction 
(Werbovetz and Englund, 1996). The ATP is thought to be required for the 
hydrolytic cleavage of myristate from M-LPG prior to myristoylation of the GPI 
anchor. Yeast GPI anchors also undergo such fatty acid remodelling steps (Sipos et 
al., 1997). Incorporation of ceramide and other long chain fatty acids can occur in 
the ER and further ceramide remodelling can occur later in the secretory pathway, in 
the Golgi apparatus. Remodelling within the ER occurs in the absence of protein 
synthesis where no anchor incorporation into protein takes place (Reggiori et al.,
1997).
The GPI anchors can be further modified by the addition of glycan side chains after 
transfer of the anchor to nascent polypeptide although this is thought to begin in the 
ER and is continued in the Golgi complex (McConville and Ferguson, 1993).
1.4.2 The cell surface molecules of Leishmania
There are three main types of molecule present on the cell surfaces of Leishmania 
species (Figure 1.3):
• Cell surface proteins that are covalently attached at their carboxyl terminus to 
glycosylphosphatidylinositol (GPI) membrane anchors.
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• Lipophosphoglycans (LPGs) that are complex carbohydrates attached to the cell 
surface via GPI anchors
• Glycoinositolphospholipids (GIPLs) that are essentially free GPI structures.
1.4.2.1 GPI anchored proteins
The major surface metalloproteinase of Leishmania promastigotes, GP63, is attached 
to the cell surface by a GPI anchor (Medina-Acosta et al., 1989; Schneider et al.,
1990). This is the most abundant GPI-linked protein of this organism, with around 
5x10s copies per cell. Possible roles of this protein are discussed in Section 1.3.2.
A second GPI-linked promastigote surface protein is promastigote surface antigen 2 
(PSA2) also referred to as GP46 (Lohman et al., 1990; Murray et al., 1989). Three 
antigenically similar polypeptides of 96, 80 and 50kDa represent the PSA2 
polymorphic family (Handman et al., 1995; Symons et al., 1994). The roles of these 
proteins are as yet unknown.
Expression of these GPI-linked proteins on the surface of amastigotes is strongly 
downregulated (Bahr et al., 1993; Handman et al., 1995). No GPI anchored proteins 
have been positively identified to date in amastigotes.
1.4.2.2 Lipophosphoglycans (LPGs)
Leishmania species possess other types of GPI structures that are not protein-linked 
(McConville and Ferguson, 1993). Lipophosphoglycans are phosphoglycans attached 
to a novel GPI anchor that is structurally quite distinct from protein-linked GPIs 
(Figure 1.3). The anchor contains the common GPI motif Manal-4GIcN-PI but the
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second mannose is attached via an a  1-3 linkage, rather than the a  1-6 bond seen in 
protein GPIs (Figure 1.3) (McConville and Ferguson, 1993). Instead of the third 
mannosyl residue, present in the protein GPI anchor, a galactofuranose residue is 
attached to the second mannose followed by two galactose residues and the 
phosphoglycan component of the LPG. The phosphoglycan component consists of 
variable numbers of disaccharide repeats
The LPGs of Leishmania are important for the survival of this organism in both the 
insect and mammalian host (Beverley and Turco, 1998). They are present in high 
copy number, (approximately 6xl06 molecules per cell) in promastigotes but, like 
GPI-anchored proteins, are downregulated in amastigotes of L. donovani 
(McConville and Blackwell, 1991). This stage-specific expression is also observed in 
L. mexicana and L. major (Bahr et al., 1993) and the promastigote LPG glycocalyx 
protects the parasite from the harsh hydrolytic environment of the sandfly midgut 
(McConville, 1997).
LPGs have been implicated in survival and development in the sandfly (Pimenta et al., 
1992; Pimenta et al., 1994). In L. donovani the LPGs in metacyclics are elongated 
compared with procyclic promastigotes, however this would not prevent binding of 
the LPG to lectin receptors on the midgut epithelial cells since the sugars on the end 
of the phosphoglycan units that interact with receptors (capping sugars) are the same 
(Butcher et al., 1996). Rather, folding and clustering of the ends of the metacyclic 
phosphoglycan units blocks access of the lectin receptors to the, now buried, capping 
sugars (Sacks et al., 1991). This LPG elongation is also observed in L. major but it is 
thought to be the nature of side chains along the length of the phosphoglycan repeats
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which differ between procyclic promastigotes and metacyclic promastigotes 
(McConville et al., 1992; McConville, 1997). It is thought that these differences in 
LPG structure and sandfly epithelial receptor specificity are fundamental in 
determining which species of sandfly a particular species of Leishmania can infect 
(Pimenta et al., 1994). Thus the geographical distribution of Leishmania species is 
reliant on the range of the insect vector.
LPGs are also thought to be involved in the avoidance of complement mediated lysis 
by promastigotes within the mammalian host (McConville, 1997). Interaction with 
components of the complement pathway by metacyclic promastigotes leads to 
opsonization and preferential uptake by host macrophages via complement receptors 
on the surface of macrophages (McConville and Ferguson, 1993; Mauel, 1996; 
Puentes et al., 1990). There is also evidence to suggest that LPGs may interact 
directly with macrophages to facilitate entry (Kelleher et al., 1992). Upon 
phagocytosis, the accompanying macrophage respiratory (oxidative) burst is 
depressed by Leishmania promastigotes. This is facilitated by LPG, which is a potent 
inhibitor of protein kinase C activity (McNeely and Turco, 1987), an enzyme 
correlating with macrophage oxidative burst (Mauel, 1996).
1.4.23 Glycoinositol phospholipids (GIPLs)
GIPLs are free GPI structures and represent the most abundant cell surface molecules 
of Leishmania promastigotes and amastigotes with approximately 107 molecules per 
cell. The survival of amastigotes in the harsh environment of the lysosome-derived 
parasitophorous vacuole is thought to be due to the network of hydrogen bonds 
existing between the GIPLs acting as a protective glycocalyx (Winter et al., 1994;
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McConville, 1997; McConville and Blackwell, 1991). Recent work by Mensa- 
Wilmot and co-workers identified two putative, ethanolamine phosphate-containing 
GIPLs that were significantly less abundant when exogenous GPI-PLC was expressed 
in L. amazonensis (Mensa-Wilmot et al., 1999). Growth of these cells in host 
macrophages (in vitro) was arrested and hamster infections produced smaller lesions 
and fewer parasites than wild type cells suggesting that free GPIs are important to 
amastigote viability. This is in agreement with the findings of Ilgoutz, McConville 
and co-workers (1999a) who demonstrated (albeit indirectly) that GEPLs were 
essential to survival of L. mexicana.
1.4.3 Biosynthesis of protein GPI, LPGs and GIPLs in Leishmania 
The biosynthesis of GPI anchored proteins in Leishmania appears to parallel that of 
African trypanosomes, considered in previous sections. Many of the early 
intermediates in protein GPI biosynthesis have been detected in a L. major cell free 
system (Smith et a l, 1997).
Because protein GPI anchors, LPGs and GEPLs share the common motif Manal- 
4GlcN-PI, it might be predicted that their biosynthesis shares some of the early 
biosynthetic steps (see Section 1.4.1 for details of these steps for protein GPI 
biosynthesis). Whilst protein and LPG anchors do appear to share some early steps, 
the nature of the lipids in PI component of the early GEPL intermediates, differs from 
those in protein and LPG anchors, indicating that the GIPL PI is derived from a 
distinct PI pool in L. mexicana (Ralton and McConville, 1998). Some GEPLs have an 
ethanolamine phosphate group added to the second mannosyl, a modification that 
appears to be unique to GEPL biosynthesis, providing further evidence of the discrete
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nature of GIPL biosynthesis from that of protein and LPG GPIs. This ethanolamine 
transfer is more commonly found in amastigote GIPLs (Winter et al., 1994).
Protein and LPG anchors do seem to share the same common intermediates during 
the early stages of GPI biosynthesis in L. mexicana promastigotes, up to and 
including the addition of the first mannosyl group to GlcN-PI (Ralton and 
McConville, 1998). The linkage between the second and the first mannosyl groups of 
protein GPI anchors is a  1-6 compared with a  1-3 in LPGs, suggesting that the 
divergence between the biosynthetic pathways occurs at this stage (Figure 1.3). The 
remainder of LPG biosynthesis requires a series of glycosyltransferases for the 
addition of the remaining sugars (galactofuranose, galactose, and glucose phosphate 
side chain) and probably occurs in the Golgi, rather than the ER (Ha et al., 1996). 
The fatty acid remodelling of protein GPIs and LPGs is also somewhat different in 
that the end product of LPG remodelling is an unusual lyso species, lacking an acyl 
chain (as seen in Figure 1.3 and (Ralton and McConville, 1998)). There is also 
evidence to suggest that the GPI biosynthetic enzymes are located within a 
subcompartment (the dolichol phosphate mannose synthase tubule) of the ER in L. 
mexicana, associated with DPMS (Ilgoutz et al., 1999b). The latter enzymes in 
protein GPI anchor biosynthesis (and the type I GIPLs), including the 
mannosyltransferases and the ethanolamine phosphotransferase as well as the fatty 
acid remodelling machinery co-localises with DPMS in this tubule, which appears to 
associate with both the Golgi and the bulk ER. The LPG anchor precursors are 
thought to complete assembly in the Golgi where the galactofuranosyltransferase is 
located, as disruption of the DPMS tubule association with the Golgi leads to a
29
buildup of a LPG precursor (Ilgoutz et al., 1999b). This suggests that there is 
transfer of material between the DPMS tubule and the Golgi.
1.4.4 The attachment of protein GPI anchors to nascent polypeptides
The final step in protein GPI anchor biosynthesis is the attachment of the complete 
anchor to proteins that are destined to undergo this post-translational modification. 
But how does this take place and why do particular proteins undergo anchor 
attachment while others do not? This section describes the nature of the GPI signal 
sequence and the evidence to support the idea that the addition of the anchor is 
mediated by a transamidation mechanism, catalysed by a GPI:protein transamidase.
1.4.4.1 The GPI anchor signal sequence of nascent polypeptides
Proteins that are destined to receive a GPI anchor are synthesised as pre-pro-proteins 
(Figure 1.4). At the amino-terminus, there is a hydrophobic domain of approximately 
30 amino acids that is an ER-signal sequence removed by signal peptidase on entry to 
the ER. There is another hydrophobic domain at the C-terminus of such proteins. 
Deletion of this 17 amino acid hydrophobic domain from decay accelerating factor 
(DAF; a human membrane glycoprotein) leads to its secretion (Caras et al., 1989) 
indicating that this domain has a role in keeping the protein associated with the ER 
membrane until processed.
Human placental alkaline phosphatase (PLAP), which is a 530 amino acid protein, is 
processed to a membrane protein of 484 amino acids containing ethanolamine, 
glucosamine, mannose, inositol and the lipids palmitate and stearate (Ogata et al., 
1988). The phosphatidylinositol anchor is attached to an aspartic acid residue at
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position 484 indicating that a 29-amino acid peptide is cleaved from the nascent 
enzyme (Micanovic et al., 1988). A cell-free system involving the use of site specific 
antibodies that recognised three different epitopes within the nascent PLAP (Bailey et 
al., 1988) was developed to investigate the processing of the immature protein 
(Bailey et al., 1989). The assay was based on the addition of PLAP mRNA to rabbit 
reticulocyte lysate, which contains all the necessary machinery for mRNA translation 
(except endogenous methionine) plus [35S]methionine, in the presence and absence of 
microsomes. Proteinase treatment of the microsomes demonstrated that PLAP was 
sequestered into the microsome lumen. The use of the site-specific antibodies 
demonstrated that nascent PLAP is processed at both the amino and carboxyl termini 
and that this processing was almost certainly specific, rather than caused by random 
proteolysis events (Bailey et al., 1989).
It was evident that there was more to the GPI signal than the hydrophobic domain 
and the region 10-20 amino acids N-terminal to the hydrophobic domain is also 
important (Caras et al., 1989). A 28 amino acid oligopeptide is removed from DAF, 
very similar in size to the removed PLAP signal, confirming the importance of the 10- 
20 amino acid domain N-terminal to the hydrophobic domain, which contains the 
cleavage/attachment site (Moran et al., 1991). The cleavage/attachment site was 
designated co (omega). Transfer of the 37 C-terminal amino acids of DAF (which 
included the hydrophobic domain and the 20 amino acids N-terminal of it) to the 
carboxyl end of proteins such as the herpes glycoprotein gD-1 (Caras et al., 1987) or 
the normally secreted human growth hormone (Caras et al., 1989) resulted in both 
proteins being directed to the plasma membrane. Anchor attachment was confirmed 
in both cases by release of the proteins by PI-PLC and incorporation of
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[3H]ethanolamine. The residue of anchor attachment to DAF was identified as 
Ser319 and this residue was replaced in the hGH-DAF fusion protein by all of the 
remaining possible amino acids by site directed mutagenesis. This demonstrated that 
particular amino acids could serve as acceptors for GPI anchors, namely alanine, 
aspartate, asparagine, glycine and serine; generally amino acids with small side chains, 
although cysteine can receive a GPI anchor when Asp484 of PLAP is replaced 
(Micanovic et al., 1990). Replacement with other amino acids, including cysteine, 
blocked GPI anchor addition and cell surface transport of hGH-DAF.
The co site was investigated by the conversion of a non-functional GPI signal, which 
was added to hGH-DAF, to a functional one (Moran and Caras, 1991a). The region 
N-terminal to the hydrophobic domain of the DAF signal sequence is 
serine/threonine-rich. Replacement of this region in the hGH-DAF fusion protein, 
with a serine/threonine-rich domain (involved in O-glycosylation) from an unrelated 
protein was insufficient to direct GPI anchor attachment (Moran and Caras, 1991a). 
Mutation of a valine residue at the equivalent position to Ser319 of the “natural” 
hGH-DAF GPI signal is insufficient to facilitate GPI anchor attachment, however, if 
the residue immediately carboxyl to this is also mutated, to glycine, then GPI 
anchoring is restored. The second residue was mutated to a bulky amino acid, 
phenylalanine, and GPI anchoring was, once again, defective. Furthermore, the 
position of the cleavage/attachment site, relative to the hydrophobic domain is also 
important (Moran and Caras, 1991a). The serine/glycine residues were placed at 
different distances from the hydrophobic domain, 2, 4, 6, 9, 12 and 16 residues N- 
terminal to the start of the domain, but processing was only observed when the 
Ser/Gly was 12 amino acids away. This was confirmed by the absence of
32
[3H]ethanolamine incorporation in all but the 12 residue-spacer protein. The data 
suggested that the structure of the hydrophobic and hydrophilic spacer domains of the 
signal were unimportant. Rather, they are there simply to provide hydrophobic and 
hydrophilic regions and the only region where sequence is important is the cleavage 
attachment site. Further evidence for this idea was provided by the production of 
functional, synthetic GPI signals by the fusion of sequence elements not normally 
involved in GPI anchor signalling (Moran and Caras, 1991b). In other words, 
hydrophilic spacers and hydrophobic regions not found in GPI signal sequences made 
up a functional GPI signal. Furthermore, as well as the residue to which the anchor is 
attached (go ), two residues carboxyl to this (© + 1 and co + 2) also exert an influence 
(Kodukula et al., 1993).
A more detailed analysis of the co site revealed that there are variations between 
species at this portion of the GPI signal sequence (Moran and Caras, 1994). When 
the VSG of T. brucei was expressed in mammalian (COS) cells, only very low levels 
of GPI-anchored VSG were detected on the cell surface. By contrast, fusion of the 
DAF GPI signal to VSG had the effect of high level surface expression of GPI- 
anchored VSG-DAF. The VSG GPI signal was fused to hGH (hGH-VSG) and was 
compared with hGH-DAF. Almost 20 fold lower GPI anchor attachment was 
observed with hGH-VSG than with hGH-DAF as determined by incorporation of 
[3H]ethanolamine. These data indicated that VSG was capable of receiving a GPI 
anchor (it was correctly folded), but that the lack of anchoring could be attributed to 
incompatibility of the natural VSG GPI anchor attachment site (Moran and Caras,
1994). To further investigate this, the DAF © site and spacer region was fused to the 
VSG hydrophobic domain and added to hGH resulting in GPI-anchored surface
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expression. The reverse protein (VSG © site and spacer region, with the DAF 
hydrophobic domain), was neither surface expressed nor GPI-anchored. Analysis of 
the © site residues (©, ©+1 and ©+2) indicated that the differences could be attributed 
to the bulkiness of the amino acids. It was proposed that the mammalian enzyme that 
catalyses the removal of the signal and addition of the GPI anchor could have trouble 
accommodating the bulky residues of the VSG © site in its binding pocket. If this is 
true, then the trypanosome enzyme may have a larger binding pocket than its 
mammalian counterpart, meaning that this enzyme could be a potential target for anti- 
parasite chemotherapy (Moran and Caras, 1994).
1.4.4.2 Evidence that a GPI: protein transamidase catalyses GPI signal cleavage 
and anchor addition
The removal of the GPI signal sequence and its replacement with the preformed GPI- 
anchor is required for the correct expression of this type of cell surface protein. 
Removal of the signal allows the newly exposed carboxyl residue to be attached to 
the amino group of the ethanolamine portion of a GPI anchor via a peptide bond. It 
has been predicted that, the simplest model of anchor attachment is one that is 
catalysed by a GPI:protein transamidase (Ferguson and Williams, 1988). This could 
be brought about by a transamidation mechanism where the peptide bond between the 
© residue and the GPI signal is broken and a new peptide bond is formed 
simultaneously between the protein and the GPI anchor. Alternatively, more than one 
enzyme could be involved: a proteinase to cleave the GPI signal and a transferase to 
form a new peptide bond between the protein and the anchor (Ferguson and Williams,
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1988). One important consideration is that transamidation would not require energy 
whereas proteolytic cleavage followed by transferase activity would.
The method described above for the demonstration of GPI anchor attachment to 
PLAP was modified to include a simpler substrate based on PLAP (Kodukula et al.,
1991) for the study of mammalian transamidase activity. The engineered form of 
PLAP, preprominiPLAP contains both the ER signal peptide and the GPI signal but 
lacks glycosylation sites, and the active site. The smaller protein size means that 
small variations in protein size, such as those observed during processing, will be 
detected. PreprominiPLAP mRNA was added to microsomes and processing was 
observed in this cotranslational assay. This modified protein was processed to 
prominiPLAP and then to miniPLAP in the cell-free system, where microsomes from 
CHO cells were added. Processing of a number of truncated forms of 
preprominiPLAP, where parts of the GPI signal were omitted revealed that the 
completely processed miniPLAP had lower mobility on SDS-PAGE than the 
truncated forms (Kodukula et al., 1992). Triton X-114 extraction causes GPI- 
anchored proteins to remain in the detergent phase unless the GPI is removed with 
PI-PLC, whereupon the proteins associate with the aqueous phase. Mini-PLAP was 
investigated by this technique and was observed to enter the aqueous phase when 
treated with PI-PLC suggesting that miniPLAP had received a GPI anchor. A cell- 
free system for analysis of GPI anchor attachment in T. brucei was also developed at 
around this time (Mayor et al., 1991). This involved analysis of GPI anchor 
attachment to endogenous VSG and provided direct evidence for GPI attachment, 
allowing the detection of radiolabelled-GPI incorporation into VSG. Furthermore, 
the process did not require ATP or GTP, which provides evidence that GPI addition
proceeds via a transamidation mechanism. This finding was apparently contradictory 
with the processing of preprominiPLAP in a further modified version of the cell free 
assay (Amthauer et al., 1992). The lag between the incorporation and processing of 
newly synthesised preprominiPLAP to prominiPLAP and the GPI anchor addition 
that was observed (Kodukula et al., 1992) was taken advantage of to allow 
simplification of the assay (Amthauer et al., 1992). Experiments indicated that GTP 
and ATP enhanced processing to miniPLAP although the authors point out that the 
ATP and GTP are more likely to be required for other steps such as chaperone- 
mediated folding of the protein or its translocation to the transamidase site (Amthauer 
et al., 1992). Further evidence for this came from the demonstration of the 
interaction of the molecular chaperone BiP with three GPI anchored proteins, 
including PLAP and the requirement for ATP (Amthauer et al., 1993). Soluble 
components of the ER lumen, of which BiP is an example, were shown to be required 
for the processing of prominiPLAP to miniPLAP (Vidugiriene and Menon, 1995). It 
was demonstrated that if removal of soluble components took place before entry of 
preprominiPLAP to the ER, processing to prominiPLAP occurred but further 
processing did not. By contrast, removal of soluble components after processing to 
prominiPLAP did not alter processing to miniPLAP suggesting the possible 
involvement of molecular chaperones such as BiP.
An interesting phenomenon that arose from the use of this preprominiPLAP system 
was that not all of the processed miniPLAP contained a GPI anchor (Maxwell et al., 
1995a). It could be argued that this actually provides evidence for the presence of a 
separate proteolytic enzyme agreeing with the alternative two or more enzyme 
hypothesis previously mentioned (Ferguson and Williams, 1988). If this were the
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case then membranes from GPI-deficient mutants would still be expected to produce 
free miniPLAP, which does not happen (Maxwell et al., 1995a). It was predicted 
previously, however, that the GPLprotein transamidase could potentially release free 
protein as well as GPI-anchored protein in the absence of suitable endogenous GPI 
precursors (Bailey et al., 1989). The ethanolamine component acts as a nucleophile, 
attacking an activated carbonyl on the protein at the © site. For the production of free 
miniPLAP, the enzyme could utilise water as a replacement nucleophile for the GPI 
anchor such that it is essentially functioning as a proteinase. Thus, when other more 
powerful nucleophiles such as hydrazine and hydroxylamine were included in the cell 
free assay an increase in the amount of free miniPLAP was observed and 
demonstrated to be a direct conversion from prominiPLAP to free miniPLAP 
(Maxwell et al., 1995b). It was not shown, however, that the miniPLAP detected 
was actually the hydrazide or hydroxamate of free miniPLAP as the amounts 
produced were too low for detection with the current assay systems. The fact that 
free miniPLAP levels were increased in the presence of these nucleophiles, in a heat- 
sensitive fashion, suggests that the reaction is catalysed by a transamidase. 
Furthermore, the © site amino acid requirement for processing with hydrazine 
parallels that required for GPI anchor addition (Ramalingam et al., 1996). This study 
determined that production of free miniPLAP using microsomes from GPI defective 
cell lines with hydrazine, was maximum at 30°C and pH 7.0-8.0.
Collectively, these data strongly suggest that GPI anchor addition is catalysed by a 
GPLprotein transamidase but all of the evidence is indirect. Identification of proteins 
that form part of the GPLprotein transamidase would provide more direct evidence 
for the transamidation mechanism.
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1.4.4.3 Identification of components of the putative GPLprotein transamidase
As with many of the proteins involved in GPI anchor biosynthesis, two components 
of the transamidase were identified by complementation of mutant cells defective in 
GPI-anchored proteins.
A yeast mutant end2, originally thought to be defective in endocytosis, was found to 
be defective in the maturation of Gaslp, a major yeast GPI-linked, cell wall protein 
(Hamburger et al., 1995). GPI anchor attachment was also severely affected and 
both of these phenotypes were reversed by expression of the gene, which was 
renamed GAAJ. Gaalp is an ER transmembrane glycoprotein of 68kDa (prior to 
glycosylation) with a large lumenal domain and as many as 5 or 6 transmembrane 
domains. Gaalp shows no significant sequence homology to proteins of known 
function. The gaal mutant synthesises a complete GPI anchor indicating that the 
mutation lies after biosynthesis but before attachment to nascent polypeptides 
carrying a GPI signal sequence. Mutation of the a> site of Gaslp to various amino 
acids had the effect of reducing the percentage of mature Gaslp, however 
overproduction of Gaalp could partially overcome the reduced GPI-anchoring of the 
Gaslp mutants (Hamburger et al., 1995). These findings are consistent with Gaalp 
being either the GPLprotein transamidase or an essential component of a 
transamidase complex.
A second putative component of the transamidase complex was identified in yeast 
(Benghezal et al., 1996). A yeast mutant (gpi8), like gaal, demonstrates a buildup of 
a complete GPI anchor precursor. Expression of the GPI8 gene from a plasmid
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prevented this buildup suggesting complementation. GPI8 predicts a 411 amino acid 
protein of 47kDa. The nascent protein contains two hydrophobic domains, at either 
terminus; the N-terminal domain is predicted to be an ER-signal peptide. There are 
three potential N-glycosylation sites which are utilised. Subcellular fractionation 
confirmed that GPI8 co-ffactionates with a known ER protein (Wbplp) and 
proteinase protection assay of yeast microsomes confirmed that GPI8 has a large ER 
lumenal domain, a single transmembrane domain and a short cytoplasmic tail 
(Benghezal et al., 1996). This structure is reminiscent of GAA1 but unlike GAA1, 
GPI8 was found to have significant homology to a family of plant cysteine 
endopeptidases known as the legumains, which belong to the C13 family on the 
cysteine proteinase classification scheme (Barrett and Rawlings, 1996). A partial 
sequence for the human homologue of GPI8 was identified (Benghezal et al., 1996).
A previously identified human mutant cell line, class K (Mohney et al., 1994) was 
found to accumulate complete GPI anchors but microsomes from this cell line, when 
used with the preprominiPLAP cell free assay, failed to produce GPI-anchored 
miniPLAP (Chen et al., 1996). Furthermore, inclusion of the nucleophiles hydrazine 
and hydroxylamine failed to produce free miniPLAP indicating that the mutation 
probably lay in the GPLprotein transamidase complex. It was later found that the 
defect was in the human homologue of GPI8 and the remainder of the human gene 
was cloned and characterised (Yu et al., 1997). Expression of this gene in class K 
cells abolished buildup of complete GPI anchors. Microsomes from these cells were 
able to produce free miniPLAP with hydrazine as well as GPI-miniPLAP indicating 
that transamidase activity had been restored.
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The observed similarity with proteolytic enzymes suggests that GPI8 is the 
transamidase itself. A modified cell-free assay was recently designed to analyse GPI 
anchor attachment in African trypanosomes and this provided the first direct evidence 
that the nucleophile hydrazine was indeed covalently incorporated at the C-terminal 
end of a VSG in place of a GPI anchor (Sharma et al., 1999a). This was done by 
using biotinylated hydrazine and demonstrating that VSG released from membranes 
with hydrazine was precipitated with streptavidin. Furthermore the VSG-hydrazide 
was not susceptible to proteolytic cleavage by carboxypeptidases (exopeptidases that 
cleave at C-termini of proteins) unlike truncated VSG indicating that the carboxyl 
terminus of released VSG was blocked. This study revealed that the transamidation 
reaction was inhibited with sulphydryl alkylating reagents such as iodoacetamide 
suggesting that a thiol group is important for the activity of the transamidase (Sharma 
et al., 1999a). Since GPI8 has homology to the legumains, which are cysteine 
proteinases, this data provides further evidence for the notion that the GPLprotein 
transamidase is a novel cysteine proteinase.
1.5 Aims of this study
The identification of components of the putative GPLprotein transamidase has paved 
the way for isolation and characterisation of homologous genes from parasitic 
protozoa. The extensive use of GPI anchors for membrane attachment of cell surface 
proteins in parasitic protozoa makes them model systems for analysing the 
GPLprotein transamidase.
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The aims of this work were to:
• Isolate and sequence GPI8 from L. mexiccma
• Delete the gene to determine the role of GPI8
• Investigate the role of GPI anchored proteins in the life-cycle of Leishmania
• Determine if GPI8 is present in other species of parasitic protozoa such as
Plasmodium and T. brucei
• Assess if the GPLprotein transamidase is a potential anti-trypanosomatid drug 
target.
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Figure 1.1: The life cycle of Leishmania
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Figure 1.2: Biosynthesis of protein GPI anchors in mammals occurs on the ER 
membrane, [l] Addition of GlcNAc to PI is catalysed by a multiprotein complex and 
is rapidly deacetylated §. The anchor is then inositol acylated (palmitoylated) before 
addition of mannose residues; at some point the GPI precursor is flipped from the
cytoplasmic face of the ER membrane to the lumen |3-5j. The third mannose residue
is added by PIG-B |6| and ethanolamine is added, presumably by PIG-F (not shown)
before fatty acid remodelling |7-8|. The complete anchor is transferred to nascent 
polypeptides carrying a GPI signal sequence on the carboxyl-terminal §. Adapted 
from Ferguson (1999).
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Figure 1.4: General structure of a nascent polypeptide prior to GPI anchor 
addition. Nascent preproproteins consist o f three main domains: an N-terminal ER 
signal sequence (yellow), a mature domain (orange) and a GPI signal domain. Both 
o f the terminal signal sequences are removed and the C-terminal domain is replaced 
with a GPI anchor. The three components of the GPI signal are indicated.
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CHAPTER 2 
MATERIALS AND METHODS
2.1 Molecular methods
2.1.1 Bacterial strains
Several strains of bacteria were used throughout this study and these are described in 
Table 2.1.
Table 2.1: Bacterial strains
XL 1-Blue MRF Supercompetent cells used for 
transformations
Stratagene
M15[pRRP4] Used for protein 
overexpression (Kanamycin 
resistant)
Qiagen
AB1899 F' Parent strain for AB1899 F' 
GroEL/ES
A gift o f Dr. John Hyde 
(UM1ST)
AB1899 F' GroEL/ES Used for co-expression of 
protein with chaperonins 
(Kanamycin resistant)
A gift o f Dr. John Hyde 
(UMIST)
LE392 Used for uptake of X phage in 
genomic library screening
(Sambrook et al., 1989)
2.1.2 Long term storage of bacteria (glycerol stocks)
Cells were plated on LB-agar plates with appropriate antibiotics and incubated 
overnight at 37°C. A single colony was used to inoculate 5ml of LB broth and cells 
were grown overnight at 37°C. 0.5ml of the overnight culture was mixed with an equal 
volume of 2% peptone/40% glycerol and cells were stored at -70°C.
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2.1.3 Bacterial culture methods
5-10ml of LB broth containing appropriate antibiotics (see Table 2.2) in a sterile glass 
test tube was inoculated with a single colony using a sterilised toothpick. Cultures were 
grown at 37°C in a rotary incubator (220rpm). Growth times were dependent on 
requirements. For example stationary phase cultures were required for plasmid 
preparations and cells were grown overnight. For small-scale plasmid preparations, the 
overnight cultures were used directly and for medium-scale plasmid preps (midi preps), 
lml of an overnight culture was used to inoculate 25ml of fresh LB broth. When cells 
were used for overexpression of exogenous protein, growth times were altered 
accordingly (see relevant results chapters).
2.1.4 Preparation of electrocompetent cells
A single colony of bacterial strain from an LB-agar plate was used to inoculate 10ml of 
LB broth containing appropriate antibiotics. The entire culture was added to 400ml of 
fresh LB-broth and incubated at 37°C (220rpm) in a rotary incubator until the OD 
(600nm) had reached 0.6. OD was measured in disposable plastic cuvettes (Sarstedt). 
Cells were harvested (4000 x g, 15 minutes, 4°C) and washed two times, each with 
400ml of ice-cold sterile water. The cells were resuspended in 200ml of ice-cold sterile 
water and harvested and the pellet was washed with 10ml of ice-cold 10% glycerol 
(sterile). The cells were resuspended in 2ml of ice-cold, sterile 10% glycerol and 
divided into 40pl aliquots that were snap-frozen in a dry ice/ethanol bath. The 
electrocompetent cells were stored at -70°C.
2.1.5 Plasmid purification
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Several different kits were used to purify plasmids depending on requirements. If 
plasmids were to be sequenced, Qiagen Tip-20 mini-preps were used according to 
manufacturer’s instructions, as particularly high quality DNA was generally obtained 
with this kit. The Wizard™ Minipreps kit (Promega) was used if plasmids were to be 
used in restriction digests, perhaps for subsequent subcloning, as the method is quick 
and efficient producing good plasmid yields. Plasmid quality and yields were assessed 
by spectrophotometry. An absorbance reading of 1 at a wavelength of 260nm is 
equivalent to 40(ig/ml of double stranded DNA (Sambrook et al., 1989).
2.1.6 Polymerase chain reaction (PCR)
PCR was used in the amplification of DNA fragments for subsequent cloning and 
analysis or for the diagnosis of ligation by whole-cell PCR. A 20pl reaction contained 
1.8|nl of 1 l . lx PCR buffer 50-100ng of template DNA, 200ng of each oligonucleotide 
primer (sense and antisense) and 2U of Taq polymerase (Applied Biosystems). Taq 
polymerase lacks proofreading activity so this enzyme was replaced with VENT 
polymerase where high fidelity PCR was required. Reaction conditions varied and are 
described where appropriate. For cloning into T-vectors such as pGEM-T (Promega) 
and pTAG (R&D Systems), Taq-amplified fragments could be ligated directly, but 
adenine overhanging residues had to be added to VENT-amplified fragments by 
incubation for an additional 10 minutes at 72°C with 2U of Taq polymerase.
When screening transformed colonies for plasmids containing the insert of interest, a 
cocktail stick was inserted into a colony and cells were transferred directly into a 20pl
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PCR reaction without template DNA, and containing 5% (v/v) dimethylsulphoxide 
(DMSO).
2.1.7 Restriction digests
Restriction enzymes were obtained from New England Biolabs (NEB) and used 
according to manufacturer’s instructions with the buffers supplied. A typical plasmid 
digest was set up as follows: 0.5-l.Op.g of plasmid DNA was digested in a 20pl reaction 
(containing appropriate enzyme buffer) for 1-3 hours at 37°C. Reactions were halted by 
the addition of a one tenth volume of DNA loading buffer at lx (v/v) final concentration 
(DNA loading buffer was prepared as a 10 fold concentrated stock) followed by 
electrophoresis. Occasionally reactions would be extracted with phenol/chloroform 
and/or ethanol precipitated to separate restriction enzymes from amplified DNA (see 
Sambrook et al., 1989).
2.1.8 DNA gel electrophoresis
Typically gels containing 0.7-1.2% agarose in TBE buffer were used for analysis of 
DNA fragments, but gels of up to 1.8% were used to separate smaller fragments, up to 
approximately 400bp. Samples were mixed with lOx DNA loading buffer to a final 
concentration of lx loading buffer and were electrophoresed at 50-110V until the dye in 
the loading buffer had migrated approximately two thirds of the length of the gel. 
Generally, ethidium bromide was mixed with the molten gel prior to setting at a final 
concentration of approximately 0.3pg/ml. Where uniform staining of a gel was 
required, the gel was soaked for 20-30 minutes in TBE buffer containing 0.3jj.g/ml 
ethidium bromide before washing in distilled water. Gels were viewed under UV
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illumination and images obtained using The Imager™ gel documentation system 
(Appligene).
2.1.9 Purification of DNA from agarose gels
Where purification of DNA fragments was required, agarose gels were prepared with 
TAE buffer rather than TBE. Following electrophoresis, the gel was visualised under 
low intensity UV light to minimise the risk of mutagenesis allowing identification of the 
band of interest. This band was cut from the gel using a scalpel blade. For small scale 
purification (approximately less than lpg), the Qiaquick Gel Extraction Kit (Qiagen) 
was used. For larger scale preps, the gel fragment was cut into small fragments and 
place in Spin-X tubes (Costar). Gel fragments were incubated at -20°C for 15 minutes 
followed by 37°C for the same duration. Tubes were centrifuged at approximately 
13000 x g in a microfiige for 15 minutes and the collected DNA solution was ethanol 
precipitated and resuspended in either sterile water or TE at the required concentration.
2.1.10 Phosphatase treatment of digested plasmids
Where plasmids were digested with a single restriction enzyme prior to ligation, it was 
treated with calf intestinal alkaline phosphatase (CIAP) to remove the 5' terminal 
phosphate. This minimised the chances of plasmid re-ligation rather than ligation with 
the added DNA fragment of interest.
The procedure used was as follows:
2pg of plasmid was digested in a 20pl reaction. 2U of CIAP (NEB) was added to the 
digest and incubated at 37°C for 15 minutes then 56°C for 15 minutes. An additional 
1U of CIAP was added and incubated at 37°C and 56°C as before. Reaction was
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diluted to 200|j.l with TE buffer and extracted once with phenol/chloroform (1:1) then 
chloroform/isoamyl alcohol (24:1). DNA was ethanol precipitated and resuspended in 
TE to appropriate concentration.
2.1.11 DNA ligation
Ligation of DNA fragments with commercially available T vectors was carried out 
according to manufacturer’s protocol.
Ligation into other vectors was carried out as follows: Plasmid and insert were mixed in 
ratios ranging from 1:3 to 3:1 in a lOp.1 reaction containing lx T4 DNA ligase buffer 
and 200U of T4 DNA Ligase (NEB). Reactions were incubated overnight at 16°C.
2.1.12 Transformation of competent bacteria
Commercially available XL 1-Blue MRF' supercompetent cells (Stratagene) were 
transformed by heat shock according to manufacturers protocol.
Transformation of electrocompetent cells was performed as follows:
1(0.1 of an overnight ligation mix was added to 40pl of electrocompetent cells kept on 
ice. Cells were mixed and placed in a pre-chilled 0.2cm electroporation cuvette 
(Biorad) and were electroporated using the Genepulser II apparatus (Biorad) under the 
following conditions: 25(oE capacitance, 200 ohms resistance and 2.5kV. Cells were 
transferred to 1ml of prewarmed (37°C) SOC medium and allowed to recover for 1 
hour at 37°C in a rotary incubator (200rpm). 50- 200j l x 1 of transformed cells was plated
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onto LB-agar plates containing appropriate antibiotics (generally lOOpg/ml ampicillin). 
Plates were incubated overnight at 37°C.
2.1.13 DNA sequencing
DNA sequencing was carried out using the ABI-Prism™ cycle sequencing kit (Perkin- 
Elmer) according to manufacturer’s instructions. Template DNA was added at 300- 
500ng in a 20pl reaction with 3.2 pmoles of an appropriate oligonucleotide primer. 
Samples were analysed by the University of Glasgow Molecular Biology Support Unit 
(MBSU) or by Oswell Sequencing, University of Southampton using ABI 373 or 377 
automated DNA sequencers.
2.2 Leishmattia mexicana and trypanosome methods
2.2.1 Cell lines
Wild type L. mexicana cell line used throughout this research was Leishmania 
mexicana mexicana (MNYC/BZ/62/M379). All newly produced cell lines were derived 
from this parent line. Trypanosoma brucei were grown and supplied by Dr. Pat Blundell 
(427 bloodstream forms) and Dr. Jaap van Hellemond (EATR0795 procyclic form).
2.2.2 Tissue culture
L. mexicana promastigotes were grown at 25°C in HOMEM medium (Berens et al., 
1976) supplemented with 10% heat inactivated foetal calf serum (FCS) (Labtech). 
Cells were inoculated into fresh medium at approximately 1 x 106 cells/ml and were 
passaged into fresh medium when cultures reached late-log or early stationary phase 
(approximately 1-2 x 107 cells/ml).
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For maintenance of transgenic cell lines, appropriate antibiotics were added to growth 
medium at the following concentrations:
• Puromycin (Calbiochem)- 10 jig/ml
• Nourseothricin (Hans Knoll Inst., Germany) -  25jjg/ml
• Geneticin (G418, GibcoBRL) -  25-50pg/ml
Cells were diluted and fixed by adding 5jj1 of cells to 45jil of PBS and 50pl of 4% 
formaldehyde in PBS. Cells were loaded onto an improved Neubauer haemocytometer 
(Weber Scientific) and counted under microscopy.
Cells were generally harvested by centrifugation at 2000xg for 5 minutes followed by 
two washes in PBS both followed by centrifugation as before. Cell pellets were used 
immediately or stored at -70°C until required.
HOMEM plates were made by a 1:1 dilution of 2 x HOMEM with 2% agar containing 
appropriate antibiotics. Plates were allowed to dry in an air-flow hood for 15 minutes 
and were pre-warmed to 25°C for 30-60 minutes before cells were spread over the solid 
medium. Liquid was allowed to absorb into the plate for 5 minutes before the plates 
were sealed with parafilm and incubated at 25°C.
2.2.3 Stabilate preparation for long term storage of L. mexicana cell lines
0.5ml of a log phase culture was diluted with an equal volume of fresh medium 
containing 10% DMSO in a Cryotube™ vial (Nunc). Samples were stored overnight at 
-70°C and then stored under liquid nitrogen until required.
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2.2.4 Transfection of L. mexicana
Transfections were carried out using the procedure of Cobum and co-workers (Cobum 
et al., 1991). Cells were harvested and washed twice in electroporation buffer (EPB) 
before being resuspended at 1 x 108 cells/ml in EPB and kept on ice. 4 x 107 cells 
(400j.il) were transferred to a pre-chilled 0.2cm electroporation cuvette (Biorad) and 
were electroporated with Genepulser El apparatus at 0.45kV (2.25kV/cm) and 500pF 
capacitance. Cells were allowed to recover for 10 minutes on ice before being 
transferred to fresh medium and incubated at 25°C overnight. Cells were then plated on 
HOMEM-agar plates containing appropriate antibiotics at the concentrations described 
in Section 2.2.2. Plates were allowed to absorb the transferred medium for 5 minutes 
before being sealed with Parafilm for growth at 25°C. Colonies were transferred to 
liquid medium plus antibiotics using a sterile, disposable Pasteur pipette and grown at 
25°C.
2.3 DNA manipulation
2.3.1 Whole cell PCR
lOpl of late-log/early stationary phase promastigotes was added to lOOpl of sterile 
distilled water. 2j l x 1 of this hypotonic lysate was used as DNA template in PCR with 
appropriate oligonucleotide primers and Taq polymerase (see Section 2.1.6).
2.3.2 Isolation of genomic DNA from L. mexicana
A mini-prep procedure based on a recently published method (Medina-Acosta and 
Cross, 1993) was utilised throughout this project. Up to 2 x 108 cells were harvested
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and resuspended in 400fil of TELT buffer and incubated at room temperature for 5 
minutes. The TELT lysate was extracted carefully with an equal volume of water- 
saturated phenol/chloroform twice (followed, each time by centrifugation, 13000 x g, 5 
minutes) and once with chloroform before ethanol precipitation with 2 x 70% ethanol 
washes. The precipitated DNA was allowed to dry for no more than five minutes and 
resuspended in TE containing 20pg/ml RNAse A. The DNA was incubated at 37°C for 
an hour and DNA quality was analysed by agarose gel electrophoresis for quality and 
spectrophotometry for concentration.
2.3.3 Southern blotting of DNA fragments
5-lOpg of genomic DNA was digested overnight and fragments were electrophoresed 
(0.7% agarose TBE gel). The gel was incubated with 0.3|ig/ml ethidium bromide and 
analysed under UV to allow a scale image of the gel to be obtained (a ruler was placed 
beside the gel to allow measurement of resulting autoradiograms to be equated with the 
position of the DNA markers). The gel was washed in distilled water for 10 minutes 
before incubation for 20 minutes in depurination solution. The gel was rinsed in 
distilled water and incubated for 30 minutes in denaturation solution. After another 
wash in distilled water, the gel was incubated for a further 30 minutes in neutralisation 
solution and washed for 10 minutes in 20 x SSC. DNA was transferred to Hybond-N 
nylon membrane (Amersham) overnight, by capillary transfer (Sambrook et a I., 1989).
2.3.4 Southern hybridisation with nucleic acid probes
The transferred DNA fragments on Hybond-N were covalently attached to the 
membrane by UV crosslinking (1200J UV Crosslinker, Stratagene) and baking at 80°C
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for 10 minutes. Membrane was added to 5ml of Church-Gilbert solution and incubated 
at 65°C (for L. mexiccma blots) or 55°C (for T. brucei blots). 30ng of the nucleic acid 
probe was radiolabelled using the Prime-It II Random Primer kit (Stratagene) according 
to manufacturer’s instructions. Probes were purified on NucTrap® columns 
(Stratagene) and boiled for 5 minutes before incubation on ice for 2 minutes. Probe 
was added directly to the Church-Gilbert solution/Southern membrane and incubated 
overnight at the appropriate hybridisation temperature (65°C for L. mexicana blots or 
55°C for T. brucei blots). Blots were washed with 3 x 1 5  minutes washes with 2 x 
SSC/0.1% SDS prewarmed to the appropriate temperature followed by 3 x 15 minute 
washes with similarly warmed 0.1 x SSC/0.1% SDS. Membranes were sealed in 
polythene and exposed to autoradiography film (Reflection™ film (NEN™ Life 
Sciences). Autorads were developed using a Kodak X-omat automated developer.
2.3.5 L. mexicana genomic library screen
2.3.5.1 Preparation of bacterial suspension
LE392 bacterial cells were prepared for library screening. A single LE392 colony was 
transferred from an LB-agar plate to 50ml LB-broth supplemented with 0.2% maltose 
and grown overnight. Cells were harvested (4000 x g, 10 minutes at room temperature) 
and resuspended in 20ml of lOmM MgSCL.
2.3.5.2 Titration of the genomic library
A previously described X Dash II L. mexicana genomic library (Mottram et al., 1997) 
was titred: a ten fold and a hundred fold dilution of the library (each in a total volume of 
100p,l) was mixed with lOOpl of LE392 bacterial suspension and allowed to adsorb at 
37°C for 20 minutes. 90mm plates containing BBL bottom agar were prepared and
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dried previously. BBL top agarose was melted, aliquoted 2.5ml each into two Bijou 
bottles and maintained in molten state at 45°C. The cells/phage were mixed with the 
molten top agarose and quickly swirled over bottom agar to produce a uniform layer, 
which quickly solidified. Plates were incubated at 37°C overnight and the resulting 
plaques in the bacterial lawn were counted.
2.3.5.3 Primary screening of the genomic library
Three 150mm Petri dishes were filled with 80ml of bottom agar and dried. 0.3ml of 
LE392 suspension was mixed with 72p,l of the L. mexicana genomic library in each of 
three sterile Eppendorf tubes and were incubated at 37°C for 20 minutes. The 
cells/phage were added to 3 x 6.5ml of molten top agarose and rapidly added to the 
three bottom agar plates. Plates were allowed to set and were incubated overnight at 
37°C. Hybond-N nylon membrane was cut to fit onto the surface of the plates (six 
membranes were prepared, two for each plate). Filters were allowed to settle onto the 
surface of each plate allowing the phage to attach to the filter by brief capillary flow. 
The first filter was added to each plate for 90 seconds during which time, at least three 
asymmetric holes were punched through the filter into the agar with a 21 gauge needle. 
The second filter was added for 2.5 - 3 minutes and the same holes were punched 
through it. Filters were floated on the surface of a container of denaturation solution 
for 1 minute and submerged for a further 5 minutes, before being transferred to 
neutralising solution for 5 minutes. Finally, filters were washed 5 minutes in 2 x SSC, 
dried for 20 minutes and baked for 10 minutes at 80°C. Filters were incubated in 
Church-Gilbert solution at 65°C for at least 2 hours before being probed overnight with 
radiolabelled nucleic acid. Filters were washed for an hour with several changes of 2 x 
SSC/0.1% SDS and exposed to autoradiography film. Positions of the punched holes
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were marked on the autorad allowing the position of hybridising plaques to be 
pinpointed on the agar plates.
2.3.5.4 Secondary screening of genomic library
Plaques identified as hybridising were removed from the agar plate by removal of a 
“plug” of agar transferred to an Eppendorf tube containing 500pl SM (phage) buffer 
and incubated at 37°C for an hour to allow the phage to diffuse out of the agar. A plug 
is assumed to contain approximately 106 phage particles and an estimated 100 phage 
and 500 phage were each added to lOOpl of LE392 suspension. The mixtures were 
incubated at 37°C for 20 minutes before plating onto 90mm bottom agar plates in 2.5ml 
of molten top agarose. Plates were incubated at 37°C overnight. Plaque lifts were 
carried out (membranes and plates were, again, needle-punctured) and the Hybond-N 
membranes were treated as before. Hybridisation with the nucleic acid probe was 
repeated and hybridising plaques were identified and plugged into SM buffer.
2.3.5.5 Large scale purification of phage DNA by the plate lysis method
The isolated phages were plated out and ten plaques were transferred to a single 
Eppendorf tube containing 650pl of SM buffer (incubated at 37°C for an hour). 500pl 
of phage was mixed with 500pl LE392 suspension, incubated 20 minutes at 37°C and 
plated out, with molten top agarose onto five 90mm bottom agar plates (200pl of cells 
and phage mixture per plate). Plates incubated at 37°C overnight produced near­
confluent lysis of the LE392 bacterial lawn. Plates were incubated at 4°C for 2 hours to 
allow hardening of the agar. 3 ml of SM buffer was added to each plate and incubated 
at 4°C for several hours. The top agarose/SM buffer of all five plates was scraped into
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a 50ml centrifuge tube using a spatula and the agar was broken up as much as possible 
and incubated for 20 minutes at room temperature. The agar was pelleted (lOOOOxg, 
10 minutes) and the liquid transferred to a 15ml Falcon tube. The Wizard™ Lambda 
Preps DNA Purification System (Promega) was used to purify the phage DNA 
according to manufacturer’s instructions. Phage DNA quality and quantity were 
assessed by DNA agarose gel electrophoresis and spectrophotometry.
2.3.6 Screening of a Trypanosoma brucei brucei genomic library
The library was supplied and titred by Nick Robinson and Nils Burman of the 
University of Glasgow and was screened in the same way as the L. mexicana genomic 
library with a few modifications. The probe was a 1.1 kb XbaVXhol DNA fragment 
containing the IMGPI8 ORF (Figure 3.11 A). Because this probe was exogenous, 
hybridisation was performed at lower stringency 55°C rather than 65°C as was 
membrane-washing (55°C, 2.5 x SSC/0.1% SDS). Phage DNA was also purified by the 
Wizard™ Lambda Preps DNA Purification System (Promega).
2.3.7 DNA and protein analysis
All DNA and protein analysis was performed using the Genetics Computer Group 
(GCG) Molecular Analysis software package (Wisconsin), Vector NTI (v5.0.3) 
software (Informax Inc.) and the molecular biology and proteomics programmes 
available at the Expasy website (http://www.expasy.ch/tools).
2.4 Biochemical methods
2.4.1 SDS-PAGE
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Generally 108 promastigotes were lysed in 75|il of 0.25% Triton X-100 on ice. 25pl of 
SDS-PAGE loading buffer was added and lysates were boiled for 5 minutes.
Proteins were separated by SDS-PAGE method on 10% acrylamide mini-gels of 
0.75mm thickness, which were prepared and run using a Mini-Protean II dual slab 
system (BioRad) according to manufacturer’s instructions. Gels could be stained to 
detect total protein by 1% Coomassie R250 or they were electroblotted to allow 
specific-protein analysis.
2.4.2 Western blotting
Following SDS-PAGE, separated proteins were transferred to Hybond-C nitrocellulose 
membrane (Amersham) by electroblotting, using a BioRad mini transblot cell according 
to manufacturer’s instructions. Kaleidoscope pre-stained molecular weight protein 
standards (Novex) were included to allow quick assessment of protein transfer to 
nitrocellulose. Proteins were transferred at 100V for 1 hour (4°C).
Membrane was rinsed in Western blotting transfer buffer to remove fragments of 
acrylamide gel before being transferred to a 50ml Falcon tube and overnight incubation 
at 4°C with a protein-rich Blocking solution (three were used, Blocking solution 1, 2 
and 3) to block the remainder of the membrane, which was protein-free.
2.4.2.1 Antibody detection of proteins
Primary antibodies were incubated with the membrane in appropriate blocking solution, 
generally for 60-90 minutes at room temperature. Blots were washed 3 x 1 0  minutes 
with TBS-Tween (TBST) and secondary antibody (either anti-mouse IgG or anti rabbit
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IgG) conjugated to horseradish peroxidase (HRP) (Promega) was generally used at 1 in 
5000 dilution in blocking buffer for 45-60 minutes at room temperature. Blots were 
washed in TBST as before. Antibody binding was detected by Supersignal™ Enhanced 
Chemiluminescence (ECL) reagents (Pierce) according to manufacturer’s instructions. 
Fluorescence was detected by autoradiography with Reflection™ autoradiography film 
(NEN™ Life Sciences). Film was developed by Kodak X-omat automated developer.
2.4.3 Immunofluorescence (L. mexicana)
Approximately 30pl of late log-phase/stationary-phase L. mexicana promastigotes were 
diluted to lOOpl in PBS. 30jff was dropped on a glass slide and smeared over the 
complete surface using a second slide. The slides were allowed to dry for 5 minutes 
before cells were fixed in 2.5% paraformaldehyde/PBS for 15 minutes. Slides were 
washed in PBS before primary antibody was added (generally at 1 in 100 dilution in 
PBS). Slides were incubated in a humidified chamber for 30 minutes, before being 
washed thoroughly with PBS for 10 minutes (with several changes of PBS). Cells were 
then blocked for 15-30 minutes with 10% FQ-FCS in PBS before being washed in PBS 
as before. A mixture of secondary antibody (between 1 in 100 and 1 in 500) and DAPI 
(4,6-diamidino-2-phenylindole) (20jjg/ml final) in PBS was added to the slides, which 
were incubated in the dark at RT for 30 minutes. Slides were washed in PBS as before 
and 25pl of the anti-quenching agent MOWIOL-DABCO was dropped onto each slide 
under a glass coverslip. Cells were viewed by UV fluorescence microscopy on a Zeiss 
Axioplan fluorescence microscope with a Hamamatsu Digital Camera using the 
OpenLab Software Package (Improvision, University of Warwick).
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2.5 Buffers and Reagents
Ampicillin: Stock solution is lOOmg/ml in distilled water. Storage at -20°C. Used at 
lOOpg/ml.
BBL Bottom agar: 1% (w/v) BBL Trypticase peptone, lOOmM NaCl, 1% (w/v) 
agarose. Autoclave and store at room temperature.
BBL Top agarose: 1% (w/v) BBL Trypticase peptone, lOOmM NaCl, 12mM MgCk, 
0.7% (w/v) agarose. Autoclave and store at room temperature.
Blocking solution 1: 5% milk powder in TBS-Tween. Made up fresh.
Blocking solution 2: 5% milk powder and 10% horse serum in TBS-Tween. Made up 
fresh.
Blocking solution 3: 3% Bovine Serum Albumin (BSA) in TBS-Tween. Made up 
fresh.
Church-Gilbert’s solution: 340mM Na2HP0 4 , 158mMNaH2P04, 240mM SDS, ImM 
EDTA. Heated gently to solubilise components. Store at room temperature.
DNA loading buffer (lOx): 25% Ficoll, 0.42% bromophenol blue. Store at room 
temperature.
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Depurination solution: 0.125M HC1. Store at room temperature.
Denaturation solution: 1.5M NaCl, 0.5M NaOH. Store at room temperature.
Dithiothreitol (DTT): Made up as a 1M stock solution in water. Store at -20°C.
Electroporation buffer (EPB): 21mM HEPES pH7.5, 137mM NaCl, 5mM KC1, 
0.7mM phosphate buffer, 5mM glucose. Store at 4°C.
Ethidium bromide: lOmg/ml stock solution in distilled water. Store at room 
temperature.
HS Buffer: As LS buffer but minus glycerol and imidazole. Store at room 
temperature.
Imidazole Buffer: As LS-T plus 250mM imidazole. Store at room temperature.
Kanamycin: Made up as a 25mg/ml stock in water. Store at -20°C. Used at 25fig/ml.
LS Buffer: 50mM MOPS, lOOmM NaCl, lmM EDTA, ImM EGTA, lOmM NaF, 
ImM NaOVa, 10% (v/v) glycerol, 25mM imidazole in distilled water. Store at room 
temperature.
LS-T Buffer: As LS Buffer plus 1% Triton X-100. Store at room temperature.
Luria-Bertani (LB) agar: LB broth plus 0.8% (w/v) agar. Autoclaved to sterilise and 
store at room temperature.
Luria-Bertani (LB) broth: 1% bactotryptone (Difco), 0.5% (w/v) yeast extract, 0.5% 
(w/v) NaCl. Made up in distilled water and autoclaved for sterilisation. Store at room 
temperature.
MG132: (carbobenzoxyl-leucinyl-leucinyl-leucinal) -  a tripeptide inhibitor of the 
proteasome, stock solution at lOmg/ml in ethanol.
Microsome Buffer 1:0.1 mg/ml leupeptin, 5pg/ml pepstatin A, 0.5mg/ml Pefabloc, 
ImM 1,10 phenanthroline in water.
Microsome buffer 2: As microsome buffer 1 plus lOOmM HEPES-NaOH pH7.4, 
50mM KC1, lOmM MgCL, 20% (v/v) glycerol
MOWIOL-DABCO: 6g glycerol and 2.4g MOWIOL 4-88 (Calbiochem) added to 6ml 
distilled water. 12ml 0.2M Tris-HCl, pH8.5 was added and incubated with agitation 
(shaking platform) for several hours at room temperature. Mixture was incubated at 
50°C for 10 minutes then centrifuged (5000 x g, 15 minutes). 1,4- 
diazobicyclo[2.2.2.]octate or DABCO (Sigma) was added to 0.1% (w/v) final 
concentration and divided into 1ml aliquots, which were stored at -20°C. Solution was 
incubated at room temperature for at least an hour before use.
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Neutralisation solution: 1.5M NaCl, 0.5M Tris-HCl pH7.0, store at room 
temperature.
PBS: lOmM phosphate buffer, 2.7mM KC1, 137mM NaCl, pH7.4. Autoclaved when 
required for tissue culture. Store at room temperature.
PCR mix (11.lx): 45mM Tris-HCl (pH8.8), llmM  ammonium phosphate, 4.5mM 
MgCl2, 6.7mM P-mercaptoethanol, 4.4mM EDTA (pH8.0), ImM dATP, ImM dCTP, 
ImM dGTP, ImM dTTP and 113pg/ml BSA. Store at -20°C.
Periodate BufFer: lOmM sodium metaperiodate, 20mM sodium acetate, pH5.4, 5mM 
NaN3, 50mM NaCl. Store at room temperature.
Periodate wash buffer 1: 0.2M glycerol, 150mMNaCl, 20mM Tris-HCl, pH7.2
Periodate wash buffer 2: As wash buffer 1 but minus glycerol
RNAse A: lOmg/ml stock solution in sterile water. Store at -20°C.
SDS-PAGE loading buffer (4x): 200mM Tris-HCl pH6.8, 400jiM  p-mercaptoethanol, 
8% SDS, 40% glycerol plus a few crystals of bromophenol blue.
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SM (Phage) buffer: 50mM Na2HP04, 22mM KH2P 04, 86mM NaCl, ImM MgS04, 
O.lmM CaCl2
SOC medium: 2% (w/v) tryptone, 0.5% (w/v) yeast extract, 0.05% (w/v) NaCl, 0.4% 
(w/v) glucose. The solution is prepared without glucose (SOB medium), autoclaved 
then sterile glucose solution is added.
SSC (20 x): 3M NaCl, 0.3M tri-sodium citrate pH7.0. Store at room temperature.
TAE (1 x): 40mM Tris-acetate, ImM EDTA. Store at room temperature.
TBE (10 x): 0.9M Tris-HCl, 0.9M boric acid, 25mM EDTA. Store at room 
temperature.
TBS-Tween (TBST, 1 x): 20mM Tris, 137mM NaCl pH7.6, 0.1% Tween 20. Store at 
room temperature.
TE buffer: lOmM Tris-HCl, pH7.4, ImM EDTA pH8.0. Store at room temperature.
TELT Buffer: 50mM Tris-HCl pH8.0, 62.5mM EDTA pH9.0, 2.5M LiCl, 4% Triton 
X-100. Store at room temperature.
Western blotting transfer buffer: 5mM Tris, 2mM glycine, 20% methanol in distilled 
water. Store at 4°C.
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CHAPTER 3
CLONING AND CHARACTERISATION OF GPI8 FROM 
PARASITIC PROTOZOA
3.1 INTRODUCTION
The biosynthesis of glycosylphosphatidylinositol (GPI) anchors occurs mainly on the 
cytoplasmic face of the endoplasmic reticulum (ER) membrane in a series of stepwise 
additions to the anchor structure beginning with phosphatidylinositol (described in 
Chapter 1). As biosynthesis nears completion, the GPI anchors are flipped to the 
lumenal face of the ER membrane where they are completed and ready for the terminal 
step in biosynthesis, attachment to particular cell surface proteins (Vidugiriene and 
Menon, 1995). Such proteins have C-terminal signal sequences that do not appear to 
be well conserved evolutionarily, in terms of their primary amino acid sequence, but 
which have overall conserved structural features (Ferguson and Williams, 1988). GPI- 
signals consist of three structural components (beginning with the most C-terminal 
component and moving towards the N-terminus):
C-terminal hydrophobic domain - 15-20 amino acids, to keep the nascent 
polypeptides associated with the lumenal face of the ER membrane.
Hydrophilic spacer - 9-12 amino acids.
Cleavage/attachment (©) site - 3 residues termed ©, ©+1 and ©+2. The © 
residue receives the anchor, ©+1 and ©+2, which are C-terminal to ©, are 
removed with the remainder of the GPI signal. The © site is restricted to a
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relatively small number of residues, namely Ser, Asn, Gly, Asp, Ala or Cys 
(Moran et al., 1991; Nuoffer et al., 1993; Micanovic et al., 1990)
The signal is recognised, removed and replaced with a GPI-anchor by a multi-protein 
complex known as the GPI:protein transamidase (Ferguson and Williams, 1988; and 
see Chapter 1). To date, most of the data relating to the transamidase subunits has 
come from yeast and mammalian systems. Two putative subunits have been identified 
in Saccharomyces cerevisiae:
Gaalp -  The protein is a 68kDa ER protein which has a large lumenal domain 
and several transmembrane domains.
Gpi8p -  A 47kDa ER protein with a large lumenal domain, a single ER- 
membrane spanning region and a short cytoplasmic tail (Benghezal et al., 
1996).
Conditional yeast mutants defective in each of these proteins demonstrated similar 
phenotypes, a build-up of GPI anchor precursors but no attachment of the GPI-anchor 
to cell surface proteins at non-permissive temperatures, indicating that the terminal 
step in biosynthesis was blocked (Hamburger et al. 1995; Benghezal et al., 1996). 
Similar phenotypes have been observed in mutant human cells referred to as class K 
cells (Chen et al., 1996), leading to the identification of the human GPI8 homologue 
by complementation of the mutant phenotypes with cDNA libraries (Yu et al., 1997). 
The human GAA1 homologue was identified in this way also (Hiroi et al., 1998). 
Gpi8p has significant similarity to jackbean asparaginyl endopeptidase, which has been
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shown to have in vitro transamidase activity (Abe et al., 1993) suggesting that Gpi8p 
is the catalytic subunit of the complex. Data from T. Kinoshita and co-workers 
(Osaka University, Osaka, Japan) presented at the International Meeting on 
Interactions of GPI-anchors with Biological Membranes, Splugen, Switzerland (1997) 
indicated that GAA1 seems to be involved in the recognition/binding of the GPI-signal 
sequences whilst GPI8 catalyses the transamidation reaction.
The GPI:protein transamidase is of considerable interest in the context of parasitic 
protozoa, which are known to make extensive use of this method of GPI-protein 
attachment; for example in Trypanosoma brucei the variant surface glycoprotein VSG 
(Ferguson et al., 1988) and procyclin (Clayton and Mowatt, 1989) membrane coats 
are the major GPI-linked proteins as is the promastigote surface metalloproteinase 
GP63 in Leishmania (Bordier et al., 1986).
The presence of GPI-anchored proteins in Leishmania (see (Cross, 1990; Ferguson 
and Williams, 1988)) implies that a GPI:protein transamidase must be present. The 
aim of this section was to identify and clone the gene (GPI8) encoding the predicted 
catalytic subunit of the complex, in L. mexicana.
Our approach was to use primers for the amplification of gene fragments using 
degenerate oligonucleotides designed to regions of genes which encode conserved 
stretches of amino acids between related proteins. This method of “fishing” for the 
presence of parasite genes rather than proteins as described originally by Sakanari and 
colleagues (Sakanari et al., 1989) and used successfully by Eakin and co-workers 
(Eakin et al., 1990) has much potential since the presence of a protein can be inferred
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from the presence of the gene. This also serves to allow subsequent characterisation 
of the primary sequence of the protein as well as further analysis, including production 
of recombinant protein. One of the ways of maximising the possibility of amplifying 
the correct gene (rather than false positives) is to carry out amino acid alignments of 
several related proteins and design primers against highly conserved regions each of 7 
or 8 amino acids. These conserved regions often surround active site residues that 
maintain structural constraints during evolution. Differences in one or more amino 
acids in these regions, as well as codon degeneracy and codon bias in the species of 
interest, means that the primers themselves will be degenerate. Thus much care must 
be taken when designing these primers and strategies must be employed to minimise 
the degeneracy since the greater the degeneracy the more dilute the homologous 
primer will be in the degenerate mixture and the less likely a successful PCR will 
occur. If tables of codon bias are available, as is the case for L. mexicana then codon 
degeneracy can be reduced. Leishmania species have a GC-rich genome (Alonso et 
al., 1992) so several codons are used at very low frequencies (less than 9%) and can 
be ignored.
The same approach was taken to identify similar genes from T. brucei and 
Plasmodium falciparum
3.2 RESULTS
3.2.1 Design and use of primers for PCR with L. mexicana template DNA
At the start of this project, three GPI8 amino acid sequences were available, (human, 
yeast and a putative Caenorhabditis elegans homologue, as well as a number of
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related proteins, including legumain, a jackbean asparaginyl endopeptidase and 
Schistosoma mansoni and S. japonicum haemoglobinases.
An amino acid alignment o f Saccharomyces cerevisiae, human and a putative C. 
elegans GPI8 identified in the C. elegans genome sequencing project with asparaginyl 
endopeptidases is shown in Figure 3.1. Several highly conserved sequences were 
identified (Figure 3.1) and used to design degenerate oligonucleotides (Table 3.1). L. 
mexicana has a GC-rich genome and four primers were designed accordingly using 
Leishmania codon bias (Langford et al., 1992) and also supplementary information 
supplied by Dr. Colin Robertson, Glasgow. The same regions were used to design 
primers for P. falciparum taking into account the AT-richness of the Plasmodium 
genome (Musto et al., 1995) and their use is described in Section 3.2.5. The 
sequences of all of these primers are shown in Table 3.1.
Table 3.1
Degenerate primers for PCR of GPI8 from L. mexicana and P. falciparum  and the 
corresponding amino acid consensus sequences— —
1) OL76 L. mexicana ACSAAYAAYTGGGCNGTBCTYGT 23
OL80 P. falciparum  
Amino Acid
ACWAATAATTGGGCWGTWCTWGT 
T N N W A V L V
23
2) OL77 L. mexicana CGBTTYTGGTTYAAYTAYCGBCA 23
OL81 P. falciparum  
Amino Acid
ARAT T T T G G T T TAAT TATAGACA 
R F W F N Y R
23
3) JATR3 L. mexicana 
Amino Acid
T C N TMV S HVC G RTART CVAC YT CVAC 
V E V D Y R G/S Y/E E
26
4) OL78 L. mexicana CCVCCRTGVCCSGTVAKRTARCT 23
OL82 P. falciparum  
Amino Acid
CCWCCRTGWCCWGTHAKATAWAT 
I Y M/L T G H G G
23
Key to nucleic acid symbols : R=A+G, Y=C+T, M=A+C, K=G+T, 
W=A+T, H=A+T+C, B=G+T+C, N=A+G+C+T, V=G+A+C
S=G+C,
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3.2.1.1 PCR using L. mexicana genomic DNA and cDNA
Nested PCR was used as a means of increasing the specificity of the polymerase chain 
reaction. In the first round of PCR the degenerate primers OL76 and OL78 were used 
with genomic DNA, log-phase (promastigote) first strand cDNA, stationary-phase 
(metacyclic promastigote) first strand cDNA and amastigote first strand cDNA
template at low annealing temperature (42°C). The cDNA template was produced 
from poly A+ mRNA purified from log-phase axenic promastigotes, stationary phase 
axenic promastigotes and mouse lesion-derived amastigotes respectively. Reactions 
were diluted 10 fold with water and 2|il was used in a second round of PCR, this time 
with primers OL77 (which is internal to OL76) and OL78 under the same conditions 
as the first round. Based on the yeast and human sequences, the size of the expected 
PCR product would be approximately 350bp. The reactions were electrophoresed on 
an agarose gel (Figure 3.2). A clear DNA fragment of the expected size was amplified 
from all L. mexicana DNA samples (Lanes 1-4). The products from all four template 
reactions were cloned into the pTAG vector utilising the overhanging adenosine 
nucleotides left at the 3' end of each strand of amplified DNA by Taq polymerase, 
during PCR (the vector is supplied in a linear form with overhanging 5' thymidine 
residues). The insert disrupts the plasmid lacZ gene allowing positive colonies to be 
screened by blue/white selection. White colonies were checked for recombinant 
plasmid by whole cell PCR using primers OL77 and OL78 under the same conditions 
that generated the original PCR products (see Figure 3.2 legend). Sequencing of these 
four PCR products using the T7 primer revealed that all had identical sequences of 
362bp, other than at the extreme ends where primer degeneracy resulted in some
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differences (see Figure 3.3). The presence of equal PCR products using each template 
suggests that GPI8 is being expressed during all stages of the life cycle, however this 
would need to be confirmed by Northern analysis to detect the transcript directly.
A BLAST search was carried out using these sequences translated using all six reading 
frames (BLASTX) and similarity was found with yeast and human GPI8, as well as the 
putative C. elegans GPI8, legumain and other cysteine proteinases (Figure 3.4).
3.2.1.2 Southern analysis with L. mexicana PCR product probe
To confirm that the PCR products were derived from L. mexicana, Southern blot 
analysis was performed. L. mexicana gDNA was digested with EcoRl, H indi, 
HindUl, Pstl or Xhol. The digests were electrophoresed and blotted by capillary
32
transfer. The blot was probed with [a] P-CTP labelled gDNA PCR product cut from 
the pTAG with Pvull yielding a 700bp fragment consisting of the PCR product 
flanked by vector sequence. After washing under high stringency, the blot was 
exposed to X-ray film for 5 days. The results are shown in Figure 3.5. A single 
hybridising band was detected in the Xhol, HindlH and £coRI lanes (Figure 3.5, lanes 
1, 3 and 5, respectively) whilst two bands were detected in the Pstl and Hincll lanes 
(lanes 2 and 4). The £coRI digest was slightly smeared which could have been due to 
more than one band or non-specific hybridisation of the probe. The hybridisation 
confirmed that the PCR products were derived from L. mexicana and indicate that the 
gene is probably single-copy. There is some discrepancy; the Pstl digest shows two 
bands, which correlates with the fact that the PCR product contains a Pstl site. By 
contrast the H indi digest gives two bands, a major one at 3kb and a second, fainter
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band of 3.8kb, despite the apparent absence of such a site within the sequence. It is 
possible that the two HincU sites have arisen through restriction fragment length 
polymorphism (RFLP) in one of the HincU sites rather than the second band being due 
to another copy of the gene since the other digests produce single bands. This was 
investigated further (see Section 3.2.3).
3.2.1.3 Isolation of full length GPI8 from an L. mexicana genomic library
The focus for subsequent work was to be with the L. mexicana putative GPI8, thus it 
was initially necessary to isolate the full-length gene. A L. mexicana genomic library 
consisting of a Sau3 Al partial genomic digest cloned into ADashll Vector (Stratagene)
(Mottram et al., 1997) was used at a titre of 5.5x10^ plaque forming units (pfu)/pl and 
was initially screened by plating out with the LE392 strain of E. coli. At least 40,000 
plaques, which arose through the localised lysis of the bacteria by the infecting 
A,phage, were lifted (by brief capillary flow) and the X DNA was fixed onto nitro­
cellulose filter (Hybond-N) following denaturing and neutralisation. The membranes 
were screened by hybridisation with the purified Pvull fragment containing the cloned 
L. mexicana gDNA PCR product originally used in the Southern analysis (Section 
3.2.1.2). Ten hybridising plaques were identified and picked into 500jil of fresh phage 
buffer and four of these were used in a second round of screening. Four independent 
X clones were isolated after secondary screening and two of these (XI and XI) were 
grown up to near confluent lysis on 150mm diameter bacterial plates and the X DNA 
purified. Both X DNA preps were digested with a number of restriction enzymes 
(BarntU, EcoFl, HindUl, Sail and Xho\\ X 2 was also digested with Xbal) and the
digested DNA was electrophoresed on an agarose gel and blotted. The blot was 
probed with the gDNA PCR fragment and washed under high stringency before being 
exposed to X-ray film for about 30 minutes. The resulting autoradiogram is shown in 
Figure 3.6. Three of the digests yielded bands of convenient sizes for subcloning i.e. 
less than 5-6kb. Three bands which hybridised to the probe, XI Sail (2.2 kb); XI Xhol 
(2.4kb) and XI Xbal (4.5kb) were subcloned into pBluescript SK+ (Stratagene). 
Following transformation of XL 1-blue supercompetent E. coli, ampicillin-resistant 
colonies were screened by blue/white selection and whole-cell PCR using primers 
OL77 and OL78. Positive colonies were grown up and plasmid mini-preps were 
carried out; test digests with the corresponding enzymes confirmed that correctly sized 
inserts were present within the plasmids (data not shown). The 2.2kb Sail fragment, 
the 2.4kb Xhol fragment and the 4.5kb Xbal fragment were called pGL185, pGL186 
and pGL187, respectively.
3.2.1.4 Sequencing of the L. mexicana genomic fragments
The subcloned lambda fragments were sequenced to yield 3.5kb of double stranded 
sequence covering the open reading frame of the L. mexicana GPI8. New primers 
were designed to overlap the ends of existing sequence (as it was obtained) as well as 
antisense primers to obtain sequence from the complementary strand. The 5' flank and 
ORF was obtained from pGL 186 whilst the 3' flank was obtained from pGL185 and 
pGL187 (see Figure 3.7). Sequence was analysed by the Molecular Biology Support 
Unit (MBSU, University of Glasgow) or Oswell Scientific (University of
75
Southampton) and between 300 and 600bp of sequence was obtained from each 
reaction.
The complete double stranded sequence of the coding region of the gene as well as 
1.3kb of 5’ and 1 kb of 3’ flanking region was determined (Figure 3.8A). The longest 
open reading frame was 1047bp (Figure 3.8A, shown in red text) and the 
corresponding amino acid sequence is given in Figure 3.8B. This sequence contained 
the predicted amino acid sequence obtained from the cloned PCR products (Section 
3.2.1.1).
There were two further open reading frames of the same orientation as the putative 
GPI8. One in the 5' flanking region of 740bp began 775bp and ended 35bp upstream 
of GPI8 start codon. The other ORF was in the 3' flanking region (704bp) and began 
32bp downstream of the GPI8 stop codon. Blast searches of the encoded proteins 
determined that neither of these proteins had significant homology to any proteins in 
the databases.
The complete 3337bp nucleotide sequence was submitted to the EMBL database with 
the accession number AJ242865 and the amino acid sequence of LMGPI8 has the 
accession number CAB55340.
3.2.2 Primary structure of LMGPI8
The longest of the three open reading frames (ORF) was 1050bp and encoded a 
protein of 349 amino acids with a predicted molecular mass of 38,900Da.
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The predicted primary sequence of LMGPI8 was compared with GPI8 from other 
species (Figure 3.9). BLAST searches at the National Centre for Biotechnology 
Information internet web site using the BLASTP programme which compares amino 
acid sequences with those in protein databases such as Swiss-prot, revealed homology 
of the predicted L. mexicana GPI8 with yeast and human GPI8 as well as the putative 
C. elegans GPI8. The plant asparaginyl endopeptidases including the Jack Bean 
endopeptidase which has been shown to exhibit in vitro transamidase activity (Abe et 
al., 1993) and the schistosome haemoglobinases (Klinkert et al., 1989; Gotz and 
Klinkert, 1993) were found to have lower homology to LMGPI8 than yeast GPI8. 
The “GAP” programme in the GCG package was used to calculate percentage 
identities between LMGPI8 and the related proteins and the data are given in Table 
3.2.
Table 3.2
Percentage identities between LMGPI8 and related proteins as calculated by the 
“GAP” programme (GCG Package, Wisconsin)
LMGPI8 31 31 31 19 21
ScGPI8 46 43 19 22
HsGPI8 46 20 22
CeGPI8 20 22
Legumain 22
Lm; Leishmania mexicana Ce; Caenorhabditis elegans
Sc; Saccharomyces cerevisiae Legumain -  a plant asparaginyl endopeptidase
Hs; Homo sapiens Sm31 -  haemoglobinase from Schistosoma mansoni
L. mexicana GPI8 shares 31% identity with both human and yeast GPI8, somewhat 
less than the 46% these two homologues share with one another. This is still
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significantly higher than the 19-21% identity shared with the other related enzymes, 
the legumains and the Schistosome haemoglobinases. The C. elegcms protein appears 
to be more similar to the yeast and human proteins, however the protein sequence may 
not be complete since this is a hypothetical protein derived from the Caenorhabditis 
elegans genome sequencing project (see next section).
3.2.2.1 LMGPI8 has several conserved amino acids of interest
Comparison of the amino acid sequence of LMGPI8 with the yeast and human 
homologues as well as Canavalia ensiformis (jack bean) legumain is shown in Figure 
3.9. Cysteine proteinases belonging to the C13 family (Barrett and Rawlings, 1996), 
possess the classical catalytic dyad residues cysteine and histidine and the positions of 
conserved Cys and His residues are indicated in Figure 3.9. Two histidine (His63 and 
His174) and two cysteine residues (Cys94, Cys216) were conserved between all of the 
GPI8 homologues. Whilst both histidine residues were found to be conserved in 
legumain and GPI8, of the cysteine residues, only Cys216 was conserved making it the 
most likely candidate for the active site cysteine, assuming that GPI8 is a cysteine 
proteinase and that legumain has a similar three dimensional structure.
LMGPI8 also possesses three potential glycosylation sites at N163, N268and N307 
(Figure 3.9).
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3.2.2.2 Comparison of hydrophobicity profiles of GPI8 homologues
The EXP AS Y Internet web site (http://www.expasy.ch/tools) provides a programme 
called “Prot-Scale” which calculates a hydrophobicity plot of any given amino acid 
sequence using a number of algorithms; the Kyte-Doolittle algorithm was used in this 
case. This assigns scores to individual amino acids according to degrees of 
hydrophobicity such that hydrophobic residues have scores greater than zero and 
hydrophilic residues score less than zero. The data is presented in numerical format, 
which can be entered into graphical software packages such as Microsoft Excel. Thus 
an overall hydropathy profile of a polypeptide can be constructed graphically and 
compared with those of related proteins. Similar profiles of hydrophobicity and 
hydrophilicity may be indicative of similar folding patterns in protein secondary 
structure. The hydrophobicity plot of LMGPI8 is compared with yeast and human 
GPI8 in Figure 3.10. There are notable patterns of similarity between the 
hydrophobicity profiles of each GPI8, including a strongly hydrophobic region at the 
N-terminus (corresponding to the endoplasmic reticulum signal peptide (Walter et al., 
1984)) and similar peaks of hydrophobicity and hydrophilicity throughout most of the 
remainder of the protein. For example, the hydrophobic peaks between approximately 
140 and 210 amino acids of L. mexicana GPI8, indicated by the blue arrows in Figure 
3.10A correspond to those between 120 and 190 amino acids of S. cerevisiae Gpi8p 
(Figure 3.1 OB). This region also has a similar profile in human GPI8, between 140 
and 200 amino acids (Figure 3.10C). There is a second strongly hydrophobic region at 
the C-terminus of both the yeast and human GPI8 proteins corresponding to ER 
transmembrane domains of these ER-lumen proteins (Benghezal et al., 1996). 
Interestingly, this is absent in LMGPI8.
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3.2.3 Confirmation of LMGPI8 copy number by Southern analysis
A number of genomic digests using either one or two restriction enzymes were set up 
to confirm that GPI8 is a single copy gene. The enzymes chosen and the fragment 
sizes are given in Table 3.3.
Table 3.3
Restriction digests of genomic DNA in the investigation of GPI8 copy number
H indi 3.1
H in d ll >10
Pstl 1.5 and 2.4
Xbal 5.0
Xhol 2.4
The digests were electrophoresed and blotted as before and were probed with a 1.1 kb 
XbaUXhol GPI8 fragment obtained from pGL187 (Figure 3.11 A) which represents the 
entire coding region of the gene (including 30bp of the 5' flank). The Southern blot 
was exposed to X-ray film for several days and is given in Figure 3.1 IB. The presence 
of a single 3.1 kb band in the Hincll digest precisely matches the known DNA 
sequence (Panel A and 3.1 IB, lane 1). This indicates that the other bands seen using 
the cloned PCR product as probe (Section 3.2.1.2) were probably due to non-specific 
hybridisation of the PCR product or the plasmid flanking regions rather than a true 
restriction fragment length polymorphism. All of the other digests produced single 
bands except Pstl (Figure 3.1 IB -  lane 3) which produced two as expected, given the 
presence of a Pstl site in the gene coding region (Figure 3.11 A). From the DNA 
sequence, a Pstl site is found 1.5kb downstream of the Pstl site within the open 
reading frame, so there must be a third Pstl site 2.4kb upstream of the this ORF site to
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yield the larger of the two fragments. Taken together, the data indicates that GPI8 is a 
single copy gene.
3.2.4 PCR using Trypanosoma brucei genomic DNA
PCR was carried out firstly using the Leishmania primers in all o f the possible 
combinations with T. brucei genomic DNA, supplied by Nick Robinson (Glasgow). A 
single specific DNA fragment was detected, however this proved to be somewhat 
larger than expected at 500bp. Nevertheless, it was selected for cloning and 
sequencing but was found to be a gene fragment encoding the major cathepsin L-like 
cysteine proteinase from T. brucei (Mottram et al., 1989) rather than a T. brucei GPI8 
homologue. The experiment on T. brucei DNA was repeated using the P. falciparum 
primers (OL80-82), however no PCR products could be detected. After the sequence 
of the L. mexicana GPI8 was obtained it was found that there were several amino acid 
substitutions within the L. mexicana primer regions that differed from those used to 
design the original degenerate primers. On the assumption that the T. brucei gene was 
likely to be very similar to that of L. mexicana two new degenerate primers were 
designed with no codon bias (reflecting the neutral G/C content of the African 
trypanosome genome (Musto et al., 1994)) to this revised sequence (corresponding to 
primers OL77 and OL78 (see Table 3.1)). These are given in Table 3.4.
Table 3.4
Degenerate primers for nested PCR of T. brucei GPI8 transamidase gene and the 
corresponding amino acid sequence.
1) OL76 Leishmania ACSAAYAAYTGGGCNGTBCTYGT 23
(and T. brucei)
Amino Acid T N N W A V I V
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2 )  O L 4 7  T. brucei MGNTAYYTNTTYAAYTAYMGNCA 23
Amino Acid R/S Y L/F F N Y R/S H
3 )  O L 4 8  T. brucei GCNCCRTGNCCNGCNACRTADAT 23
Amino Acid I Y V A G  H G  A
Key to nucleic acid symbols: R=A+G, Y=C+T, M=A+C, K=G+T, S=G+C, 
W=A+T, H=A+T+C, B=G+T+C, N=A+G+C+T, V=G+A+C
PCR was carried out as described previously (Figure 3.2 Legend) using primers OL76 
and OL48 in the first round and OL47 and OL48 in the second round. This time, 
however, no PCR products were detected despite repeated attempts at this reaction. 
It is possible to vary the components of reactions to obtain optimum conditions, 
however this was not attempted, as an alternative method of isolating the gene, 
heterologous library screening was attempted.
3.2.4.1 Screening of a T. brucei brucei genomic library with the L. mexicana 
GPI8
The close evolutionary distance between African trypanosomes and Leishmania means 
that there would be expected to be a high level of nucleotide sequence identity 
between GPI8 homologues, as has been found for many homologue genes between the 
species. For example, the type I (cathepsin L-like) cysteine proteinases (Souza et al., 
1992; Mottram et al., 1989) and the cyclin dependent kinase CRK3 (Grant et al., 
1998) share 47% and 78% identity respectively. Thus the XbaVXhol fragment from
pGL187 containing LMGPI8 ORF (Figure 3.11 A) was used as a probe to screen a T.
brucei brucei genomic library (prepared and supplied by Dr. Nils Burman and Nick 
Robinson of the University of Glasgow) at low • stringency (see Materials and 
Methods). The procedure was carried out as described in Section 3.2.1.3 except that
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only one obvious hybridising plaque was obtained in the primary screen. Secondary 
screening yielded several hybridising plaques of which two were isolated and their 
DNA purified.
Both phage preps were digested with a number of restriction enzymes (see Figure 3.12 
legend), electrophoresed, blotted and probed at low stringency to determine which 
fragments contained the putative TBGPI8. The gels were stained with ethidium 
bromide and visualised prior to blotting. Both clones produced identical restriction 
patterns as expected from having come from a single plaque at primary screening 
(Figure 3.12A). The probe hybridised to fragments of just over 5kb in the Hindlll and 
Xhol digests (Figure 3.12B, Lanes 1 and 4, respectively). The Sail digest (Figure 
3.10A, Lane 2) produced a smear of DNA in each case, which may be due to the 
presence of contaminating deoxyribonucleases (restriction enzymes are stored as 
communal stocks used by several research groups, so the possibility of contamination 
is increased). Despite this, a lOkb fragment was labelled on the Southern blot (Figure 
3.12B, lane 2).
Due to time constraints, the TBGPI8 has not yet been subcloned, however the Hindlll 
and Xhol fragments are of a good size for subcloning and will be gel purified and 
ligated with pBluescript (Stratagene) for further analysis in the near future.
3.2.4.2 PCR with T. b. brucei X DNA containing putative TBGPI8
PCR reactions using both primer pairs OL76 and OL48 and OL47 and OL48 were
carried out using as template, DNA isolated from X phage described in the previous
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section. A PCR product of the expected size of about 350bp was detected with 
primers OL76 and OL48 but not with OL47 and OL48 (Figure 3.13A). This fragment 
was gel-purified and cloned into pGEM-T Vector (Promega), similar to the pTAG 
vector used with L. mexicana PCR products (Section 3.2.1.1). Plasmid (pGL446) 
was isolated from transformants using Plasmid Mini-Prep Kit (Sigma) and it was 
sequenced in double stranded form (Figure 3.13B).
The sequence was used in a BLAST search using the BLASTX programme (as 
described in Section 3.2.1.1) and was found to have greatest similarity to GPI8 
proteins of yeast and humans (Figure 3.13C). If the primer regions, which are 
degenerate and unlikely to be of the exact gene sequence, are ignored, the predicted 
amino acid sequence is found to share around 70% identity with L. mexicana GPI8 
over this region (Figure 3.13D) as determined by the “GAP” programme (GCG, 
Wisconsin). Thus a putative T. brucei GPI8 has been isolated.
3.2.5 PCR using Plasmodium falciparum  genomic DNA
To identify a putative Plasmodium homologue of GPI8 PCR was carried out with the 
L. mexicana primers on P. falciparum genomic DNA (a gift from Dr. John Hyde, 
UMIST; all conditions were identical to those described in Section 3.2.1.1.), however 
no PCR products were obtained. Primers were redesigned (Table 3.1: OL80-82) 
using P. falciparum codon bias (Musto et al., 1995) and these were used in nested 
PCR as described previously, for L. mexicana (Section 3.2.1.1). This time, however, 
three bands were detected between about 300 and 500bp (Figure 3.14). In order to 
confirm which of these were genuine products of all primers used (and not just from 
single primers binding non-specifically at this relatively low annealing temperature),
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reactions using all of the combinations of primers both alone and with another primer 
were also carried out (see Figure 3.14 legend). Only one band (arrowed in yellow) 
was found to be specific as the other bands were also amplified when only one primer 
was used. This band was selected for purification, cloning and sequencing.
The gel purified 350bp fragment was cloned into the pGEM-T vector and a number of 
positive colonies were identified. Recombinant plasmid (pGEM-T/PfPCR, the plasmid 
was not assigned a pGL number) was isolated by the Wizard Plus Mini-Prep Kit and 
sequenced. BLAST sequence similarity searches with the nucleotide sequence 
translated in all six reading frames (BLASTX programme) revealed that the PCR 
product had high percentage identities with both human and yeast GPI8 (70 and 85 
percent respectively) while the nucleotide sequence identity was 62 and 73% identical 
respectively. The percentage of either A or T in the third position of each codon was 
more than 75%, which is indicative of Plasmodium DNA due to high A/T-rich genome 
(Musto et al., 1995). To test if this PCR product was of Plasmodium origin Southern 
analysis was carried out using the cloned fragment excised from the plasmid vector, as 
a probe.
3.2.5.1 P. falciparum  Southern analysis
P. falciparum genomic DNA was digested with EcoRl and HindUl and these reactions 
were electrophoresed on a gel and blotted as before. The probe was derived from the 
P. falciparum cloned fragment, which was excised from pGEM-T/PfPCR by digestion 
with Sacl and Sail giving a fragment of about 550bp (including some vector sequence)
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and this was labelled with [a]32P-CTP using the Prime It II Random Primer Kit 
(Stratagene). No hybridisation to Plasmodium DNA was observed, even when low 
stringency conditions were used (not shown). A positive control to check the quality 
of Plasmodium DNA, consisting of a 750bp PCR fragment of the P. falciparum 
dihydrofolate reductase gene was labelled and used to probe the same blot. This 
demonstrates a single hybridising band in each digest lane as expected indicating that 
the DNA had indeed transferred to the nitro-cellulose (not shown). Thus it is likely 
that the PCR product was not of P. falciparum origin. The high level of sequence 
identity with the yeast GPI:protein transamidase suggests that there may have been 
some contaminating yeast DNA in the Plasmodium DNA used for PCR reaction. 
Perhaps the culture was yeast-contaminated prior to DNA purification.
The finding that the cloned PCR product amplified from a sample of P. falciparum 
gDNA did not hybridise to Plasmodium DNA suggested a low-level contamination of 
the template with DNA from another source. The encoded amino acid sequence of 
cloned fragments had high homology to both yeast and human proteins, but was 
sufficiently different to rule out contamination from either of these sources. It should 
be possible to identify P. falciparum GPI8 from sequence data generated by the 
genome project and the database is screened on a regular basis.
3.3 DISCUSSION
We predicted the presence of L. mexicana GPI8 and subsequently cloned a gene, 
which encodes a protein with homology to yeast and human Gpi8p (yeast 
nomenclature). Fragments of genomic DNA, which included the ORF and 5' and 3'
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flanking regions, were characterised by automated sequencing using specifically 
designed primers such that double stranded sequence was obtained for a 3.5kb region, 
consisting of GPI8 and 1.3 kb and 900bp of the 5' and 3' flanking regions, 
respectively.
The initial PCR data where fragments of GPI8 were cloned from cDNA produced 
from different life cycles, indicated that the gene was likely to be expressed during all 
three stages of the Leishmania life cycle. This remains to be confirmed, either by the 
direct detection of the protein itself or by Northern analysis to detect the transcript. It 
is known, however that, in many cases, regulation of gene expression occurs post- 
transcriptionally in trypanosomatids since many genes are transcribed simultaneously in 
the form of large, polycistronic messenger RNA molecules which are processed into 
individual mRNA molecules of varying stability (Coulson et al., 1996; Curotto de 
Lafaille et al., 1992; Vanhamme and Pays, 1995). Regulation at the post-translational 
level is apparently not as prevalent but does also occur. Expression of GP63, for 
example, is regulated post-translationally, where glycosylation of the protein 
contributes to its intracellular stability and the addition of a GPI-anchor is necessary 
for the protein to remain associated with the cell ((McGwire and Chang, 1996; Mensa- 
Wilmot et al., 1994) and Chapter 4). The presence of GPI-anchored proteins in all life 
cycle stages, for example GP63 in promastigotes but not in amastigotes (Medina- 
Acosta et al., 1993) and promastigote surface antigen 2 (PSA2), which has recently 
been detected in amastigotes (Handman et al., 1995) would also mean a requirement 
for the transamidase in each. Therefore direct detection of the protein by Western 
blotting using GPI8 specific antibodies would be better evidence for the presence of 
the GPI: protein transamidase in each stage of the life cycle.
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The primary sequence of L. mexicana GPI8 shares a significant degree of identity with 
both yeast and human homologues. The proteins have similar hydropathy profiles to 
one another, perhaps indicating similarities in protein secondary structure (something 
that can be clarified, eventually, by X-ray crystallography) although no GPI:protein 
transamidase structures have been solved to date. The apparent lack of a C-terminal 
transmembrane domain, which keeps the yeast and human homologues associated with 
the ER membrane, may suggest differences in the way GPI8 is anchored to the ER 
membrane. It is possible that GPI8 interacts with another ER integral membrane 
protein, perhaps with a homologue of GAA1 (Hamburger et al., 1995; Hiroi et al., 
1998). If GPI8 does not contain an ER transmembrane domain, then how is the 
protein retained within the ER? The four amino acid residues at the C-terminus are 
YDLE and may function as an ER retention motif given that they are similar to the 
classical mammalian ER-retention signal, KDEL (Munro and Pelham, 1987) and 
HDEL in yeast (Pelham et al,, 1988). The ER molecular chaperone, BiP in T. brucei 
has the tetrapeptide MDDL and deletion of this motif results in secretion of the protein 
(Bangs et al., 1996). The GPI8 tetrapeptide could be investigated by addition of this 
sequence to a protein that is normally secreted (or targeted to post-ER compartments 
such as the lysosome) and immunofluorescence could be used to determine its final 
location compared with wild type cells. Alternatively, the tetrapeptide could be 
deleted and the effect on GPI8 could be determined either directly, by 
immunofluorescence (when antibodies are available), or indirectly, by the assessment 
of GPI8 activity through analysis of GPI-anchor attachment for proteins such as GP63.
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Variation between ER isoenzymes involved in GPI biosynthesis has been reported in 
other organisms. Two classes of dolichol phosphate mannose synthase (DPMS), have 
been identified in T. brucei, yeast (Saccharomyces cerevisiae and 
Schizosaccharomyces pombe) and humans (Colussi et al., 1997). The trypanosome 
and budding yeast enzymes contain a C-terminal hydrophobic domain, whereas human 
and fission yeast enzymes do not. Both the human and Saccharomyces cerevisiae 
genes can complement a lethal null mutant in fission yeast, however, indicating that the 
enzymes are functionally equivalent (Colussi et al., 1997). It is likely that the L. 
mexicana GPI8 will be able to functionally replace the human enzyme; there may be 
differences associated with the substrate binding pockets as has been demonstrated 
with T. brucei GPI:protein transamidase (Moran and Caras, 1994). VSG, when 
expressed in mammalian cells was not expressed on the cell surface until the 
cleavage/attachment site (co, g>+1, co+2) of a mammalian protein was used to replace 
the VSG co site. It was concluded that the binding pocket of the trypanosome 
transamidase would have to be larger than that of the human homologue because to 
accommodate the VSG © site. We would expect the T. brucei GPI:protein 
transamidase to be similar to the L. mexicana enzyme in terms of structure and 
perhaps also substrate specificity; the former appears to be less stringent than its 
mammalian homologue.
GPI8 belongs to the C13 family of cysteine proteinases (Barrett and Rawlings, 1996; 
Riezman and Conzelmann, 1998), which includes a family of plant cysteine proteinases 
known collectively as the legumains (Ishii, 1994) and the schistosome 
haemoglobinases (Dalton et al, 1995a; Dalton et al, 1995b; Gotz and Klinkert 1993). 
Cysteine proteinases such as papain and legumain require a cysteine and a histidine
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residue for activity and primaiy sequence analysis has revealed four residues that could 
potentially be part of the GPI8 active site. Cys94, Cys216, His63 and His174 residues (L. 
mexicana GPI8 numbering) are conserved between L. mexicana, yeast and human 
GPI8. Cys216, is also conserved in legumain from Ccmavalia ensiformis, which has 
been shown to have in vitro transamidase activity (Abe et al., 1993) making it the 
most likely candidate, if GPI8 is a cysteine proteinase. Activity of the T. brucei 
GPI:protein transamidase is sensitive to sulphydryl alkylating reagents, strongly 
suggesting that GPI8 is indeed a cysteine proteinase (Sharma et al., 1999a). The 
protein also contains three potential N-glycosylation sites however, none of these are 
conserved with the N-glycosylation sites on yeast Gpi8p, which is heavily glycosylated 
(Benghezal et al., 1996). Further investigation of the active site residues and 
glycosylation of GPI8 is described in Chapter 5. In addition to these features, there is 
a 5 amino acid insert (beginning at residue 112, Leishmania numbering, Figure 3.9) 
not present within either Saccharomyces cerevisiae Gpi8p or in human GPI8. 
Interestingly, part of this insertion is absent from the putative TBGPI8 described 
below (and Figure 3.13C).
The use of LMGPI8 ORF as a heterologous probe to screen a T. b. brucei genomic 
library has led to the isolation of a single lambda clone which is likely to contain the 
ORF of TBGPI8. PCR using the primers specifically designed for amplification of a T. 
brucei PCR product (OL76 and OL48) with the purified lambda clone yielded a PCR 
product of the expected size. When cloned, sequenced and translated, this was found 
to have a high degree of identity (70%) with the L. mexicana protein over this region. 
Interestingly, the outermost primer pair designed for nested PCR produced this 
fragment, however the innermost primer pair (OL47 and OL48) did not, suggesting
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that there is a problem with primer OL47. Analysis of the sequence to which OL47 
would anneal indicates that there is no obvious reason that the primer doesn’t function 
since the actual TBGPI8 sequence is found within the degeneracy of the primers. 
Perhaps the primer has been synthesised incorrectly. The sequence of the L. mexicana 
equivalent primer (OL77) is similar enough that it may work with T. brucei DNA 
template in combination with the other T. brucei primers (OL76 and OL48), however 
this remains to be tested.
Sequence analysis is highly indicative that the L. mexicana gene encodes a functional 
equivalent of yeast Gpi8p however it remains to be seen if the encoded protein does 
indeed have a role as a component of the GPI:protein transamidase complex as has 
been seen with yeast and human homologues. It remains a possibility that LMGPI8 is 
an asparaginyl endopeptidase involved in some, as yet unknown, biochemical pathway 
in Leishmania perhaps analogous to the seed storage protein-maturation role exhibited 
by the legumains (Hara-Nishimura et al., 1995; Abe et al., 1993) since it is now 
known that legumains are not confined to plants (Chen et al., 1997; Chen et al., 
1998b). In addition, the similarity to the schistosome haemoglobinases, which are 
thought to be processing enzymes that bring about the activation of another proteinase 
(Dalton et al, 1995a; Dalton et al, 1995b; Gotz and Klinkert 1993) could mean that 
LMGPI8 has some role in proteinase processing. The remaining chapters will describe 
experiments carried out to address the question of the role of LMGPI8. The fact that 
a single copy gene encodes LMGPI8 means that the function of the protein can be 
assessed by gene knockout experiments.
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Figure 3.1: Amino acid sequence alignment of N-terminal regions of 
Saccharomyces cerevisiae and Homo sapiens GPI8, Caenorhabditis elegans 
putative GPI8, two Schistosome asparaginyl endopeptidases (haemoglobinases)
and legumain. Numbering of the pileup is according to H. sapiens GPI8. Note that 
this protein was predicted from a partial cDNA such that the N-terminus is incorrect. 
The complete protein sequence is now known (Yu et al., 1997). The conserved 
regions used to design primers are highlighted as follows: OL77, JATR3 and
OL78
Abbreviations:
Sc = S. cerevisiae GPI8 (Benghezal et al., 1996)
Hs = H. sapiens GP18 (Benghezal et al., 1996) 
and (Yu et al., 1997)
Ce = C. elegans putative GPI8
Sj = Schistosoma japonicum  haemoglobinase (Swiss-Prot accession number P42665) 
Sm = Schistosoma mansoni haemoglobinase (Gotz and Klinkert, 1993)
Lg = Legumain (Canavalia ensiformis asparaginyl endopeptidase (Takeda et al., 
1994; Abe et al., 1993)).
1
S c   ----------------- M RIAMHLPLLL l y i f l l p l s g  a n n t d a a h e v  i a t n i
Hs SLHEADSLSR AATVLATVLL LSFGSVAASH IEDQAEQFFR . SGhI
Ce   MRST AIHNSAQFPP LRFRIFFG FR FERSSGLSEK VTGh|
S j  --------------------m F Y S IF F IH IL  RIVLVDCN...................EYSEENV DDR . . HKWAV
Sm ----------------- MM L F S L F L IS IL  HILLVKCQLD TNYEVSDETV SDN..NKW AV
Lg ------------- ~MVM MLVMLSLHGT AARLNRREWD SVIQLPTEPV DDEVGTRWAV
S c  M STSRFW FN YRHMANVLSM YRTVKRLGIP DSQIILM LSD
Hs H c t s r f w f n  YRHVANTLSV YRSVKRLGIP DSHIVLMLAD
Ce - -k H j f n ' I H h v s n v l a l  y h s i k r l g i p  d s n i i m m l a e
S j  LVAGSNGFEN YRHQADVCHA YHVLLSKGVK PEHIITFMYD
Sm LVAGSNGYPN YRHQADVCHA YHVLRSKGIK PEHIITMMYD
Lg LVAGSNGYGN YRHQADVCHA YQLLIKGGVK EENIVVFMYD
100
DVACNSRNLF
DMACNPRNPK
DVPCNSRNPR
DIAHNKENPF
DIAYNLMNPF
DIAYNAMNPR
101 150
S c  PGSVFNNK..........................DHAI DLYGDSVEVD YRGYEVTVEN FIRLLTDRWT
Hs PATVFSHK......................... NMEL NVYGDDVEVD YRSYEVTVEN FLRVLTGRIP
Ce PGTVYAAR............................ AGT NLYGSDVEVD YRGEEVTVES FIRVLTGRHH
S j PGKIFNDYRH.KDYYKG.................................VVID YKGKKVNPKT FLQVLKGDKR
Sm LGKLFNDYNH KDWYEG.................................VVID YRGKKVNSKT FLKVLKGDKS
Lg PGVIINHPQG PDVYAG.................................VPKD YTGEDVTPEN LYAVILGDKS
151
S c  EDHPKSKRLL 
Hs PSTPRSKRLL 
Ce PATPRSKRLL 
S j  . . . . AGGKVL 
Sm . . . . AGGKVL 
L g KVKGGSGKVI
. TDEN SNIi l  YMTGHQjDDF  
. SD D R SN IL I  Y M T G H ajNGF 
. TDHQSN'. I  Y L T G H *  D SF
KSGKNDDVFI YFTDHGAPGI 
KSGKNDDVFI YFTDHGAPGL 
N SN P E D R IF I FYSDHGGPGV
LKFQDAEEIA 
LKFQDSEEIT  
MKFQDSEELT 
LAFPDDD. LH 
IA F P D D E . LY 
LGMPNAPFVY
2 0 0
SEDIADAFQQ
NIELADAFEQ
NVDLAYAIQT
AKPFINTLKY
AKEFMSTLKY
AMDFIDVLKK
201 250
S c MYEKKRYNEI FFMIDTCQAN TMYSKFYSPN ILAVGSSEMD ESSYSH HSDV+++
Hs MWQKRRYNEL LFIIDTCQGA SMYERFYSPN IMALASSQVG EDSLSHQPDP+++
Ce MFEDNRYHEM LVIADSCRSA SMYEWIDSPN V LSLSSSLTH EESYSYDVDT+++
S j LRQHRRYSKL VIYVEACESG SMFAGLLPTD INIYATTAAR PDESSYATFC+++
Sm LHSHKRYSKL V IY IEA N ESG SMFQQILPSN LSIYATTAAN PTECSYSTFC+++
Lg KHASGGYKEM V IY IEA C ESG SIFEGIM PKD LNIYVTTASN AQENSFGTYC+++
92
Figure 3.2: Leishmania mexicana PCR products using nested PCR. Initially, 
primers OL76 and OL78 (see Table 3.1) were used with Taq polymerase using 
template DNA derived from L. mexicana (genomic DNA and cDNA from each of 
the three life cycle stages). These reactions were diluted ten fold in sterile water 
and lpl of each was used as the template for a second round of PCR, this time using 
primers OL77 and OL78. Both rounds of PCR were run as follows:
94°C, 4 minutes 
94°C, 30 seconds ^  
42°C, 30 seconds V 
72°C, 60 seconds
72°C, 4 minutes
x 1
x 25 cycles
x 1
The PCR product was expected to be approximately 350bp. Reactions were 
electrophoresed on 1.2% agarose gel and the gel was stained with ethidium 
bromide.
Lane 1: Genomic DNA template
Lane 2: Middle log-phase (promastigote) cDNA template
Lane 3: Stationary-phase (metacyclic promastigote) cDNA template
Lane 4: Lesion-derived amastigote cDNA template.
Markers: lkb ladder (GibcoBRL)
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Figure 3.3: Alignment of the nucleotide sequences of four cloned L. mexicana 
PCR products. The PCR products from each of the four reactions were cloned 
into pTAG and sequenced with the T7 primer using automated sequencing with the 
AmpliTaq Ready Mix. Sequences were aligned using the Pileup programme from 
the GCG Software Package. Differences in the sequences are highlighted in green.
P = Promastigote 
M = Metacyclic 
A = Amastigote 
G = Genomic
1 5 0
P CGGTTiTGGT t | a a | t a | cg  | c a c a c c g c c  a a t g c g c t t a  CCATGiACCA
m c g g t t I t g g t  : i .  r J cg  I c a c a c c g c c  a a t g c g c t t a  c c a t g I a c c a
a  c g g t t I t g g t  t I a a I t a I cg  I c a c a c c g c c  a a t g c g c t t a  c c a t g I a c c a
g c g g t t | t g g t  t | a a | t a | c g  I c a c a c c g c c  a a t g c g c t t a  c c a t g | a c c a
5 1  1 0 0
p CCTCTTGCGT CAGCACGGCA TTGACGACGA CCATATTCTT CTCTTTTTGA
M CCTCTTGCGT CAGCACGGCA TTGACGACGA CCATATTCTT CTCTTTTTGA
A CCTCTTGCGT CAGCACGGCA TTGACGACGA CCATATTCTT CTCTTTTTGA
G CCTCTTGCGT CAGCACGGCA TTGACGACGA CCATATTCTT CTCTTTTTGA
1 0 1 1 5 0
P GTGACAGCTT CGCCTGCGAC CCGCGAAATG TGTACCCTGC GGAGATTTTT
M GTGACAGCTT CGCCTGCGAC CCGCGAAATG TGTACCCTGC GGAGATTTTT
A GTGACAGCTT CGCCTGCGAC CCGCGAAATG TGTACCCTGC GGAGATTTTT
G GTGACAGCTT CGCCTGCGAC CCGCGAAATG TGTACCCTGC GGAGATTTTT
1 5 1 2 0 0
P TCGCAGCCCC CCGGAGCACA CGACGCGGAT GGGCGCGCTA GCATGAATCT
M TCGCAGCCCC CCGGAGCACA CGACGCGGAT GGGCGCGCTA GCATGAATCT
A TCGCAGCCCC CCGGAGCACA CGACGCGGAT GGGCGCGCTA GCATGAATCT
G TCGCAGCCCC CCGGAGCACA CGACGCGGAT GGGCGCGCTA GCATGAATCT
2 0 1 2 5 0
P GTACGGCTGC AGCGCGCAGG TGGACTACGC GGGCAGCGAC GTGGACGTGC
M GTACGGCTGC AGCGCGCAGG TGGACTACGC GGGCAGCGAC GTGGACGTGC
A GTACGGCTGC AGCGCGCAGG TGGACTACGC GGGCAGCGAC GTGGACGTGC
G GTACGGCTGC AGCGCGCAGG TGGACTACGC GGGCAGCGAC GTGGACGTGC
2 5 1 3 0 0
P GCCGTTTTCT AAGTGTGTTG CAGGGCCGTT ATGACGAGAA CACGCCGCCC
M GCCGTTTTCT AAGTGTGTTG CAGGGCCGTT AT GAC GAGAA CACGCCGCCC
A GCCGTTTTCT AAGTGTGTTG CAGGGCCGTT ATGACGAGAA CACGCCGCCC
G GCCGTTTTCT AAGTGTGTTG CAGGGCCGTT ATGACGAGAA CACGCCGCCC
3 0 1  3 5 0
ACGCGGCGAC TCCTTTCGGA CAACACATCG AACATCATCA G |T A |A T |A C  
ACGCGGCGAC TCCTTTCGGA CAACACATCG AACATCATCA g | t a | a t | a C 
ACGCGGCGAC TCCTTTCGGA CAACACATCG AACATCATCA g| t a | a t | a C 
ACGCGGCGAC TCCTTTCGGA CAACACATCG AACATCATCA g | t a | a t | a C
P
M
A
G
3 5 1  3 6 2
CG G |( H [  |  gg 
cg g | c ^ B g |  gg 
c g g | c c a t g |  tg  
c g g | c | . t g  $  GG
p
M
A
G
Reading High Probability
Sequences producing High-scoring Segment Pairs: Frame Score P (N) N
g i |2558891 (AF022913) GPI transamidase [Homo. . . +1 170 1 .4e-34 2
gnl|PIDIe259413 (Y07596) gp±8 [Homo sapiens] + 1 170 1 .4e-34 2
sp|P49048|YJ96 CAEEL HYPOTHETICAL 35.7 KD PROTEIN T05E. . . +1 165 1.2e-32 2
gnl|PID|e349322 (Z68751) T05E11.6 [Caenorhabditis. . . +1 165 1 .5e-32 2
gnl|PID|e257726 (Z75551) T28H10.3 [Caenorhabditis. . . +1 134 3 .8e-17 2
sp|P49018|GPI8 YEAST GPI-ANCHOR TRANSMIDASE /pir||S597. . . +1 168 4.2e-16 1
gnl|PID|e286211 (Y09862) legumain [Homo sapiens] +1 107 2 .0e-10 2
gnl|PID|dl010173 (D55696) cysteine protease [Homo . . . +1 107 2 .0e-10 2
sp|P49043|VPE CITSI VACUOLAR PROCESSING ENZYME PRECUR. . . +1 106 1 .8e-09 2
sp|P42665|HGLB SCHJA HEMOGLOBINASE PRECURSOR (ANTIGEN . . . +1 104 5 .5e-09 2
sp|P09841|HGLB SCHMA HEMOGLOBINASE PRECURSOR (ANTIGEN . . . +1 102 5 .6e-09 2
gnl|PID|dl019665 (D61395) gamma-VPE [Arabidopsis t . . . +1 100 4 .le-07 2
g i |161019 (M21308) hemoglobinase [Schistose. . . +1 92 7 .3e-07 2
gnl|PID|e354317 (Z99956) asparagine-specific endo. . . +1 98 8.7e-07 2
sp|P49044|VPE VICSA VACUOLAR PROCESSING ENZYME PRECUR. . . +1 100 1 .8e-06 2
sp|P49042|VPE_RICCO VACUOLAR PROCESSING ENZYME PRECUR. . . +1 99 1 .8e-06 2
pir||S60050 vacuolar processing enzyme (EC 3.. . . +1 95 2 .7e-06 2
sp|P49046|LEGU CANEN LEGUMAIN PRECURSOR (ASPARAGINYL E. . . +1 93 5. 0e-05 2
sp|P49047|VPEA ARATH VACUOLAR PROCESSING ENZYME, ALPHA. . . +1 87 5 .0e-05 2
gnl|PID|e354316 (Z99957) legumain-like proteinase. . . +1 91 5 .2e-05 2
gnl|PID|e348871 (Z99174) cysteine proteinase prec. . . +1 100 5 .4e-05 1
pir||A57293 latent transforming growth factor. . . -1 48 0.0011 4
Figure 3.4: BLAST search data showing proteins similar to that encoded by cloned 
L. mexicana PCR products. Data was submitted as nucleic acid sequence to the NCBI 
BLAST search web site (http://www.ncbi.nlm.nih.gov/BLAST) using the BLASTX 
programme, which translates nucleotide sequence into all six reading frames and 
compares the resulting amino acid sequences with those of known proteins. The 
closest matching proteins are named and the most relevant matches are shown in 
boldface.
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Figure 3.5: Southern blot of L. mexicana genomic digests probed with the cloned 
gDNA PCR product. 5pg of genomic DNA isolated from wild type L. mexicana was 
restriction digested, electrophoresed on 0.7% agarose TBE gel, blotted and probed with the 
700bp, plasmid-derived PvuII fragment containing the cloned gDNA PCR fragment. The 
positions of the marker DNA bands (lkb ladder, GibcoBRL) are shown.
Lane 1: Xho\
Lane 2: Pstl 
Lane 3: HindUl 
Lane 4: Hincll 
Lane 5: £coRI
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*Figure 3.6: Southern blot of lambda clones containing GPI8. A.1 and XI clones 
were digested with the following restriction enzymes: BamW[, EcoPA, Hindlll, Sail 
and Xhol before the fragments were electrophoresed on a 0.7% agarose TBE gel, 
blotted and probed with the plasmid-derived Pvull fragment containing the cloned 
gDNA PCR product (described in Section 3.2.1.2). Markers were lkb Ladder 
(GibcoBRL).
97
Figure 3.7: Strategy for sequencing of the GPI8 locus. The position of the internal 
primers (OL458 - 473) used to obtain the sequence contigs, are shown as red arrows
(A). Other primers that anneal to plasmids on either side of inserted fragments were 
used to determine the remainder of the sequence (not shown). The distribution of 
LMGPI8 and its flanking regions in pGL185, pGL186 and pGL187 are also indicated 
(X = Xhol site; S = Sail site). The contig figure (B) was produced using the 
Gelmerge, Gelassemble and Gelview programmes from the GCG package, which 
takes multiple sequence fragments and determines the positions of overlap, producing 
a single consensus sequence of the entire nucleotide sequence. This has been 
overlaid with the schematic of the gene and its 5' and 3' flanking regions from (A).
Large Blue Arrow = GPI8 ORF
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Figure 3.8: The complete nucleotide sequence of L. mexicana GPI8 locus and 
predicted amino acid sequence of the ORF. (A) The sequence is contained on a 
3337bp Xhol-SaR fragment (the restriction sites are marked). The positions of 
oligonucleotides used to obtain the sequence are shown in blue whilst the open reading 
frame of the gene is given in red. Note that the position of the stop codon is 
highlighted in dark blue. (B) The predicted ORF was translated using the Translate 
program (GCG, Wisconsin).
A
X h o l
1 CTCGAGCGTA CGTCTCACCC ACGGCGGTGA CACTGCCCGC TGGTGAGGGA
GAGCTCGCAT GCAGAGTGGG TGCCGCCACT GTGACGGGCG ACCACTCCCT
5 1 AGCGGCTGTG AGGCGACCTG CGCGCCGCGG GGTGGTGGGC GGAGATTGAG
TCGCCGACAC TCCGCTGGAC GCGCGGCGCC CCACCACCCG CCTCTAACTC
1 0 1 GCGCAGGCCG TGCTCAGATG ACCGAGCCGG CGCATTTGGT GTACCACGTG
CGCGTCCGGC ACGAGTCTAC TGGCTCGGCC GCGTAAACCA CATGGTGCAC
1 5 1 TGTTTTTCTA CGGCTGCCTC GCACCACACC CGTGGGTGGG GTGGGTGAGG
ACAAAAAGAT GCCGACGGAG CGTGGTGTGG GCACCCACCC CACCCACTCC
2 0 1 GGCCTGTGAC GGGCCAGAGA AGTGTCGAGC CAAGTTGACC TCACCGTTGT
CCGGACACTG CCCGGTCTCT TCACAGCTCG GTTCAACTGG AGTGGCAACA
2 5 1 ATGGCGGCGG ATGGACGCTT TTGGCGCGAA AATTTGAATG TACTTCTTGA
TACCGCCGCC TACCTGCGAA AACCGCGCTT TTAAACTTAC ATGAAGAACT
3 0 1 GGCGAGCTTG TGGCTGTTGG TGAAGTGGAG GAGAGGTGCG GAAGGGCGGC
CCGCTCGAAC ACCGACAACC ACTTCACCTC CTCTCCACGC CTTCCCGCCG
O L467 1 0 0 .0 %
3 5 1 TGTGGGGGAG GGGGTGGAGG ACGAGTACGG CGGGTGGAGA AGGTGGCGGC
ACACCCCCTC CCCCACCTCC TGCTCATGCC GCCCACCTCT TCCACCGCCG
4 0 1 TATCTGTTTC CGTGCTCCGT AAGAGAATGG GCTGGACGCA TTCCCAGGCC
ATAGACAAAG GCACGAGGCA TTCTCTTACC CGACCTGCGT AAGGGTCCGG
4 5 1 TCTACAAGCC CTCCAGCGAG CTGAGAGGGT GATAGGGTAG GAGGGAGCTT
AGATGTTCGG GAGGTCGCTC GACTCTCCCA CTATCCCATC CTCCCTCGAA
O L 468 1 0 0 .0 %
5 0 1 CTGGTGTCTT CTCGGGTGAC GGTCTGCGCT ACCCTATGGC GGGGATCTTT
GACCACAGAA GAGCCCACTG CCAGACGCGA TGGGATACCG CCCCTAGAAA
O L468 1 0 0 .0 %
5 5 1 CCTAGCCCGC ACGCTTTCTC TCTCCACATC GACGACTGCC TCACACGCCC
GGATCGGGCG TGCGAAAGAG AGAGGTGTAG CTGCTGACGG AGTGTGCGGG
6 0 1 TCCCACTGTT TTTCGCGTTC GACTGGCTAC TGCGCGCATG CACCTTCACC
AGGGTGACAA AAAGCGCAAG CTGACCGATG ACGCGCGTAC GTGGAAGTGG
6 5 1 CAAACGGAGA ACGAGAGATG AGTCATCATG TCTCTCTGCT ACGCGGTTCT
GTTTGCCTCT TGCTCTCTAC TCAGTAGTAC AGAGAGACGA TGCGCCAAGA
7 0 1 GTTGCTCGTG CTGGCCTCCT CCAGCACGGA CCTGCCTCGC CACGCGCAAA
CAACGAGCAC GACCGGAGGA GGTCGTGCCT GGACGGAGCG GTGCGCGTTT
OL4 69  1 0 0 .0 %
7 5 1 GCCTTCGGTT GCGGCGGGAT CGTCGGGCGA GGACAGTGCC GGTGCCTTCT
CGGAAGCCAA CGCCGCCCTA GCAGCCCGCT CCTGTCACGG CCACGGAAGA
O L469 100 .0%
8 0 1 TGTTCAGTGG TGTCTCACAT TCCACGCTGG ATCGCTCTTG CAGTCGTCGA
ACAAGTCACC ACAGAGTGTA AGGTGCGACC TAGCGAGAAC GTCAGCAGCT
8 5 1 GTTCGCGAGA ACCGGGGCGT GAGGTCGAGG GGGAGGATGG GTGGGCTTTT
CAAGCGCTCT TGGCCCCGCA CTCCAGCTCC CCCTCCTACC CACCCGAAAA
9 0 1 TTTTTGGGCG GCGCAAATCA CAGAGACGGC GTGGCCCAGA AAGGCGACAG
AAAAACCCGC CGCGTTTAGT GTCTCTGCCG CACCGGGTCT TTCCGCTGTC
O L464 100 .0%
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9 5 1  CGCGCGAGTT GCACCGCTTG TGCACATGTG CCGTTACGGC GTTGATGTGA
GCGCGCTCAA CGTGGCGAAC ACGTGTACAC GGCAATGCCG CAACTACACT
OL47 0 1 0 0 .0 %
1 0 0 1  GGAGTGCGTG TACGGTGCCA CTGCCGGTGC GCCGATGGGC TTGCCCAGTC
CCTCACGCAC ATGCCACGGT GACGGCCACG CGGCTACCCG AACGGGTCAG
O L470 1 0 0 .0 %
1 0 5 1  CCTCTGCTTC CCTTCCTCAT CTGATCCCTT TCTCCTCTAC CTCGCTCTCG
GGAGACGAAG GGAAGGAGTA GACTAGGGAA AGAGGAGATG GAGCGAGAGC
1 1 0 1  CTCACGCACG GAAGCTCCTT TTTTCCCTTT CGCTGGCTCT CCCTCGTTCT
GAGTGCGTGC CTTCGAGGAA AAAAGGGAAA GCGACCGAGA GGGAGCAAGA
O L460 100 .0%
1 1 5 1  CCCGCTACTG GTGCGTGCCA CCTCTCTCTT GCGAATCGCG CAGACGGCGA
GGGCGATGAC CACGCACGGT GGAGAGAGAA CGCTTAGCGC GTCTGCCGCT
12 01  CACAGCTCAT CAGCCGCGGC AGCAGAAGGT AGTGGGAGAG GGGCGTGCGG
GTGTCGAGTA GTCGGCGCCG TCGTCTTCCA TCACCCTCTC CCCGCACGCC
1 2 5 1  GTGTGCCGGC TCTTCCTTTC ATATTCTAGA AAACGGCAGC TAGTGCAGTT 
CACACGGCCG AGAAGGAAAG TATAAGATCT TTTGCCGTCG ATCACGTCAA
OL4 61  1 0 0 .0 %
1 3 0 1  CCGGCTGTTT ATGCGCACCA CAGCTTACGT GATGACGTCG CCAACAAGGT 
GGCCGACAAA TACGCGTGGT GTCGAATGCA CTACTGCAGC GGTTGTTCCA
1 3 5 1  GTATCGCGAC GGCATTGATC GTCTTTGCTT TTCTTGTTCT CACCGCCGCG 
CATAGCGCTG CCGTAACTAG CAGAAACGAA AAGAACAAGA GTGGCGGCGC
1 4 0 1  GCCGCCGCGT CTGCGCCGCT GGGGGCGACA GGCAAGGGCC AGAGCAACAA 
CGGCGGCGCA GACGCGGCGA CCCCCGCTGT CCGTTCCCGG TCTCGTTGTT
1 4 5 1  CTGGGCTGTC ATTGTCTCCT CCTCGCGATA CCTCTTCAAC TACCGCCACA 
GACCCGACAG TAACAGAGGA GGAGCGCTAT GGAGAAGTTG ATGGCGGTGT
1 5 0 1  CCGCCAATGC GCTTACCATG TACCACCTCT TGCGTCAGCA CGGCATTGAC 
GGCGGTTACG CGAATGGTAC ATGGTGGAGA ACGCAGTCGT GCCGTAACTG
1 5 5 1  GACGACCATA TTCTTCTCTT TTTGAGTGAC AGCTTCGCCT GCGACCCGCG 
CTGCTGGTAT AAGAAGAGAA AAACTCACTG TCGAAGCGGA CGCTGGGCGC
O L458 1 0 0 .0%
1 6 0 1  AAATGTGTAC CCTGCGGAGA TTTTTTCGCA GCCCCCCGGA GCACACGACG
TTTACACATG GGACGCCTCT AAAAAAGCGT CGGGGGGCCT CGTGTGCTGC
1 6 5 1  CGGATGGGCG CGCTAGCATG AATCTGTACG GCTGCAGCGC GCAGGTGGAC
GCCTACCCGC GCGATCGTAC TTAGACATGC CGACGTCGCG CGTCCACCTG
O L 459 10 0 .0 %
1 7 0 1  TACGCGGGCA GCGACGTGGA CGTGCGCCGT TTTCTAAGTG TGTTGCAGGG 
ATGCGCCCGT CGCTGCACCT GCACGCGGCA AAAGATTCAC ACAACGTCCC
17 51  CCGTTATGAC GAGAACACGC CGCCCACGCG GCGACTCCTT TCGGACAACA
GGCAATACTG CTCTTGTGCG GCGGGTGCGC CGCTGAGGAA AGCCTGTTGT
1 8 0 1  CATCGAACAT CATCATCTAC GTCGCGGGGC ACGGCGCCAA GTCGTACTTC
GTAGCTTGTA GTAGTAGATG CAGCGCCCCG TGCCGCGGTT CAGCATGAAG
100
1 8 5 1 AAGTTTCAGG ACACGGAGTT TCTGAGCTCG TCGGACATCT CGGAAACGCT
TTCAAAGTCC TGTGCCTCAA AGACTCGAGC AGCCTGTAGA GCCTTTGCGA
1 9 0 1 TACAATGATG CACCAGCAGC GGCGGTACGG TCGCGTTGTT TTCCTGGCAG
ATGTTACTAC GTGGTCGTCG CCGCCATGCC AGCGCAACAA AAGGACCGTC
1 9 5 1 ATACATGCCA TGCGATTGCG CTGTGCGAGC ATGTAGAGGC GCCGAACGTG
TATGTACGGT ACGCTAACGC GACACGCTCG TACATCTCCG CGGCTTGCAC
2 0 0 1 GTATGTCTCG CCGCCTCAGA TGCCGAGTCG GAGAGCTACT CGTGCCAGTA
CATACAGAGC GGCGGAGTCT ACGGCTCAGC CTCTCGATGA GCACGGTCAT
O L462 1 0 0 .0 %
2 0 5 1 CGATGAACAG CTTGGCACTC ATATGGTCTC CTTTTGGATG AATGAGATGT
GCTACTTGTC GAACCGTGAG TATACCAGAG GAAAACCTAC TTACTCTACA
2 1 0 1 ACTTGTTGCT GAACGGCACG AGTTGCAGCA ACCCGCTCAC TCGCCGCATC
TGAACAACGA CTTGCCGTGC TCAACGTCGT TGGGCGAGTG AGCGGCGTAG
2 1 5 1 GGCGACGATG CAGTGTCCGT GCTGCATCAA TCGTGGTACA ACTTCAATTA
CCGCTGCTAC GTCACAGGCA CGACGTAGTT AGCACCATGT TGAAGTTAAT
O L463 100 .0%
2 2 0 1 TCACCCCTAC CGCGTGGAGG CGAGCCGAAA CCGCTCGAAG CCAGCGCACC
AGTGGGGATG GCGCACCTCC GCTCGGCTTT GGCGAGCTTC GGTCGCGTGG
O L463 10 0 .0 %
2 2 5 1 GCGACGCCGT GAACGACCCG ACGGCTCTGA GAGAATGGAT TGTAGCCGAC
CGCTGCGGCA CTTGCTGGGC TGCCGAGACT CTCTTACCTA ACATCGGCTG
2 3 0 1 TTTGTGTGCG GCCAGGTGTC CGCAGCGGTA CCAGTGGACG TCCGCTACGA
AAACACACGC CGGTCCACAG GCGTCGCCAT GGTCACCTGC AGGCGATGCT
X h o l
2 3 5 1 CCTCGAG^g CGTGTGGCAT CTACGTCGCT GCGCTGATGG TATGTACGTG
GGAGCTC^g GCACACCGTA GATGCAGCGA CGCGACTACC ATACATGCAC
2 4 0 1 GGTGCGTGTG ACGTGCGTCG TGTGCTTGGA GGTGCCCACA CGCACACGCG
CCACGCACAC TGCACGCAGC ACACGAACCT CCACGGGTGT GCGTGTGCGC
2 4 5 1 CACGGGTTCA GGACTAGACG TGACCTCCTC TTTTCCCACC GAAGAACAAC
GTGCCCAAGT CCTGATCTGC ACTGGAGGAG AAAAGGGTGG CTTCTTGTTG
O L472 1 0 0 .0%
2 5 0 1 AACAAAAAAG ACGGCTAAGG CGACTACAAC GTCGAAGGCC TGTACCGGAA
TTGTTTTTTC TGCCGATTCC GCTGATGTTG CAGCTTCCGG ACATGGCCTT
2 5 5 1 CCGTCTGCGT GGTGCGCAGC GCAAGTGGGG CGGAGGGGGA GGGGGACAAG
GGCAGACGCA CCACGCGTCG CGTTCACCCC GCCTCCCCCT CCCCCTGTTC
O L 471 1 0 0 .0%
2 6 0 1 AAAATGCGAT GCGGAGCGGG GCGCGGCTGA CGAGCGCTGC TGCGCCAGTT
TTTTACGCTA CGCCTCGCCC CGCGCCGACT GCTCGCGACG ACGCGGTCAA
O L471 1 0 0 . C1%
2 6 5 1 CTCTCTCGTC TCTCTCTTTT TATGTCTGTG GCTTTTTCTT TACTTGTCCA
GAGAGAGCAG AGAGAGAAAA ATACAGACAC CGAAAAAGAA ATGAACAGGT
101
2701 TGTGAAGTAC ACGTCTCCAC ATGCTTTCCC AGCAGCATGT ATGGGGGTGT
ACACTTCATG TGCAGAGGTG TACGAAAGGG TCGTCGTACA TACCCCCACA
2751 AGCGTCGCAA ACCCGTGGTG GCGATGACTC CTGGTCGGCT TTCATGTTGC
TCGCAGCGTT TGGGCACCAC CGCTACTGAG GACCAGCCGA AAGTACAAC G
2801 CTTCAGGGGG GTGGGGTGGG GAGCATACGG GCACTCACTC GTACACGCGG
GAAGTCCCCC CACCCCACCC CTCGTATGCC CGTGAGTGAG CATGTGCGCC
2851 AACGGCTCCC AATCTTGTGG CTCAGCGCGC CGTCTGCCTC TGTGTGGGGC
TTGCCGAGGG TTAGAACACC GAGTCGCGCG GCAGACGGAG ACACACCCCG
2901 GATGCGTGGA ACCTGGTACC CATCTCTCTC TCTGTCTTCG ACCGCGCACA
CTACGCACCT TGGACCATGG GTAGAGAGAG AGACAGAAGC TGGCGCGTGT
2951 ATCACCTCAC TATGTTTCGA TATCTTCCTC GCCCACTTTG CTGATTTTTC
TAGTGGAGTG ATACAAAGCT ATAGAAGGAG CGGGTGAAAC GACTAAAAAG
3001 ACCCGTGGCC TTCCGAATCA CCCATGCGCA CCCCAAAATG GGATGCACCA
TGGGCACCGG AAGGCTTAGT GGGTACGCGT GGGGTTTTAC CCTACGTGGT
3051 GCGAAGAGCG TTCGTTGGCT TCCTTTTCTA ATGCGCGCGT TTACGCTAGC
CGCTTCTCGC AAGCAACCGA AGGAAAAGAT TACGCGCGCA AATGCGATCG
3101 TACTGGTGCG GCGCCGCGCC AACTCTTGGC CGTGGCGATG GCGACCGCAC
ATGACCACGC CGCGGCGCGG TTGAGAACCG GCACCGCTAC CGCTGGCGTG
3151 GCATGTCGGC GTCATCGAGC ACGCCTGCTG AATCCTCCAC CCCAGTCGGT
CGTACAGCCG CAGTAGCTCG TGCGGACGAC TTAGGAGGTG GGGTCAGCCA
OL473 100.0%
3201 GCGTTGCAAG CTGCAGCGGC GACGGGGCCG ACCGTGGCGC CGAAGAAGCC
CGCAACGTTC GACGTCGCCG CTGCCCCGGC TGGCACCGCG GCTTCTTCGG
3251 ACGCCGTCGT AT CAC GAGCA AGCTCGACGC YTCTGCCCTG CTTAAGAATG
TGCGGCAGCA TAGTGCTCGT TCGAGCTGCG RAGACGGGAC GAATTCTTAC
Sail
3301 TGCCGAGCGA ACCCGGCGCG CATGCGGAGC TGTCGAC
ACGGCTCGCT TGGGCCGCGC GTACGCCTCG ACAGCTG
B 
Amino acid sequence of LMGPI8
1 MRTTAYVMTS PTRCIATALI VFAFLVLTAA AAASAPLGAT GKGQSNNWAV
51 IVSSSRYLFN YRHTANALTM YHLLRQHGID DDHILLFLSD SFACDPRNVY
101 PAEIFSQPPG AHOADGRASM NLYGCSAQVD YAGSDVDVRR FLSVLQGRYD
151 ENTPPTRRLL SDNTSNIIIY VAGHGAKSYF KFQDTEFLSS SDISETLTMM
201 HQQRRYGRW FLADTCHAIA LCEHVEAPNV VCLAASDAES ESYSCQYDEQ
251 LGTHMVSFWM NEMYLLLNGT SCSNPLTRRI GDDAVSVLHQ SWYNFNYHPY
301 RVEASRNRSK PAHRDAVNDP TALREWIVAD FVCGQVSAAV PVDVRYDLE
1 0 2
Figure 3.9: Amino acid sequence alignment of the complete predicted 
amino acid sequence of LMGPI8 with S. cerex’isiae and H. sapiens GPI8 
and legumain. Coloured arrows indicate the conserved regions to which the 
original PCR primers were designed (S0 |Q . OL77, JATR3 and OL78) 
Conserved cysteine (*), histidine (#) and serine (A) residues are indicated. L.
163mexicana GPI8 has three potential N-glycosylation sites at positions N , 
N“ and N (+). Amino acid numbering is according to the LMGPI8 
sequence. All of the proteins compared are larger than LMGP18 and are only 
shown up to amino acid 349.
Abbreviations:
Lm = L. mexicana GPI8 
Sc = S. cerevisiae GPI8 
Hs = H. sapiens GPI8
Lg = Legumain (Canavalia ensiformis asparaginyl endopeptidase)
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Figure 3.10: Hydrophobicity plot of GPI8 proteins. The plots were calculated 
by the “Prot-Scale” programme from the EXPASY Internet site (see text for 
details) according to the Kyte-Doolittle algorithm. The data was entered into 
Microsoft Excel which was used to plot the profile graphically with Amino Acid 
Scores (which are either greater than zero for hydrophobic residues and less than 
zero for hydrophilic) are given on the y-axis while the amino acid positions (from 
the amino to the carboxy terminus) are represented on the x-axis. Areas of notable 
similarity are indicated between blue arrows.
A: L.mexicana GPI8 
B: S. cerevisiae Gpi8p 
C: H. sapiens GPI8
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Figure 3.11: Southern analysis of L. mexicana DNA using the LMGPI8 ORF as 
probe. 5pg of DNA was digested with Hindi, Hindlll, Pstl, Xbal and Xhol. A 
schematic of the gene indicating the relevant restriction sites is shown (A). The 
digests were electrophoresed on a 0.7% agarose gel, blotted onto Hybond N and 
probed with the LMGP18 ORF contained on a 1. lkb XballXhol fragment (B).
Lane 1: Hincll 
Lane 2: Hindlll 
Lane 3: Pstl 
Lane 4: Xbal 
Lane 5: Xhol
The positions of the DNA marker fragments (lkb ladder, GibcoBRL) are shown.
APstl (3216)
Hinc\\{22>l) K ’
Xho\{\) Psfl(1687) Sail
Xbal(l276) Xhol(2353)
M E M &
Probe
B
1 2 3 4 5
kb
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Figure 3.12: Southern blot analysis of restriction digested X DNA containing 
TBGPI8 using LMGPI8 as a heterologous probe. 0.5jug of each of the two 
purified X DNA clones was digested with Hindlll, Sail, Xbal and Xhol and 
electrophoresed on a 0.8% agarose gel, which was stained with ethidium bromide
(A) prior to blotting onto Hybond N. This was done to determine if the two X clones 
were identical.
Lane 1: XI, Hindlll 
Lane 2: XI, Sabi 
Lane 3: XI, Xbal 
Lane 4: XI, Xhol
M: DNA markers, 1 kb ladder (GibcoBRL)
Lane 5: X2, Hindlll 
Lane 6: X2, Sail 
Lane 7: X2, Xbal 
Lane 8: X2, Xhol
(B) The blot of X2 was probed with the 1.1 kb XbaUXhol fragment containing L. 
mexicana GPI8 ORF at lower stringency (55°C, 2xSSC, 0.1% SDS).
Lane 1: X2, Hindlll 
Lane 2: X2, Sail 
Lane 3: X2, Xbal 
Lane 4: X2, Xhol
AB
1 2  3 4
—  10+
—  5.0
—  4.0
— 3.0
—  2.0
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Figure 3.13: Characterisation of the PCR product from T. brucei X clone 1. The
PCR was carried out with two sets of primer pairs on DNA purified from T. brucei X 
clone 1 that hybridised to the LMGPI8 ORF. (A) Primers OL47 and OL48 (lane 1) 
and OL76 and OL48 (lane 2) were used in this experiment (see Tables 3.1 and 3.4 
for details of primers). (B) A cloned PCR product (in pGL446) was sequenced in 
double stranded form using the universal sequencing primers T7 and SP6. 
Translation of this nucleotide sequence produced an ORF and the amino acid 
sequence is given. Primer positions are indicated by arrows (Blue = OL76 and Red 
= OL48). (C) A BLAST search for similar proteins using the BLASTX programme 
at the NCBI web site (http://www.ncbi.nlm.nih.gov/BLAST/) shows the most closely 
related amino acid sequences to those encoded by the T. brucei fragment in all six 
reading frames. (D) The similarity of the amino acid sequence encoded by this 
fragment (tb) to the same region of L  mexicana GPI8 (lm) was determined using the 
GAP programme (GCG Molecular Analysis Package, Wisconsin).
A 1 2
Nucleic Acid Sequence
•
1 CCAACAACTG GGCAGTGCTC GTCTCC’TCCC GTTACTTCTT TAATCTCCGT
51 CATACAACGA ATGCGCTGGC CATGTACCAT TTGTGTCGAA AACACGGGAT
1 0 1 GGATGACGAC CACATCCTTG TCTCTCTTAG CGATAGCTAC GCCTGCGATC
1 5 1 CCCGCAAACC CAACCCAGCG ACAATTTACG GAGCACCTGC CCAAGCGGAG
2 0 1 CAACCGAATC TATACGGCTG CAATATTAGA GTGGACTACG CGAGCTACGA
2 5 1 TGTCGGTGTT CGCCGGTTCC TTGGCGTCCT GCAGGGCCGA TATGATGAGA
3 0 1 ATACTCCTCC TTCACGGCGT CTCGACACCG ACGAGAACTC GAACATAATC
3 5 1 ATTTATGTAG CCGGCCATGG CGC
4 ------------------- i. —  — —  .
Amino Acid Sequence
1 NNWAVLVSSR YFFNLRHTTN ALAMYHLCRK HGMDDDHILV SLSDSYACDP
51 RKPNPATIYG APAQAEQPNL YGCNIRVDYA SYDVGVRRFL GVLQGRYDEN
1 0 1 TPPSRRLDTD E N S N IIIY V A GHGA
107
c
Sequences producing sign ifican t alignments: (bits)
gi12558891 (AF022913) 6PI transamidase [Homo sapiens] 125
emb|CAA68871| (Y07596) gpi8 [Homo sapiens] 125
sp|P49048|YJ96_CAEEL HYPOTHETICAL 36.9 KD PROTEIN T05E11.6 IN C 120
sp|P49018|GPI8_YEAST GPI-ANCHOR TRANSMIDASE > g i|2132503|p ir | |S 5 . 114
emb|CAA15687.1 | (AL009192) /prediction=(method:; /prediction^(m. 108
gi13063464 (AC003981) F22013.26 [Arabidopsis thaliana] 94
sp|P49043|VPE_CITSI VACUOLAR PROCESSING ENZYME PRECURSOR (VPE) . 61
giI 4154281 (AF082347) C13 endopeptidase NP1 precursor [Zea mays] 60
embICAB01126I (Z77653) Sim ilarity to Arabadopsis vacuolar proce. 60
sp|P09841|HGLB_SCHMA HEMOGLOBINASE PRECURSOR (ANTIGEN SM32) >gi. 57
giI 3413718 (AC004747) alpha-vacuolar processing enzyme [Arabido. 56
dbj|BAA7 67 44.1 | (D89971) asparaginyl endopeptidase (VmPE-1) [Vi. 56
sp|P42665|HGLB_SCHJA HEMOGLOBINASE PRECURSOR (ANTIGEN SJ32) >gi. 56
sp|P49044|VPE_VICSA VACUOLAR PROCESSING ENZYME PRECURSOR (VPE) . 55
emb|CAA21203I (AL031804) gamma-VPE (vacuolar processing enzyme). 54
dbj|BAA18924| (D61395) gamma-VPE [Arabidopsis thaliana] 54
emb|CAA04439| (AJ000990) legumain [Mus musculus] 54
dbj|BAA09530| (D55696) cysteine protease [Homo sapiens] 54
sp|P49047|VPEA_ARATH VACUOLAR PROCESSING ENZYME, ALPHA-ISOZYME . 53
pir||S60050 vacuolar processing enzyme (EC 3.4.22.-) isozyme be. 53
gi1161019 (M21308) hemoglobinase [Schistosoma mansoni] 52
sp|Q99538|LEGU_HUMAN LEGUMAIN PRECURSOR (ASPARAGINYL ENDOPEPTID. 52
emb|CAB17078| (Z99956) asparagine-specific endopeptidase precur. 52
sp|P4 9042|VPE_RICCO VACUOLAR PROCESSING ENZYME PRECURSOR (VPE) . 51
emb|CAB16318| (Z99174) cysteine proteinase precursor [Vicia nar. 48
emb|CAB17079| (Z99957) legumain-like proteinase precursor [Phas. 48
sp|P4 9046|LEGU_CANEN LEGUMAIN PRECURSOR (ASPARAGINYL ENDOPEPTID. 48
emb|CAB42 650.1 | (AJ238880) putative preprolegumain [Nicotiana t .  46
dbjIBAA767 45.1| (D89972) asparaginyl endopeptidase (VmPE-lA) [V. 46
emb|CAA07 639| (AJ007743) cysteine proteinase precursor [Vicia s. 45
embICAB42655.1| (AJ238882) putative preprolegumain [Vicia narbo. 45
sp|P4 90 45|VPE_SOYBN VACUOLAR PROCESSING ENZYME PRECURSOR (VPE) . 43
D
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Figure 3.14: Nested PCR with Plasmodium falciparum DNA. Nested PCR was 
carried out as follows: first round of PCR, three reactions were set up:
Reaction A: Primer OL80 only (control)
Reaction B: Primer OL82 only (control)
Reaction C: Primers OL80 and 82
The reactions were run as described in Figure 3.2 legend. Reactions were diluted 10 
fold with water and these were used as template in a second round of PCR with 
primer combinations as follows:
Reaction A template: (1) OL81 only, (2) OL82 only (3) OL81 and 82 (all controls) 
Reaction B template: (4) OL81 only, (5) OL82 only, (6) OL81 and 82 (all controls) 
Reaction C template: (7) OL81 only, (8) OL82 only, (9) OL81 and 82 (7&8 are 
controls)
The reactions were electrophoresed on a 1.2% acrylamide gel and stained with 
ethidium bromide (A). The primer orientation with respect to PFGPI8 is also shown.
(B) A 350bp fragment (marked by yellow arrow in (A)) was gel-purified, cloned into 
pGEM-T, sequenced and translated to give the amino acid sequence. A BLASTx 
database search was carried out with the nucleotide sequence (C) and a sequence 
comparison of the P. falciparum with H. sapiens and S. cerevisiae, produced by the 
GAP programme (GCG Wisconsin) is shown (D).
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Nucleotide Sequence
1 TTTTGGTTTA ATTATAGACA TATGGCCAAC ACTCTTAGTA TGTATCGTAC
5 1  TGTTAAGAGA TTAGGTATAC CAGATTCACA GATTATATTA ATGCTAGCGG
1 0 1  ATGATGTTGC TTGCAATCCA AGAAACGCAT TTCCTGGTTT TGTATTCAAC
1 5 1  AATCAAGATA GACAGTTAGA ACTATACGGT GATAATATTG AGGTTGATTA
2 0 1  TCGTGGATAT GAGGTTACCG TTGAAAATTT TATCAGATTA TTAACTGACC
2 5 1  GCTGGAGTGA AGACCAACCT AGATCAAAAA GATTATTAAC CGATGAAAAT
3 0 1  TCGAATATTT TTATTTATCT TACTGGACAC GGAGG
Amino Acid Sequence
1 FWFNYRHMAN TLSMYRTVKR LGIPDSQIIL MLADDVACNP RNAFPGFVFN 
51 NQDRQLELYG DNIEVDYRGY EVTVENFIRL LTDRWSEDQP RSKRLLTDEN 
101 SNIFIYLTGH G
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c
sp|P49018|GPI8_YEAST GPI-ANCHOR TRANSMIDASE >gi|2132503|p i r . . .  210 4e-54
emb|CAA68871| (Y07596) gpi8 [Homo sapiens] 171 2e-42
g i 12558891 (AF022913) GPI transamidase [Homo sapiens] 171 2e-42
emb|CAA15687.1 | (AL009192) /prediction=(method:; /p red ic tio . . .  170 3e-42
g i | 3063464 (AC003981) F22013.26 [Arabidopsis thaliana] 148 le-35
sp|P49048|YJ96_CAEEL HYPOTHETICAL 36.9 KD PROTEIN T05E11.6 . . .  146 4e-35
emb|CAB55340.1 1 (AJ242865) GPI:protein transamidase [Leishm... 107 4e-23
emb|CAB01126| (Z77653) Similarity to Arabadopsis vacuolar p . . .  88 2e-17
emb|CAA04439| (AJ000990) legumain [Mus musculus] 7 6 9e-14
ref|NP_005597.1 |PPRSCl| protease, cysteine, 1 (legumain) >g... 75 3e-13
dbj|BAA09530.1 | (D55696) cysteine protease [Homo sapiens] 75 3e-13
emb|CAB51545.1 | (AJ243876) vacuolar processing enzyme [Lyco... 72 le-12
sp|P0 98 41|HGLB_SCHMA HEMOGLOBINASE PRECURSOR (ANTIGEN SM32)... 71 2e-12
sp|P42665|HGLB_SCHJA HEMOGLOBINASE PRECURSOR (ANTIGEN SJ32)... 69 le-11
gi1161019 (M21308) hemoglobinase [Schistosoma mansoni] 68 3e-ll
sp|P4 9047|VPEA_ARATH VACUOLAR PROCESSING ENZYME, ALPHA-ISOZ. . .  65 2e-10
gi13413718 (AC004747) alpha-vacuolar processing enzyme [Ara... 64 3e-10
g i | 4154281 (AF082347) C13 endopeptidase NP1 precursor [Zea . . .  64 3e-10
P. falciparum  vs H. sapiens
1 ............ FWFNYRHMANTLSMYRTVKRLGIPDSQIILMLADDVACNPRNAFP
I 1 1 11 I l I I  I I I  I I  I I I I I I I I I 1 * 1 1 1 1 1 1  I I I 1 I I 1
4 5
5 6
1 1 1 1 1 1 1 • 1 1 1 I I  • 1 1 • 1 1 1 1 1 1 1 1 1 1 * 1 1 1 1 1 1 * 1 1 1 1 1 1  1 
............ FWFNYRHVANTLSVYRSVKRLGIPDSHIVLMLADDMACNPRNPKP 1 0 0
4 6 GFVFNNQDRQLELYGDNIEVDYRGYEVTVENFIRLLTDRWSEDQPRSKRL
I I -------  : 1 * 1 1 1 * : 1 1 II 1 1 1 1 II II 1 : 1 * 1 1 1 II 1 1 1 1
ATVFSHKNMELNVYGDDVEVDYRSYEVTVENFLRVLTGRIPPSTPRSKRL
9 5
1 0 1 1 5 0
9 6 LTDENSNIFIYLTGHG 1 1 1
i i • m i  i i * i i M
1 5 1
1 * 1 *  I I I  1 1 * 1 1 1 1  
LSDDRSNILIYMTGHG 1 6 6
P. falciparum  vs S. cerevisiae
1 ............................................................................................................................................FWF 3
I I I
4 8  ............................................................................................................................................FWF 5 0
4 NYRHMANTLSMYRTVKRLGIPDSQIILMLADDVACNPRNAFPGFVFNNQD 5 3  
I I I I I I I I I I II I I I I I I I I I I I I I I I I . I I I I I I II I I I  H I M
5 1  NYRHMANVLSMYRTVKRLGIPDSQIILMLSDDVACNSRNLFPGSVFNNKD 1 0 0
54  RQLELYGDNIEVDYRGYEVTVENFIRLLTDRWSEDQPRSKRLLTDENSNI 1 0 3  
: : I I I I • : I I I I I I I II I I I I I I I I I I I I I . I I I : I I I I I I I I I II I 
1 0 1  HAIDLYGDSVEVDYRGYEVTVENFIRLLTDRWTEDHPKSKRLLTDENSNI 1 5 0
1 0 4  FIYLTGHG 1 1 1  
111:1111 
1 5 1  FIYMTGHG 1 5 8
1 1 0
CHAPTER 4
TARGETED GENE REPLACEMENT OF LMGPI8 AND 
MUTANT PHENOTYPE ANALYSIS
4.1 INTRODUCTION
One method of investigating the function of a gene product is to remove the gene by 
targeted gene replacement and determine what effect or effects this may have on the 
organism. Targeted gene replacement was first described in L. major by Beverley and 
co-workers where the NEO gene was inserted into the DHFR-TS locus (Cruz and 
Beverley, 1990) and was then used to remove both allelic copies of the gene giving 
rise to DHFR-TS null mutants that require the addition of thymidine for growth (Cruz 
et al., 1991). It was also described in L. enrietti by Wirth and co-workers (Tobin and 
Wirth, 1992) after demonstrating homologous recombination between two plasmids 
containing independent mutations within the chloramphenicol acetyltransferase (CAT) 
gene, each causing a lack of activity (Tobin eta l., 1991). The detection of high levels 
of CAT activity demonstrated that recombination had occurred between plasmids 
yielding an active CAT gene and Southern analysis and PCR confirmed this. 
Subsequent experiments resulted in stable integration of the NEO  gene (previously 
demonstrated to be expressed reliably in L. enrietti (Laban et al., 1990)) flanked by 
a-tubulin flanking regions at the a-tubulin locus of L. enrietti, with the result that the 
cells were resistant to the antibiotic Geneticin (Tobin and Wirth, 1992). Further 
experiments led to the deletion of an entire array of a-tubulin genes (Curotto de 
Lafaille and Wirth, 1992).
I l l
The gene-targeting process involves the exploitation of naturally occurring, 
homologous recombination of chromosomal DNA by introducing into the parasite an 
engineered knockout cassette consisting of a selectable marker, such as an antibiotic- 
resistance gene, flanked by gene-specific regions of DNA. These regions also flank or 
include part of the open reading frame of the gene of interest and therefore target the 
knockout cassette to the correct locus within the chromosome (recombination of 
DNA is more likely to occur between homologous stretches) and replacing or 
disrupting the target gene. Knockout cassettes are introduced into the parasite by 
electroporation, a technique used to allow plasmids to be taken up by Leishmania 
(LeBowitz, 1994). Integration of such knockout constructs causes cells to express 
the gene and thus become resistant to the antibiotic. The procedure has been used 
extensively to disrupt or remove both individual genes and multi-copy gene arrays. 
Individual genes, such as those encoding two cysteine proteinases of L. mexicana 
(CPA and CPC), were disrupted in this way (Souza et al., 1994; Bart et al., 1997). 
Further, the entire gene array encoding cysteine proteinase b (CPB) in L. mexicana 
(comprising 19 copies of the gene tandemly arranged over 50kb of a chromosome) 
was disrupted using this method (Mottram et al., 1996a). Studies in Leishmania 
species determined that the optimum length of flanking regions is approximately lkb 
for high efficiency homologous recombination (Papadopoulou and Dumas, 1997). 
Leishmania is a diploid organism, therefore two successive rounds of transfection 
with two independent selectable markers are required to delete each allelic copy of a 
gene.
Genes that are essential for the viability of Leishmania species can be identified using 
this procedure, since the only cells that survive transfections are those that retain a
112
copy o f an essential gene. Attempts to knock out an essential gene such as the cyclin- 
dependent kinase CRKl of L. mexicana (Mottram et al., 1996b) or the dihydrofolate 
reductase-thymidylate synthase (DHFR-TS) gene without providing the required 
thymidine (Cruz et al., 1993) can result in clones that have altered their ploidy in 
order to retain at least a single copy of the gene. Alternatively, rearrangement of the 
genome can take place such that the gene “jumps” to a different location within the 
same or a different chromosome, as was seen with L. donovani (Dumas et al., 1997).
There are several selectable marker genes that confer resistance to a number of 
antibiotics that can be used with Leishmania. These are shown in Table 4.1.
Table 4.1:
Antibiotic-resistance genes used as selectable markers in Leishmania integration 
experiments.
Jjgljj
NEO Neomycin phosphotransferase Geneticin or G418 (Laban et al., 1990)
SAT Streptothricin acetyltransferase Nourseothricin (Joshi et al., 1995)
PAC Puromycin N-acetyltransferase Puromycin (Freedman and 
Beverley, 1993)
HYG HygromycinB phosphotransferase Hygromycin B (Lee and Van der Ploeg, 
1991)
BLE Bleomycin hydrolase Phleomycin (Zeocin) (Souza et al., 1994)
There are alternative selectable markers, such as the Green Fluorescent Protein 
(GFP), from the jellyfish Aequorea victoria, which can be detected by fluorescence. 
Cells that express GFP can be detected and isolated from those that do not by using 
fluorescence activated cell sorting (FACS) (Ha et al., 1996). This provides an 
alternative to the production of antibiotic-resistant cell lines. Such mutants could be 
used potentially as attenuated live vaccines since they avoid the problem o f possible
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transmission of antibiotic-resistance genes to other pathogenic organisms (Gueiros- 
Filho and Beverley, 1994).
It was the aim of this section of work to delete GPI8 from L. mexicana and analyse 
the phenotype of resulting mutants. This would determine if the gene is essential and 
also confirm that LMGPI8 is a homologue of yeast Gpi8p and a component of the 
GPI:protein transamidase.
Our approach was to use the technique that has already been used successfully in this 
laboratory to disrupt several cysteine proteinase genes (Souza et al., 1994; Mottram 
et al., 1997; Bart et al., 1997). The preparation and transfection of targeted gene 
replacement constructs specific for the GPI8 locus and the subsequent deletion of 
GPI8 is described. A combination of PCR, Southern blotting and flow cytometry was 
used to confirm the removal of GPI8 and thus the generation of GPI8 null mutants. 
Phenotype analysis was performed using immunofluorescence and Western blotting to 
determine if GPI-anchoring was functional in the mutants. The most abundant 
surface protein of L. mexicana promastigotes is GP63 and is attached via a GPI 
anchor (Medina-Acosta et al., 1989); GP63 antibodies (Button et al., 1991) were 
available to examine the presence of GP63 in the mutants. The ability of null mutants 
to infect macrophages in vitro was assessed and compared with wild type infections 
and in vivo mice infections were used to determine the mutant’s virulence compared 
with wild type parasites (Bates et a l, 1992).
4.2 METHODS
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4.2.1 Preparation of all constructs described in this chapter
4.2.1.1 Preparation of GPI8 knockout constructs
Constructs prepared originally by Dr. Darren Brooks (WCMP, Glasgow) for the 
removal of the multi-copy gene array encoding the major lysosomal cysteine 
proteinases (CPB) were used as the backbone for the GP/5-targeting knockout 
constructs. These constructs carry the PAC (pGL207) and SAT (pGL51) genes 
flanked by CPB 5' and 3' flanks as well as dihydrofolate reductase-thymidylate 
synthase (.DHFR-TS) flanking regions. These DHFR-TS flanks were included in the 
original vector to provide the signals required for trans-splicing and polyadenylation 
of the antibiotic-resistance gene transcript (LeBowitz et al., 1994).
The aim, however, was to remove both the 5' and 3' CPB and DHFR-TS flanking 
regions and replace them with the 5' and 3' flanking regions of L. mexicana GPI8. 
This would allow the utilisation of the naturally occurring trans-splicing and 
polyadenylation sites of GPI8 in the expression of the antibiotic-resistance genes in L. 
mexicana promastigotes. As GPI-anchored proteins are found on the surface of the 
promastigote form, then one would predict that GPI8 must be expressed in this life­
cycle stage. Thus the trans-splicing and polyadenylation sites of GPI8 would be used 
to process the antibiotic-resistance mRNA following integration in the GPI8 locus.
Primers were designed to allow the amplification of the 5' and 3' flanking regions of 
GPI8 (Figure 4.1) by PCR and these are given in Table 4.2. The 5' flank had HindUl 
and Spel sites engineered onto the 5' and 3' ends respectively whilst the 3' flank had 
BamHL and BglU. sites.
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Table 4.2: Primers used to amplify the 5' and 3' flanking regions of GPI8.
: ’ ... E S S '7 $ 8 #
OL83
OL84
OL85
OL132
GCCAAGCTTTGCTCAGATGACCGAGCCGGCGC 
GACT AGT AAAC AGCCGGAACT GCACT AGCT 
CGCGGATCCCGTGTGGCATCTACCTCCCTGCG 
AGATCTGCAACGCACCGACTGGGGTG
5' flank 5' primer - Hindlll site 
5' flank 3' primer -  Spe I site 
3' flank 5' primer - BamHL site 
3' flank 3' primer - Bglll site
Primers outwith the amplified regions (see Figure 4.4A) were available making it 
possible to screen for integration at the correct locus by PCR (see Section 4.3.1.1).
PCR amplification o f both flanks was carried out as follows:
94°C, 4 minutes xl
94°C, 1 minute 
55°C, 1 minute 
72°C, 1 minute 
72°C, 7 minutes
>  x20
xl
The proof-reading DNA polymerase VENT (NEB) was used, which, together with a 
relatively low number o f cycles (15), maximised the fidelity o f the amplified DNA 
fragments. Adenosine-overhangs were added to products by incubation for a frirther 
10 minutes at 72°C with Taq polymerase to allow cloning into pGEM-T vector 
(Promega). Positive plasmid clones were digested with the appropriate restriction 
enzymes to drop out the 5' and 3' flanks, which were gel-purified. The original pX53 
vectors (pGL207 and pGL51) supplied by Dr. Darren Brooks (WCMP, Glasgow) 
were initially digested with Hindlll and SpeI to drop out the 5' flank and the plasmid
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backbone was gel-purified. GPI8 5' flank was ligated with this vector and positive 
clones were identified by colony PCR using a 5' flank sense primer (OL474) and a 
PAC (OL15) or SAT (OL17) antisense primer. These clones were grown up and 
plasmid was purified by the Qiagen (Tip20) Mini-Prep kit. The 3' CPB and DHFR- 
TS flank was removed by digestion with BarriHA and BglE and replaced with the 
similarly digested GPI8 3' flank as before, resulting in the constructs pGL236 {PAC) 
and pGL237 (SAT), which are shown schematically in Figure 4.2A.
Constructs which were identified as positive by colony PCR screening (not shown) 
were purified and subjected to a number of test restriction digests to confirm that the 
constructs are complete and correct (Figure 4.2B). The predicted restriction 
fragment pattern was obtained for both clones (described in Figure 4.2 legend) 
indicating that the knockout constructs were correct.
4.2.1.2 Preparation of episomal copy of LMGPI8
An episomal copy of GPI8 was prepared in pBluescript (pBS) using the constructs 
containing the lambda fragments described in the previous chapter as shown in Figure 
4.3. GPI8 and its 5' and 3' flanking regions were removed from pBS by digestion 
with H indi and subcloned into the pXG vector (designated pGL269) which was used 
to transform XL 1-blue supercompetent E. coli (Stratagene).
4.2.2 Targeted gene replacement of LMGPI8
4.2.2.1 Preparation of knockout cassettes for replacement of first allele
Medium-scale production of pGL236 and pGL237 was performed using the Qiagen 
Tip 100 Midi-Prep kit with 25ml of E. coli overnight cultures. 60pg of each plasmid
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was digested overnight with 4(j.l each of HindJTL (80U) and BglYl (40U) in a 200j.il 
reaction volume. Digests were electrophoresed on 0.7% agarose TBE gels. The 
plasmid backbone and the excised knockout cassette were indistinguishable on the 
gel. The 300bp difference in size is sufficient to separate fragments but the amount of 
DNA was so large in this instance that the two fragments co-migrated on a medium­
sized gel. Thus both fragments were co-purified using Spin X columns. The eluted 
DNA was ethanol precipitated and dried before being resuspended in lOjul of sterile 
water. Yields of DNA were around 10 - 15jig of which about half would have been 
plasmid backbone.
4.2.2.2 Transfection of L. mexicana with knockout cassette and selection for 
transfectants
Mid-log phase L. mexicana promastigote cells were washed in electroporation buffer 
(EPB) before being resuspended in the same buffer at a density of lx l07 cells ml'1. 
4xl07 cells were mixed with DNA and placed in 0.2cm electrocuvettes as follows:
1) WILD TYPE cells + No DNA (control)
2) WILD TYPE cells + HindlH/Bglll fragment from pGL236 (PAC)
3) WILD TYPE cells + HindJU/BglU. fragment from pGL237 (SAT)
Following electroporation, cells were allowed to recover on ice for 10 minutes before 
being, transferred to 10ml of HOMEM medium containing 10% (v/v) HI-FCS. 
Cultures 2) and 3) were immediately divided into two to provide two independent 
cultures from each transfection. The cells would not have had sufficient time to 
undergo a cell division hence transfectants produced from individual cultures would
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have arisen from independent integration events. All cultures were grown overnight 
at 25°C and were then exposed to antibiotics as follows:
(1) Control Transfection.
Solid Medium: 5ml of culture was pelleted, resuspended in 400jil of supernatant and 
spread equally on 1 agar plate containing 25jj,g/ml nourseothricin, and 1 agar plate 
containing 10p,g/ml puromycin.
Liquid medium: 2.5ml of culture was added to 7.5ml of medium (HOMEM) 
containing of 10pg/ml puromycin (final concentration) and 2.5ml into medium 
containing of 25p,g/ml nourseothricin (final concentration).
(2) Transfection with knockout cassette containing PAC gene
Solid medium: 2.5ml of each overnight culture was pelleted, resuspended in 200fil of 
supernatant and spread equally on two agar plates, each containing lOjig/ml 
puromycin.
Liquid medium: 2.5ml of each culture were added to 7.5ml of medium containing 
10|ng/ml puromycin (final concentration).
(3) Transfection with knockout cassette containing SAT gene.
Solid medium: 2.5ml of each overnight culture was pelleted, resuspended in 200jil of 
supernatant and spread equally on two agar plates, each containing 25 jig/ml 
nourseothricin.
Liquid medium: 2.5ml of each culture were added to 7.5ml of HOMEM with 
25jj.g/ml nourseothricin (final concentration).
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Plates were allowed to absorb the liquid medium for 5 minutes. They were then 
sealed with Parafilm, inverted and incubated at 25°C for 2-3 weeks.
4.2.3 In vitro macrophage infections
Freshly culled BALB/c mice were injected intraperitoneally with 5 ml of ice-cold 
RPMI medium (GibcoBRL) complete with lOU/ml penicillin and 10pg/ml 
streptomycin sulphate (GibcoBRL). After 5 min gentle massaging of the mouse 
abdomen, the RPMI containing macrophages was harvested and kept on ice. 
Macrophages were counted and diluted to a cell density of 5 x 105 cells/ml with ice- 
cold RPMI. 2 x 105 macrophages (400pi) were placed in each chamber of an eight- 
chamber Permanox slide (Labtek) and allowed to adhere overnight at 32°C under 5% 
C02/95% air. Chambers were washed with RPMI to remove non-adhered cells 
before 2xl05 stationary phase promastigotes were added in RPMI with 10% foetal 
calf serum (FCS) and incubated at 32°C under 5% C02/95% air. After four hours, 
slides were washed to remove free promastigotes and fresh RPMI with 10% FCS was 
added. Infection was allowed to proceed for seven days at 32°C under 5% C02/95% 
air. Individual chambers were fixed with 100% methanol for 5 min at 8 h, 1 day, 3 
days and 7 days after addition of promastigotes. Slides were stained with Modified 
Giemsa Stain (Sigma Diagnostics), diluted 20-fold with distilled water, for 30 min and 
viewed by light microscopy using a Zeiss Axioplan microscope
4.2.4 Mutation of episomal copy of LMGPI8
His63, Cys94, His174 and Cys216 of LMGPI8 were selected for mutation by site directed 
mutagenesis using the QuikChange Site Directed Mutagenesis Kit (Stratagene). The
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primers shown in Table 4.3 were designed to bring about the mutations of the 
episomal copy of GPI8 in pGL269 using PCR according to the manufacturer’s 
protocol such that cysteine was mutated to glycine and histidine was mutated to 
alanine. Note that for each primary primer used, a complementary primer (including 
the mutation) was used as the second primer in the PCR and that a 20 minute 
elongation time for each cycle o f PCR was used due to the size o f pGL269 (lOkb).
Table 4.3:
Primers used to mutate potential active site residues (mutated nucleotides are shown 
in bold) _______
m u
OL330 CTCTTCAACTACCGCGCCACCGCCAATGCGC His“ -Ala
OL332 GACAGCTTCGCCGGCGACCCGCGAAATG Cys94-Gly
OL334 CTACGTCGCGGGGGCCGGCGCCAAGTC His174-Ala
OL336 CCTGGCAGATACAGGCCATGCGATTGCG Cys216-Gly
Following PCR, plasmid was treated according the QuikChange Kit protocol and 
used to transform E. coli. Plasmids were purified from several colonies using Tip20 
mini-preps (Qiagen) and sequenced to check if the mutation had been incorporated.
4.3 RESULTS
4.3.1 Targeted gene replacement of GPI8
No growth was observed on the control plates or in the control liquid cultures 
indicating that antibiotic selection was effective. Transfection (2) yielded three 
puromycin-resistant clones, two from one plate and one from the second (designated 
PI, P2 and P3). Transfection (3) yielded just one nourseothricin-resistant clone on 
solid medium (SI). Growth was observed in all liquid cultures of these transfections
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but since clones were obtained on solid medium, these cultures, which were not 
clonal, were not examined further. Clones were transferred into liquid media with 
appropriate antibiotics and were grown up for further analysis.
4.3.1.1 Check for integration using PCR on whole cells
Primers designed to anneal upstream and downstream of the 5' and 3' flanking 
regions of the knockout cassettes were synthesised and used to check for integration 
by PCR (Figure 4.4).
OL133 GGGTGGTGGGCGGAGATTGAG 5' (Sense) Primer
OL86 GAAGATCTTTGCTCGTGATACGACGGCGTGG 3'(Antisense) Primer
The SAT and PAC genes are about 550bp and 450bp, respectively, smaller than GPI8 
and these differences can be detected by electrophoresis. PCR of wild type L. 
mexicana produced a single fragment of 3.1 kb, corresponding to the wild type GPI8 
alleles (Figure 4.4, lane 1). Clones PI, P2, P3 and SI all yielded a 3.1kb fragment 
corresponding to wild type GPI8 as well as one fragment of 2.6-2.7kb (lanes 2-5, 
respectively) which correspond to integration of PAC or SAT cassettes.
4.3.1.2 Second round transfections of PI, P2, P3 and SI clones
The three puromycin-resistant clones, PI, P2 and P3, and the nourseothricin-resistant 
clone S1 were grown up for transfection as before. The puromycin-resistant clones 
were transfected with the SAT knockout cassette, which was prepared by restriction 
digest and gel-purification as described in the previous section. One alteration to the 
procedure was that Pvul was included in the digestion. This enzyme bisects the
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plasmid backbone allowing most of the plasmid to be separated from the knockout 
cassette by electrophoresis, thus minimising the possibility of plasmid re-ligation 
which would inhibit chromosomal integration of the cassette. SI was transfected with 
the PAC knockout cassette prepared in the same way. P2 and P3 produced several 
clones on HOMEM plates containing both nourseothricin and puromycin (25pg/ml 
and lOpg/ml, respectively). On further analysis by PCR these clones, which were 
nourseothricin- and puromycin-resistant, were found to retain a copy of GPI8 (Figure 
4.5A). SI produced no double resistant clones at all. PI, however, yielded three 
clones, which were analysed by PCR and appeared to have lost the GPI8 gene (Figure 
4.5B). The 3.1 kb fragment that corresponds to the GPI8 allele is absent in all of 
these clones; only the 2.6-2.7kb fragment corresponding to the PAC and SAT 
cassettes are detectable (Figure 4.5B -  lanes 2, 3 and 4). The clones were named 
P1S1, P1S2 and P1S3.
4.3.1.3 Southern analysis of potential GPI8 null mutants
To confirm the PCR results, Southern blot analysis was performed. Genomic DNA 
was extracted from two of the three potential GPI8 null mutants (PI SI and PI S3; 
P1S2 was not analysed further in this study) together with wild type and PI, the 
heterozygote parent cell line of PI SI and PI S3. Use was made of an Xhol site 
immediately 5' to the stop codon in the GPI8 ORF (see Figure 4.6A). This site is not 
present in either the SAT or PAC genes and would be predicted to be lost if correct 
integration of the knockout cassettes had occurred. Thus 5pg of DNA from each cell 
line was digested withATzoI and electrophoresed on 0.7% agarose TBE gel. The gel 
was stained with ethidium bromide prior to blotting, confirming the complete 
digestion of DNA (Figure 4.6B).
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The blot was probed with the XbaVXhol fragment containing the complete ORF of 
the gene (Figure 4.6C). A strongly hybridising band of 2.4kb was detected with wild 
type DNA (lane 1). A weaker signal was detected with the GPI8 heterozygote, PI 
(lane 2), as expected given that the amount of GPI8 DNA would be expected to be 
half that of wild type. No hybridisation could be detected in either of the putative 
GPI8 null mutants (lanes 3 and 4) suggesting that GPI8 had been lost. To confirm 
this finding, several other probes were used. The blot was stripped by the boiling
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SDS method and re-probed with a [a] P-CTP labelled SAT gene (Figure 4.6D). 
3.6kb fragments could be detected in both the putative null mutant lanes (Figure 
4.6D, lanes 3 and 4) but not in wild type or PI lanes (lanes 1 and 2 respectively). 
This is what we would expect, given that the heterozygote is puromycin-resistant (not 
nourseothricin-resistant). The restriction digests were repeated, electrophoresed and 
blotted. Probing with the PAC gene produced bands of 3.7kb with PI, PI SI and 
PI S3 (Figure 4.6E, lanes 2, 3 and 4) as expected. One final hybridisation was carried 
out to make certain that integration had occurred at the correct locus. The previous 
blot was stripped as before and probed with the 5' flanking region. The probe, which 
was produced by PCR with primers OL85 and OL132 (Figure 4.1), detected a single 
2.4kb fragment in wild type as expected from the map (Figure 4.6F). We would 
expect fragments to hybridise in all four lanes but to differ from the wild type DNA in 
size, due to the loss of the Xhol site in the GPI8 ORF. A 2.4kb fragment was labelled 
by this probe in both wild type and PI heterozygotes (4.6F, lanes 1 and 2) 
corresponding to the 5' flank and GPI8 ORF contained on a single Xhol fragment (as 
shown in Figure 3.11 A, Chapter 3). A second band of approximately 3.7kb was also
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detected with PI DNA corresponding to the replaced allele (containing the PAC 
gene). Only the 3.7kb fragment was detected in the putative null mutants, PI SI and 
PI S3 (Figure 4.6F -  lanes 3 and 4).
These data indicate that integration has taken place at the correct locus and that GPI8 
has been deleted. PI SI and PI S3 are GPI8 null mutants (AGPI8).
4.3.1.4 Transfection of episomal copy of GPI8 into null mutants
PI SI and PI S3 cells were transfected with pGL269. After the overnight recovery 
stage, transfected cultures were spread on agar plates containing 10fig/ml puromycin 
and 25pg/ml of both nourseothricin and Geneticin (G418 -  GibcoBRL). One triple- 
resistant clone was analysed from each parent cell line by Southern Blotting. DNA 
was isolated from each cell line (PlSl[pGL269] and PlS3[pGL269]), digested with
32
Xhol, electrophoresed and blotted. Blots were probed with [a] P-CTP-labelled 
GPI8 ORF. Fragments of approximately 5kb were labelled in each lane (Figure 4.7) 
and these correspond to the expected size of the episomal fragments, given that 
pGL269 contains two Xhol sites (Figure 4.6). The episome is also multi-copy in L. 
mexicana, reflected in the high intensity of the hybridising signal.
Thus PlSl[pGL269] and PlS3[pGL269] are GPI8 null mutants re-expressing the 
gene from an episome.
4.3.1.5 Confirmation of ploidy by flow cytometry
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Genetic manipulation of Leishmcmia by transfection can result in changes of ploidy, 
particularly if the gene concerned is essential (Cruz et al., 1993; Mottram et al., 
1996b). To assess the DNA content of the mutants, flow cytometry was used. This 
was done for wild type, PI (heterozygote), PI SI, PI S3, PlSl[pGL269] and 
PlS3[pGL269] cell lines (Figure 4.8). FACS produces a trace with two peaks, one 
corresponding to cells in the first gap phase of the cell cycle (Gl) after mitosis, and 
the other to the second gap phase following DNA synthesis but before mitosis (G2). 
By comparison with the trace for diploid wild type cells, all of the mutant cell lines 
appeared diploid (see Figure 4.8 legend for details). This result confirms that no 
changes in ploidy had taken place during deletion of GPI8 and that the gene is not 
essential to the viability of L. mexicana under these in vitro conditions.
4.3.2 Phenotype analysis of GPI8 null mutants and re-expresser cell lines
At this point of the work, a L. mexicana gene with homology to both yeast and 
human GPI8 had been identified, characterised and knocked out. However, it was 
still not certain whether this gene encoded a component of the L. mexicana 
GPI:protein transamidase. Analysis of the phenotype of the null mutants and re- 
expresser cell lines compared with wild type cells would provide further evidence on 
whether LMGPI8 is indeed the homologue of yeast and human GPI8 and a key 
component of the transamidase complex.
4.3.2.1 Growth of GPI8 null mutants and re-expressers compared with wild type 
cells
To determine the growth rate of null mutants and re-expresser promastigote cell lines, 
three 12ml cultures were seeded with lx l03 cells ml'1 for each cell line (wild type,
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PI SI and PlSl[pGL269]) and their growth was monitored by recording their 
spectrophotometric absorbance at 600nm on a daily basis (Figure 4.9). An unseeded 
control culture was also prepared. Prior to measurements, cells were fixed by the 
addition of 50j j 1 of 40% formaldehyde to 950j j 1 of culture. The in vitro growth of 
GPI8 null mutant promastigotes was found to be comparable with both wild type and 
the re-expresser cell lines. A slight lag in PI SI growth was found after day 1, 
however the cells recovered and reached stationary phase at around the same time as 
the other cell lines. The reason for this is unclear, although it is possible that the 
cultures were not at the same stage of the growth cycle when used to inoculate the 
fresh medium for this experiment. Further experiments are needed to clarify this.
4.3.2.2 In vitro invasion of mouse peritoneal exudate cells (PEC) by GPI8 null 
mutants
Mouse macrophages, harvested from peritoneal flushing of BALB/c mice, were 
exposed to wild type, PI SI and PlSl[pGL269] promastigotes at a 1:1 ratio in 8 well 
Permanox chamber slides (Labtek). Time points were taken at 8 hours, 1 day, 3 days 
and 7 days after which the cells were fixed by immersion in methanol. Slides were
stained with Giemsa’s stain and viewed by light microscopy at lOOOx magnification
using an oil immersion lens. Approximately 100 macrophages were examined for 
infection at each time point and the following measurements were recorded:
• Number of macrophages counted
• Number of macrophages infected
• Number of amastigotes in infected macrophages
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The ratio of infected to uninfected macrophages was plotted against the time over 
which data were recorded (Figure 4.10A). The level of infection by the GP18 null 
mutants was similar to that of wild type and re-expresser cell lines. PI S3 and 
PlS3[pGL269] infections, unlike PI SI and PlSl[pGL269], were slightly reduced 
with respect to wild type, however the cell lines were still capable of infecting and 
proliferating within macrophages. The average number of PI SI and PI S3 
amastigotes per infected macrophages increased over the 7 days to between 3 and 4 
amastigotes per infected macrophage (Figure 4.1 OB). A similar increase was found 
with wild type and both GPI8 re-expresser cells.
These PI SI cells have a similar growth phenotype to wild type cells. In addition, 
episomal re-expression of GPI8 has no obvious effect on cell growth. These data 
show that GPI-anchored proteins are not required for entry of promastigotes into 
macrophages, their subsequent differentiation into amastigotes or their survival under 
these ex vivo conditions.
4.3.2.3 In vivo infection of BALB/c mice by GPI8 null mutants
To assess the ability of GPI8 null mutants to survive under in vivo conditions, wild 
type, PI (heterozygote), PI SI, PlSl[pGL269], PI S3 and PlS3[pGL269] were each 
inoculated into six BALB/c mice and lesion volume in each mouse was monitored 
over a period of up to 11 months. Stationary phase promastigotes were prepared for 
inoculation by Mr. David Laughland; cells were resuspended in PBS at 2.5xl07 
cells/ml and 0.2ml (5x106 cells) was injected subcutaneously into the shaven rump of
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each mouse. Inoculations and monitoring of lesion data was carried out by staff at 
the University of Glasgow Animal Facility.
The data are shown as plots of lesion volume over the 47 week (11 month) period 
(Figure 4.11).
Mice inoculated with wild type cells had begun to produce lesions within 7-9 weeks 
of inoculation and the volume of the lesions increased throughout the 9 month period 
except for mouse 4 (Figure 4.11 A). Mice were culled at the 34th week due to the 
size of the lesions.
The GPI8 heterozygote PI began to form lesions approximately 11 weeks after 
inoculation and interestingly, while lesion volume was seen to increase over time, it 
was on average, about 10 fold smaller than wild type by the end of the 6th month 
(Figure 4.1 IB). By 47 weeks, however, lesions ranged from 30mm3 to 680mm3. The 
largest (mouse 6) was three-fold smaller than the largest wild type. However, it 
should be noted that these measurements were made at week 47 when mice infected 
with wild type parasites had been culled.
Lesions for PI SI and PI S3 cell lines were first noticed at around the 20th week post­
infection, however, these remained very small for the first six months (Figure 4.11C 
and D; note the difference in the scale of y-axes compared with 4.11A and B). 
Thereafter, lesions were observed to increase in volume. PI SI lesions ranged from 
none to 240mm3 and PI S3 were between 50 and 230mm3 (all PI S3 mice had
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produced lesions, whereas two PI SI mice had not). Thus the largest was 8-fold 
smaller than the largest wild type lesion (at the 34 week stage).
GPI8 re-expresser cell lines were found to have a similar or even poorer growth 
profile than the null mutant, indicating that complementation in vivo was not achieved 
by episomal expression of GPI8 (Figure 4.1 IE and F). By the 47th week following 
inoculation, PlSl[pGL269] mutants failed to produce lesions in three of the six mice 
and only one had a lesion of appreciable volume (67mm3). PlS3[pGL269] mutants 
produced similar results. One mouse developed a lesion of 80mm3 (culled after 36 
weeks) whilst another developed a lesion of 195mm3, that is, around 10- to 20-fold 
less than wild type.
It should be noted that a number of mice infected with the different cell lines were 
observed to exhibit a sudden increase in lesion volume between weeks 43 and 44. It 
seems likely that this increase was an artefact, perhaps due to human error.
4.3.2.4 Effects on surface expression of the GPI-Iinked protein GP63
The major surface metalloproteinase, GP63, is the most abundant GPI-linked protein 
in the insect (promastigote) stage of the life cycle of the Leishmania species 
(Frommel et al., 1990; Medina-Acosta et al., 1989). If GPI8 encodes a key 
component of the transamidase complex, then the surface expression of GP63 should 
be affected when GPI8 is deleted. Therefore, the presence of GP63 was assessed by 
immunofluorescence and Western blotting using monoclonal GP63 antibodies.
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4.3.2.4.1 Immunofluorescence with anti-GP63 antibodies
Wild type, PI SI and PlSl[pGL269] cells were fixed on slides with 2.5% 
paraformaldehyde. The primary anti-GP63 antibody used was a monoclonal antibody 
named L3.6 that had been raised against L. mexicana GP63 and was a gift of Dr. 
David Russell, Washington University, St. Louis, USA (see Medina-Acosta et al, 
(1989)). Cells were visualised by fluorescence microscopy (Figure 4.12). Wild type 
cells fluoresced strongly whilst the control cells exhibited very little fluorescence, 
indicating that the non-specific interactions of the secondary antibody were minimal 
and that the signals viewed were due to the binding of primary antibody. By contrast, 
PI SI cells exhibited little or no fluorescence, indicating that GP63 was not expressed 
in detectable levels on the surface of these cells. Re-expression of the gene from the 
pXG episome restored the surface expression of GP63.
4.3.2.4.2 Western blotting with anti-GP63 antibodies
If GP63 is not being expressed on the cell surface, what is the fate of the protein in 
these null mutants? To attempt to answer this question, extracts of wild type, PI SI 
and PlSl[pGL269] were prepared by the lysis of 108 cells for SDS-PAGE and 
Western blotting. Following electrophoresis on a 10% acrylamide gel, the gel was 
electroblotted onto Hybond C (Amersham) and the membrane blocked overnight in 
Blocking Buffer 2. The primary antibody used was a mouse monoclonal raised 
against L. major GP63, which cross-reacts with L. mexicana GP63, a gift of Dr. 
Robert McMaster, University of British Columbia, Vancouver, Canada (see Button et 
al., (1991)). This antibody worked well with Western Blotting but was not suitable 
for immunofluorescence since it is unable to detect native GP63 on fixed cells.
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Blots were washed and exposed to secondary antibody (anti-mouse IgG-horseradish 
peroxidase conjugated - Promega) at a 1 in 5000 dilution for 50 minutes. After 
washing, antibody binding was detected using Enhanced Chemiluminescence (ECL) 
reagents (Pierce). Blots were exposed to X-ray film from 15 seconds to 2 minutes 
and these are shown in Figure 4.13. A protein of approximately 60kDa (GP63) was 
detected in wild type and PI cells (Figure 4.13A -  lanes 1 and 2, respectively) but 
was absent from GPI8 null mutant cells (lane 3). Episomal re-expression of GPI8 
restored GP63 to these cells (lane 4). When the blot was overexposed, a small 
amount of GP63 was detected in the null mutant in comparison with wild type (Figure 
4.13B). Note that a well was left empty between samples on the gel, to minimise the 
risk of sample over-spill into adjacent wells. As a control, the same lysates were 
electrophoresed, blotted and probed with an anti-CRKl antibody. CRK1 is found at 
relatively constant levels throughout the life cycle of L. mexicana (Mottram et al., 
1996b) and therefore makes a good control for protein loadings. A similar signal was 
detected in all samples (Figure 4.13C) indicating that the loss of GP63 is not due to 
underloading of the mutant cell lysates.
4.3.3 The fate of GP63 in GPI8 null mutants
Several fates of GP63 in GPI8 null mutants could be envisaged. It could be secreted 
into the growth medium, which has been observed during an artificially induced GPI- 
negative phenotype (Mensa-Wilmot et al., 1994), or it could be retained and 
degraded, as is seen with incorrectly transamidase-processed proteins in mammalian 
systems (Wainwright and Field, 1997), and is mediated by the cytoplasmic 
proteasome (Wilboum et al., 1998). It is known that GPI anchor attachment plays a
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determining role in the forward transport of an artificially expressed protein in I  
brucei (Bangs et al., 1997). To begin to address this, attempts were made to detect 
secreted GP63 in GPI8 null mutant growth medium. Inhibitors of the proteasome 
and the major lysosomal proteinases were added to growing cultures and the effects 
on GP63 in GPI8 null mutant cells were determined.
4.3.3.1 Do GPI8 null mutants secrete GP63?
To begin to address this question, 108 late-log phase promastigotes (wild type, PI, 
PI SI and PlSl[pGL269]) were added to 5ml of serum-free HOMEM and incubated 
for 7 hours. Cells were then pelleted and media was filter-sterilised and concentrated 
50-80 fold using Vivaspin lOkDa molecular weight cut-off columns (Vivascience Ltd. 
Lincoln, UK). Media samples were analysed by Western blotting with anti-GP63 
antibodies but no GP63 could be detected in any of the samples (not shown). Thus 
GP63 does not appear to be secreted from GPI8 null mutants, although this method 
may not be sensitive enough to detect secreted proteins.
4.3.3.2 Inhibition of degradative enzymes and the effect on GP63 loss in GPI8 
null mutants
The proteasome has been implicated as being involved in the quality control of GPI- 
anchoring in mammalian systems (Wilboum et al., 1998). To determine if the L. 
mexicana proteasome is involved in GP63 degradation, wild type, PI, PI SI and 
PlSl[pGL269] promastigotes were grown for 24 hours in medium containing the 
potent proteasome inhibitor MG132 (IOjjM). Lysates were prepared and analysed by 
Western blotting with anti-GP63 antibodies (Figure 4.14). GP63 was readily detected 
in both wild type and PlSl[pGL269] (Figure 4.14A - lanes 1 and 3), however the
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loss of GP63 from GPI8 null mutant cells had not been affected (Figure 4.14A - lane
2). This indicates that GP63 was not being degraded by the proteasome.
Perhaps degradation occurs via the lysosome pathway. The peptidyl diazomethane 
cysteine proteinase (CP) inhibitor Z-Phe-Arg-CFENk is known to affect CPs of both 
mammals (Kirschke and Barrett, 1987) and parasitic protozoa (North et al, 1990a; 
Scory et al., 1999), including the known L. mexicana CPs. The inhibitor was 
incubated with wild type, PI, PI SI and PlSl[pGL269] promastigotes for 48 hours 
and lysates were analysed for GP63 content by Western blotting (Figure 4.14B). 
GP63 levels in GPI8 null mutants, although apparently slightly recovered, were not 
fully restored when cells were grown in the presence of this inhibitor (Figure 4.14B -  
lane 2) compared with the control (lane 5) indicating that GP63 is unlikely to be 
degraded solely by the lysosomal cysteine proteinases. The differences could also be 
due to slight variations in the amount of material loaded in each lane.
4.3.4 Investigation of potential residues of importance to GPI8
GPI8 belongs to the cysteine proteinase family C13 (Riezman and Conzelmann, 
1998), which includes the cysteine proteinase legumain, which was first identified in 
plants such as Jack Bean (Abe et al., 1993) and later in mammals (Chen et al., 1997). 
It has been shown that the T. brucei GPI:protein transamidase is sensitive to 
sulphydryl alkylating agents suggesting the involvement of an essential cysteine 
residue (Sharma et al., 1999a). If GPI8 is a cysteine proteinase, then it most likely 
possesses the classical dyad residues of cysteine and histidine that would mediate 
activity. Four potential active site residues of LMGPI8 had been identified previously 
(see Chapter 3), Cys94, Cys216, His63 and His174. These residues are conserved
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between all of the GPI8 molecules analysed whereas Cys216 and both histidine 
residues are also conserved in the cysteine proteinase legumain (Figure 3.9). As the 
Leishmania GPI8 is also likely to have an essential cysteine residue, Cys216 would 
seem to be the most likely candidate.
Attempts to mutate these potential active site residues were made (Section 4.2.1.3) 
and of the four mutations only C216G was successful. This plasmid was designated 
pGL403. Insufficient time was available for further attempts to produce and confirm 
the other mutations but the C216G mutant plasmid was transformed into the PI SI 
(GPI8 null mutant) cell line and a single clone was obtained. This was analysed by 
Western blotting with anti-GP63 antibody and little GP63 could be detected (Figure 
4.15 -  lane 4). PlSl[pGL403] appears to have a similar phenotype as PI SI GPI8 
null mutant cells (lane 2). However, to confirm that Cys216 is essential for 
GPI: protein transamidase activity, it is necessary to show that GPI8 protein is 
expressed in the PlSl[pGL403] mutant. Unfortunately, monospecific antibodies 
were not available to confirm the results at the time. This work is ongoing.
4.4 DISCUSSION
In the work described in the previous chapter, several circumstantial lines of evidence 
pointed to the L. mexicana GPI8 being a functional homologue of yeast Gpi8p. 
These were based on the relatively high degree of homology between these proteins 
as well as the conservation of particular residues that may be involved in transamidase 
activity. The aim of this section of work was to provide further evidence that GPI8 
of L. mexicana encodes the GPI:protein transamidase by investigating a possible role 
for the protein in the attachment of GPI anchors to proteins.
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PCR and Southern data provide evidence that PI SI and PI S3 are indeed GPI8 null 
mutants. The absence of hybridisation with the GPI8 ORF probe together with the 
observed hybridisation with the 5' flank probe, which demonstrated the loss of the 
Xhol site within the ORF, indicated that the GPI8 ORF had been lost. Further 
experiments that would support the absence of GPI8 in PI SI and PI S3 would be the 
detection of GPI8 directly in wild type cell lysates by Western blotting and the failure 
to do so in PI SI and PI S3 extracts. Northern blotting could also be employed to 
demonstrate the absence of transcript in these mutant lines.
GPI8 null mutant promastigotes, which grow as well as wild type cells in liquid 
culture, have the ability to infect macrophages, differentiate to amastigotes and grow 
and replicate within macrophages under in vitro conditions. Recent studies suggest 
that the GPI biosynthesis is essential for growth of L. mexicana promastigotes, 
however it is proposed that it is the free GPIs (glycoinositolphospholipids or GIPLs) 
that are the essential membrane components (Ilgoutz et al., 1999). It was found that 
dolichol phosphate mannose synthase (DPMS) is an essential gene catalysing the 
formation of dolichol phosphate mannose, the sugar donor of mannose addition in all 
GPI biosynthesis. This includes the production of other GPI structures such as the 
carbohydrate-linked GPIs (the lipophosphoglycans or LPGs) and the free GPIs called 
glycoinositolphospholipids (GIPLs). This study supports the idea that it is the free 
GPIs that are essential for growth of Leishmania promastigotes (Ilgoutz et al., 1999) 
and amastigotes (Mensa-Wilmot et al., 1999) since, in collaborative studies (data not 
shown) it has been determined that the levels of LPG and GIPL are unaffected in 
GPI8 null mutants (Hilley, J.D., Zawadzki,J., McConville, M.J. Coombs, G.H. and
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Mottram, J.C. manuscript submitted). This is consistent with the idea that the 
biosynthesis of these non-protein associated GPIs is independent from the 
biosynthesis of protein GPIs in L. mexicana (Ralton and McConville, 1998).
Nevertheless the mice-infectivity studies show that GPI8 null mutants have difficulty 
in establishing infection in BALB/c mice, resulting in lesion volumes of at least 8-fold 
smaller than the largest wild type lesion. Thus, although GPI-anchored proteins do 
not seem to be required for parasite survival and macrophage invasion under in vitro 
conditions, they appear to play some role in in vivo survival. It is possible that the 
transfection and selection processes used to generate these mutants could be, in some 
way, compromising the ability of cells to survive in vivo by reduction in virulence. To 
investigate this L. mexicana wild type, PI (heterozygote), PI S3 (GPI8 null mutant) 
and PlS3[pGL269] amastigotes have been purified from mouse lesions and re­
injected into BALB/c mice. Increased infection would probably mean that the 
virulence of the mutant promastigotes was indeed compromised by the 
transfection/selection process.
Interestingly, episomal expression of GPI8 could not rescue this in vivo mutant 
phenotype. GPI-anchored proteins may be necessary when amastigotes emerge from 
dead macrophages into the lesion and are available to re-infect more macrophages. 
GP63 surface expression is dramatically down-regulated in the amastigote stage of 
some Leishmania species (Bahr et al., 1993) and, to date, only the GPI-anchored 
promastigote surface antigen 2 (PSA2) family of proteins, also known as GP46 
(Lohman et al., 1990; Murray et al., 1989) are believed to be expressed on 
amastigote surface albeit at a considerably lower level than promastigotes (Handman
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et al., 1995). Since antibiotics are not present to provide additional selection 
pressure, the episome could be lost while the parasites are existing intracellularly. As 
an alternative approach to determine whether re-expression of GPI8 can restore 
virulence, it should be possible to integrate a copy of the gene back into the 
chromosome, perhaps at the original locus or a different locus such as that of the L. 
mexicana cysteine proteinase c (Bart et al., 1995). This non-essential gene does not 
contribute to virulence (Bart et al., 1997) and integration at an alternative locus, such 
as this, would allow a third selectable marker to be used to screen for integration. 
Integration at the GPI8 locus would result in the deletion of one of the present 
antibiotic-resistance markers making screening for transfectants more difficult. 
Constructs for this are already available (prepared by Dr. Hubert Denise, University 
of Glasgow); GPI8 has been ligated into these and the work has begun but re­
integration has not yet been achieved.
If the transfection/selection procedure has compromised the virulence of the mutant 
promastigotes, then differences in in vivo infectivity between the GPI8 null mutants 
and re-expressers may not be apparent. The observation that the GPI8 re-expresser 
mutant lines are apparently even less capable of lesion formation in mice than the 
GPI8 null mutants could be explained by the fact that the re-expressers have 
undergone three rounds of transfection compared with two for the null mutants. The 
amastigote re-infection experiment described previously may provide further evidence 
for this.
The GPI8 heterozygote PI also produced smaller lesions in BALB/c mice than did 
wild type parasites, despite the retention of one copy of the gene. A possible
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explanation for this stems from the observation with Trypanosoma cruzi that, during 
an artificially induced GPI-deficiency proteins that normally are GPI-anchored have 
divergent fates (Garg et al., 1997). The fates of four GPI-anchored proteins were 
examined. Two proteins, gp50/55 and p60 were observed to be absent or decrease 
over a 20 hour period in cells expressing exogenous GPI-PLC and these proteins 
could not be detected in medium. This indicates that these proteins were retained and 
degraded intracellularly. Two other proteins, ssp-4 and p75 were detected in the 
growth medium indicating secretion. It was proposed that during GPI deficiency, i.e. 
when one of the transamidase substrates was limiting, GPI-signal sequences could 
have different “strengths of interaction” with the transamidase. The two secreted 
proteins interacted more readily with the transamidase, out-competing the other two 
proteins, which were retained and degraded. Ssp-4 and p75 may have been processed 
by the transamidase without receiving an anchor, producing soluble forms of each 
protein. Water could have replaced the anchor as the nucleophile required for 
completion of the reaction, as was seen with the modified transamidase substrate 
preprominiPLAP in mammalian cell-free systems (Maxwell et al., 1995a). These 
surface protein-deficient T. cruzi were able to infect macrophages but were unable to 
replicate. In the case of the L. mexicana GPI8 heterozygote (PI), perhaps the levels 
of the transamidase are less than normal since one copy of the gene is absent. If the 
proteins are competing for the transamidase, then it could be that a protein important 
for survival of amastigotes in the bloodstream when they emerge from one 
macrophage to re-infect another is not getting to the cell surface and this results in a 
less well-established infection of the mice. To investigate whether limiting 
transamidase levels or perhaps the transfection/selection process causes reduced 
virulence, two of the three remaining GPI8 heterozygotes described in Section 4.3.1,
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SI and P2 were inoculated into BALB/c mice to compare with PI. Time constraints 
for this project mean that the data from this experiment cannot be included here.
GPI-anchored proteins may be essential during the sandfly stages of infection, 
however passage of these mutants through the sandfly stage of the life cycle remains 
to be tested.
The ability of the GPI8 null mutants PI SI and PI S3 and the re-expresser cell lines 
PlSl[pGL269] and PlS3[pGL269] to express GPI-anchored proteins on their 
surface was investigated. GP63 is an excellent protein to study in terms of its anchor 
attachment because it is the major GPI-linked protein of Leishmania promastigotes. 
The effects of deletion of GPI8 on this protein were dramatic, with the apparent total 
loss of GP63 expression on the cell surface as determined by immunofluorescence on 
whole cells (Figure 4.12). Western blotting confirmed this; only very low levels of 
GP63 could be detected in GP/# null mutants (Figure 4.13). This remaining GP63 
could be either unprocessed GP63 or the non-GPI form of GP63, expressed in both 
promastigotes and amastigotes of L. mexicana by the Cl gene class (Medina-Acosta 
et al., 1989; Medina-Acosta et al., 1993; Ilg et al., 1993). Collaborative work within 
the laboratory of Dr. Malcolm McConville has demonstrated that incorporation of 
[3H]ethanolamine into GP63 (i.e. GPI anchor addition) was not detectable in PI SI 
mutants, indicating a loss of GPI anchor attachment to GP63 (Figure 4.16). This is 
fully concurrent with the GP63 immunofluorescence and Western data (Hilley et al.,
The fate of the non-anchored GP63 is not clear. Two possibilities exist; rapid 
secretion of the unprocessed GP63 or its retention and rapid degradation within the 
cell. These have not been investigated extensively and further study is required. 
Attempts to detect the secreted protein in serum-free medium were unsuccessful 
indicating a lack of secretion. The hydrophobic C-terminal GPI-signal of GP63 is 
probably not removed in the absence of the transamidase thus causing GP63 to 
remain associated with the ER membrane and be retained within the cell. A similar 
case has been reported in mammalian systems where human growth hormone (hGH) 
fused to the GPI anchor signal sequence of decay accelerating factor (DAF) protein 
with a mutated cleavage/attachment (go) site remained unprocessed and was degraded 
(Moran and Caras, 1992). In contrast, ectopic expression of T. brucei PI-PLC 
caused the cleavage of GPI anchors before they entered the ER, resulting in an 
artificial GPI-negative phenotype (Mensa-Wilmot et a l, 1994). As a result, no GPIs 
were available for attachment to protein, which led to the secretion of GP63. This 
situation differs from that of the. GPI8 null mutants in that in the other study the 
processing of the C-terminal signal sequence could still occur, since the transamidase 
was still present/active. In yeast and trypanosomal in vitro systems, a degree of 
processing without anchor addition occurs; small nucleophiles such as water, 
hydrazine and hydroxylamine act as alternatives to the ethanolamine component of the 
GPI anchor and are able to attack the activated carbonyl formed during 
transamidation causing the release of processed, but GPI-free protein (Ramalingham 
et al, 1996; Sharma et a l, 1999a; Maxwell et al, 1995b). Interestingly, mutation of 
the © site of GP63 (Asn577) also caused GP63 to be secreted although it was not clear 
if the protein was indeed being processed (McGwire and Chang, 1996). Attempts 
were made to influence GP63 degradation by inhibition of the L. mexicana
proteasome and major lysosomal CPs (Figure 4.14). Inhibition of the proteasome 
(using MG132) had no apparent effect on the loss of GP63 whilst the inhibition of the 
cysteine proteinases (by Z-FA) had a slight effect. In both cases further experiments 
are required to confirm that full inhibition was accomplished, although these 
conditions have been used successfully in the past (Mutomba et al., 1997; Frame,
1997). Perhaps another class of proteinase degrades GP63. Clearly the fate of GP63 
in L. mexicana GPI8 null mutants merits further study.
Further work within Dr. McConville’s laboratory demonstrated an accumulation of 
GPI anchor precursors in GPI8 null mutants (Hilley et al., 1999), which is the 
phenotype observed in yeast gpi8-l mutants (Benghezal et al., 1996). Collectively, 
the data strongly suggest that L. mexicana GPI8 is the GPI:protein transamidase but 
it remains to be seen if all GPI-anchoring of proteins has been prevented in GPI8 null 
mutants.
Because of its similarity to the C13 family CPs (Chapter 3) and because T. brucei 
transamidase activity requires an essential cysteine (Sharma et al., 1999a) it is 
hypothesised that GPI8 is a cysteine proteinase and as such it will probably rely on the 
classical active site dyad (cysteine and histidine) for activity (Barrett and Rawlings,
1996), The cysteine is required as a nucleophile mediating proteolytic activity. GPI8 
belongs to the C13 family of cysteine proteinases, which includes the plant cysteine 
proteinases known as the asparaginyl endopeptidases (Riezman and Conzelmann,
1998). The most likely residue for the catalytic cysteine of LMGPI8 is Cys216 as it is 
conserved between the three GPI8 proteins (yeast, human and L. mexicana) as well as 
legumain. When the C216G mutant was used to transfect the GPI8 null mutant cell
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line PI SI, it was found that surface GPI-linked GP63 could not be detected in this 
cell line. GPI8 antibodies capable of detecting the protein in cell lysates were not 
available (Chapter 5), thus the only evidence that the mutant gene was expressed lies 
in the fact that the cells were resistant to Geneticin (the antibiotic-resistance marker 
encoded from the episome). If the protein was actually expressed in the cell line then 
it is not active providing evidence that Cys216 is the active site cysteine. However, 
Cys216 could be involved in disulphide bridge formation to maintain protein tertiary 
structure rather than catalysis itself and there are a total of 9 cysteine residues within 
the protein. Clearly it is important to mutate these other cysteines to see if they have 
any effect. If not, then we have identified the active site residue. Since nothing is 
known about the three dimensional structures of GPI8, it is not possible to predict 
which residues, if any, are involved with disulphide bridge formation.
The wild type GPI8 and C216G GPI8 could be expressed as 6xHis fusion proteins in 
E. coli and both enzymes could be assessed for activity using an adapted version of 
GPI-anchoring cell free assay (Sharma et al., 1999a).
The validity of GPI8 as a potential anti-parasite drug target is open to question, 
however, the decreased ability of the parasites to infect in vivo, associated with the 
loss of protein GPI-anchoring suggests that the enzyme may still be exploitable. A 
non-essential gene can still encode a potential target (Barrett et a l, 1999). Cysteine 
proteinase inhibitors have been used effectively against Leishmania (Selzer et al,
1997) despite the fact that, of all the CPs identified to date, none have been shown to 
be essential (Souza et a l, 1994; Mottram et al., 1996a; Bart et al., 1997). Inhibition 
of a T. cruzi cysteine proteinase was shown to prevent its autocatalytic processing,
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leading to accumulation of the precursor molecule in the Golgi complex (Engel et al.,
1998). This had a lethal effect as the build up prevented normal functioning, which 
in turn led to cell death.
Although GPI8 may not be essential in Leishmania, the gene is likely to be essential 
in the related organism T. brucei, which depends on GPI anchors for the attachment 
of the variant surface glycoproteins (VSGs), used in the avoidance of the host 
immune response (see (Barry, 1997) and Pays and Nolan (1998) for reviews). L. 
mexicana GPI8 null mutants could be exploited as a model system for the study of 
the T. brucei homologue (TBGPI8). Once TBGPI8 has been isolated and 
characterised, it can be determined if it is able to functionally replace the L. mexicana 
gene. If so, the gene can then be subject to modifications and the GPI-anchoring 
ability can be assessed using GP63 surface expression as a marker in a transamidase 
null background (Alternatively, VSG could be expressed in Leishmania 
promastigotes providing a more “natural” substrate). Fluorescence due to anti-GP63 
antibody conjugated to FITC can be quantified'by flow cytometry (Joshi et al., 1998) 
and therefore GP63 surface expression can be quantified. The efficacy of potential 
inhibitors of the transamidase could also be determined in this system.
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Figure 4.2: Schematic of constructs containing PAC and SAT  genes flanked by 
GPI8 5' and 3' flanking regions. The constructs pGL236 and pGL237 were 
synthesised from the existing pX53/MC (pGL207) and pX53SAT (pGL51) constructs, 
by removing the existing 5' and 3' flanks of the antibiotic resistance genes (DHFT-TS 
and LMCPB flanking sequences) by restriction digests and replacing them with those 
of GPI8. A map of the constructs and predicted fragment sizes are shown (A). 
Constructs were tested by restriction digest to confirm that they were complete. 
Digests were electrophoresed on a 0.8% agarose gel and stained with ethidium 
bromide (B).
Lanes 1-5 were pGL236 digests:
1 Hindlll/Bglll,
2 Hindttl/Spel,
3 Bamm/BgBl,
4 Spel/Bglll,
5 Smal only
Lanes 6-10 were pGL237 digests:
6 HindlWBglll,
I  HindllHSpel,
8 BamHl/BgBl,
9 Spel/BgBl,
10 Smal only
Lanes 11 and 12 were uncut plasmid:
II  pGL236 (uncut),
12 pGL237 (uncut)
DNA markers (M) used: lkb ladder (GibcoBRL).
co a
-os:
£ C3og CQ
n Flank 3 Flank
<----  1231  600 >k-
pGL236
870
3.0kb
Predicted Restriction Fragments
TDs: suSi.
I I
<3QQ
S3k<0oq
5' Flank
1231
SAT 3 Flank
■>!< 498 4^ 870
Restriction Digests
Hindlll/BglU
Hindlll/Spel
BamVn/BglU
Spel/BglU
Smal
pGL236 fragments
2.7kb & 3.0kb
1.2kb & 4.5kb 
0.9kb & 4.8kb 
1.5kb & 4.2kb 
5.7kb (linearised plasmid)
pGL237 
3 0kb
pGL237 fragments
2.6kb& 3.0kb
1.2kb & 4.4kb 
0.9kb & 4.7kb 
1,4kb & 4.2kb 
uncut plasmid
B
M 6 10 11 12
m m
m m ^  6.0— 5.0 
“ 4.0
— 3.0
—  2.0
— 1.5
—  1.0
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Figure 4.3: Construction of episomal copy of GPI8 in pXG. The gene together 
with 5' and 3' flanks was not available on a single construct and had to be produced 
by cloning fragments of the gene from the two plasmid subclones generated from the 
original lambda clones. pGL185 contained the 2011 bp Sail fragment and pGL186 
contained the 235 lbp Xhol lambda fragment. | |  pGL185 was digested with Xhol to 
remove the majority of the GPI8 ORF and phosphatase-treated. The Xhol digested 
plasmid was gel purified. §  pGL186 was digested with Xhol to drop out the 5' flank 
and GPI8 ORF (shown as green block), which was gel-purified. §  The Xhol digested 
pGL185 was ligated with the Xhol fragment from pGL186 and used to transform E. 
coli producing pBS-GPI8. Ampicillin-resistant colonies were screened for both 
cloning and orientation using specific primers (OL460 and OL471) marked on pBS- 
GPI8 by yellow arrows. §  The Hincll fragment from pBS-GPI8 was gel-purified 
and cloned into Smal-digested, gel-purified pXG § to give pGL269 §. Primers 
OL472 and T3 were used to check for cloning and orientation.
Xho I (669)
Sal I (675)
pGL185
Sail fragment 
(2011bp)
Xho I (1706)Sal 1(2686)
w
H in cll (236)
5' flank
Xhol fragment (2351 bp;
OL460Imgpi8
/line  II (3334)
Neo Sal I
Smal
3‘ flank
OL471
Imgpi8 5’ flank
Imgpi8Hincll fragmentNeo
Xho I (2117)
Xho  I (7232)
Imgpi8 3' flankSal l
OL472
T3
pGL186
Xho 1 (4638)
Xho\ fragment 
(2351 bp)
Xho I (2287)
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Figure 4.4: PCR analysis of clones derived from first round transfection.
Nourseothricin- or puromycin-resistant clones were isolated and grown to near- 
stationary phase. lOjul of each cell line (wild type, PI, P2, P3 and SI) was added 
directly to lOOpl of sterile water for hypotonic lysis. 2pl of each lysate was used as 
DNA template in 20jli1 PCR reactions with Taq polymerase (Applied Biosystems) and 
primers OL133 and OL86 under the following conditions:
94°C, 4 minutes xl
94°C, 45 seconds ^
60°C, 45 seconds >- x28
72°C, 3 minutes
72°C, 7 minutes xl
A map of the GPI8 locus showing primer positions is shown (A).
The reactions were electrophoresed on a 0.8% agarose gel, which was stained with 
ethidium bromide (B):
Lane 1: wild type 
Lane 2: PI 
Lane 3: P2 
Lane 4: P3 
Lane 5: SI
DNA markers used were lkb Ladder (GibcoBRL)
OL133 OL86
\ '
PAC I SAT
OL133 OL86
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Figure 4.5: PCR analysis of clones derived from second round transfections.
Puromycin- and nourseothricin- resistant promastigote clones were isolated on solid 
medium and subjected to whole cell PCR with primers OL133 and OL86 as 
described in Figure 4.4. PCR conditions were exactly as described in Figure 4.4 
legend.
(A) PCR of double-resistant clones from transfections with P2 and P3 GPI8 
heterozygotes.
Lane 1: Wild type 
Lane 2 :P2S1 
Lane 3: P2S2 
Lane 4: P2S3 
Lane 5 :P3S1 
Lane 6: P3S2
(B) PCR analysis of three double-resistant clones from transfection with the PI GPI8 
heterozygote.
Lane 1: Wild type 
Lane 2 :P1S1 
Lane 3 :P1S2 
Lane 4: PI S3
DNA Markers: 1 kb Ladder (GibcoBRL)
A149
Figure 4.6: Southern analysis of GPI8 mutants. The schematic structure of the 
GPI8 locus is shown with the predicted size of Xhol fragments (A). 5pg of gDNA 
isolated from wild type, PI, PI SI and PI S3 cells was digested with Xhol, 
electrophoresed on a 0.7% agarose gel, which was stained with ethidium bromide (B), 
and blotted onto Hybond N (Amersham). Markers used were lkb Ladder 
(GibcoBRL).
(C) The blot was probed with [a] P-CTP labelled GPI8 ORF and hybridisation was 
detected by autoradiography. The GP18 ORF was prepared by digesting pGL136 (see 
Figure 4.5) with Xhol and Xbal and gel-purifying the l.lkb fragment prior radio­
labelling.
(D) This blot was stripped by the boiling SDS method and reprobed with similarly 
labelled PUR gene.
(E) More gDNA from these cell lines was Xhol digested, electrophoresed and blotted 
and this time was probed with the SAT gene.
The PUR and SAT genes were prepared for hybridisation by digesting the KO 
constructs pGL236 and pGL237, respectively, with SpeI and BarnRl (see Figure 4.1) 
and gel-purifying the fragments.
(F) Finally, the blot was stripped as before and reprobed with the 5' flanking region 
of GPI8. The 5' flank probe was produced by PCR (OL83 and OL84), using pGL186 
as a template. The PCR product was gel-purified prior to labelling.
Ah
5' flank 
Probe GP18 ORF 
Probe
X H
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X
PAC I SAT
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200bp
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Figure 4.7: Southern analysis of the GPI8 null mutants, transfected with an 
episomal copy of the gene. 5pg of total DNA, isolated from clones PlSl[pGL269] and 
PlS3[pGL269], were digested with Xhol, electrophoresed on a 0.7% agarose gel and 
blotted. The blot was probed with GPI8 ORF (Figure 4.4) and exposed to X-ray film 
overnight.
Lane 1: PlSl[pGL269]
Lane 2: PlS3[pGL269].
DNA markers: lkb Ladder (GibcoBRL).
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Figure 4.8: Flow cytometry was used to assess DNA content of GPI8 mutant cell 
lines. Mid-log phase promastigotes were harvested (2000xg, 5 minutes at 4°C) and 
washed in 10ml PBS. Cells were fixed in 70% methanol/30% PBS for an hour. Cells 
were pelleted by slow-speed centrifugation (lOOOxg, 10 minutes at 4°C), washed in 
10ml PBS before resuspending in 1ml of PBS + 10jag/ml RNAse A and lOpg/ml 
propidium iodide and incubation for 45 minutes at 37°C. Stained cells were analysed 
using a Becton Dickinson FACScalibur flow cytometer. Fluorescence was recorded for 
10000 cells from each cell line and the data were plotted using the CellQuest software 
(Becton Dickinson). The 2N peak represents the fluorescence due to diploid cells and 
the 4N peak represents fluorescence due to dividing cells that have doubled their DNA 
content but have yet to undergo mitosis.
The following cell lines were analysed:
WT
PI
P1S1
PlSl[pGL269]
PI S3
PlS3[pGL269]
PlS3|pGL269|
J ^  PI S3 
PlSl[pGL269|
WT
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Figure 4.9: The rate of growth of GPI8 null mutant and re-expresser cell lines was 
compared with wild type cells. Wild type, PI SI and PlSl[pGL269] were inoculated 
into 3x12 ml cultures each, at a density of lxlO" cells m l 1. Absorbance readings at 
600nm were taken daily with a spectrophotometer after the cells were fixed by 
incubating 950pl culture with 50pl 40% formaldehyde. Culture medium was used as a 
blank.
Data are means ±  standard deviation from 3 replicates.
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Figure 4.10: In vitro macrophage infection by wild type, GPI8 null mutants and 
GPI8 re-expresser cell lines. 2xl05 macrophages (Peritoneal exudate cells harvested 
from freshly killed mice) were added to each chamber of an eight chamber slide 
(Labtek) and adhered to the slide overnight before exposure to L. mexicana 
promastigotes from each cell line at a 1:1 ratio. After four hours incubation, cells 
were washed to remove free promastigotes and incubated at 32°C for seven days, with 
infections being monitored at 8 hours, 1 day, 3 days and 7 days. Cells were 
methanol-fixed at each time point. Slides were stained with Giemsa’s stain and 
viewed by light microscopy. Greater than 100 macrophages were counted for each 
cell line, and the number of infected macrophages recorded together with the number 
of amastigotes per infected cell. The experiment was repeated three times.
(A) The ratio of infected to uninfected macrophages was plotted to allow comparison 
of the ability of each cell line to infect macrophages.
(B) The average number of amastigotes per infected macrophage was plotted against 
time.
Data are means ± standard deviation from 3 experiments.
AWT
* -P 1 S 1
P1S1[pGL269] 
-x—P1S3 
■*— P1S3[pGL269]
1 2 3 4 5 6 7 8
Days post infection
B
-h^ WT
-■-P1S1
P1S1[pGL269] 
—x—P1S3 
— P1S3[pGL269]
0 1 2 3 4 5 6 7 8
Days post infection
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Figure 4.11: BALB/c mice were inoculated with the GPI8 mutant cell lines 
described below, to compare virulence. Each cell line was inoculated into 6 mice and 
infection was monitored over a period of 47 weeks by the University of Glasgow 
Animal Facility. Lesion volumes were recorded on a weekly basis as follows:
Lesions are assumed to be half-spheres and the volume of a half-sphere is 
calculated by ((4/3tt)/8) x length x width x height. (4/37i)/8 = 0.5236.
Therefore Lesion volume = 0.5236 x length x width x height
(A) Wild type
(B) GPI8 heterozygote, PI
(C) GPI8 null mutant, P1S1
(D) GP18 null mutant, P1 S3
(E) GPI8 re-expresser, P1S1 [pGL269]
(F) GPI8 re-expresser, P1 S3 [pGL269]
A
Wild type mice infections
2000
1800
1600
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wt2
wt4
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- a  1000
= 800
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400
200
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100
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Figure 4.12: Immunofluorescence of GP63 in the GPI8 null mutant. GP63 was 
detected by immunofluorescence with anti-GP63 antibodies. Wild type, PI SI and 
PlSl[pGL269] cells were smeared on slides and fixed with paraformaldehyde before 
exposure to a 1 in 100 dilution of L3.6 monoclonal antibody (raised against GP63 
from L. mexicana (Medina-Acosta et al., 1989)) in PBS for 30 minutes or, as a 
negative control, just PBS. Cells were washed and blocked (10% HI-FCS in PBS for 
30 minutes) before exposure to a 1 in 500 dilution of secondary antibody (anti-mouse 
IgG-FITC conjugate (Sigma)) and 20pg/ml DAPI in PBS for 30 minutes in the dark. 
After washing in PBS, 20pl of the anti-quenching agent MOWIOL/DABCO was 
dropped onto each slide under a glass coverslip and cells were viewed using a Zeiss 
Axioplan fluorescence microscope with a Hamamatsu Digital Camera using the 
OpenLab Software Package (Improvision, University of Warwick).
PI SI [pGL269|
Figure 4.13: Western analysis of GP63 in GPI8 null mutants. GP63 was analysed 
by Western blotting. Cells were lysed in 0.25% Triton X-100, Laemmli sample 
buffer and lysates were electrophoresed (SDS-PAGE) and electroblotted onto Hybond 
C (Amersham). Blots were exposed to a mouse monoclonal antibody raised against 
L. major GP63 (after overnight blocking) at a 1 in 25 dilution in blocking buffer for 
60 minutes. Secondary antibody (anti-mouse IgG-HRP conjugate (Promega)) was 
used at a 1 in 5000 dilution and antibody binding was detected by ECL (Pierce) (A). 
The blot was overexposed to detect any faint bands (B). The same lysates were 
electrophoresed, electroblotted and exposed to affinity-purified anti-CRKl antibody 
(1 in 50 dilution) as a loading control (C).
Lane 1: wild type
Lane 2: PI
Lane 3 :PISI
Lane 4: PlSl[pGL269],
Molecular weight markers: MultiMark Multi-Colored Standard (Novex)
A 1 2 3 4
60kD a- GP63
GP6360kDa
CRK136kDa
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Figure 4.14: The effects of inhibition of the proteasome and lysosomal cysteine 
proteinases on the loss of GP63 in GPI8 null mutants. (A) Wild type, PI SI and 
PlSl[pGL269] promastigotes were resuspended at lxlO7 cells ml'1 in 5ml of fresh 
medium and were incubated in both the absence and the presence of the proteasome 
inhibitor MG132 at lOpM. Cells were incubated at 25°C for 24 hours and cell counts 
were performed. Lysates were prepared and fractionated by SDS-PAGE before 
electroblotting and detection with anti-L. major GP63 antibodies at 1 in 25 dilution. 
(B) Promastigotes were resuspended at lxlO7 cells ml'1 in 5ml of fresh medium in 
both the presence of lOmM Z-phe-ala-CHN2 (Z-FA) and its absence. Cells were 
incubated for 48 hours at 25°C before harvesting and lysis. Lysates were analysed by 
Western blotting with anti-L. major GP63 as before.
In both cases, samples were electrophoresed as follows:
Lane 1: wild type plus inhibitor 
Lane 2: PI SI plus inhibitor 
Lane 3: PlSl[pGL269] plus inhibitor 
Lane 4: wild type minus inhibitor 
Lane 5: PI SI minus inhibitor 
Lane 6: PlSl[pGL269] minus inhibitor
A1 2 3 4 5 6
60kDa
M G 132 +  +  +
60kDa
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Figure 4.15: Detection of GP63 by Western blotting in cell lysates of PI SI cells 
re-expressing a mutated copy of GPI8. The cysteine residue at position 216 of 
LMGPI8 was mutated to glycine and the modified gene was expressed in GPI8 null 
mutant (P1S1) cells. Lysates of this cell line were prepared, electrophoresed (SDS- 
PAGE) and electroblotted, together with wild type, PI SI and PlSl[pGL269] before 
being exposed to anti-A. major GP63 antibodies at a 1 in 25 dilution.
Lane 1: wild type 
Lane 2: PI SI 
Lane 3: PlSl[pGL269]
Lane 4: PlSl[pGL403] (C216G mutation)
Molecular weight markers: MultiMark Multi-Colored Standards (Novex)
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Figure 4.16: [3H| ethanolamine incorporation of GP63. Promastigotes were 
labelled with [ H]ethanolamine and proteins were fractionated by SDS-PAGE for 
analysis by fluorography. This work was carried out by Dr. Malcolm McConville 
and colleagues and is included with his permission.
Lane 1: wild type lysate
Lane 2: PI SI (GPI8 null mutant) lysate
Lane 3: PlSl[pGL269] (re-expresser) lysate
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CHAPTER 5
PRODUCTION OF RECOMBINANT GPI8 AND FURTHER 
INVESTIGATIONS OF L. MEXICANA GPI8
5.1 INTRODUCTION
GPI8 from yeast has been demonstrated to exist within the lumen of the endoplasmic 
reticulum (ER) as a type I membrane protein (Benghezal et al., 1996). The yeast 
protein consists of three domains, as determined by proteinase protection assay: a 
large ER lumenal domain, the transmembrane region and a short cytoplasmic tail of 
unknown function. The human homologue also seems to have this overall structure 
based on the similar hydrophobicity plot to the yeast protein (Benghezal et al., 1996; 
Yu et al., 1997). By a combination of enzymatic treatment to remove glycans and 
Western blotting techniques, it was found that yeast Gpi8p is post-translationally 
modified by the attachment of N-linked glycans at three predicted sites (Benghezal et 
al., 1996). The human homologue lacks any potential N-glycosylation sites. The L. 
mexicana GPI8 protein, however, contains three potential sites for N-linked 
glycosylation and part of this section of the thesis was to determine if these are 
utilised. LMGPI8 (38kDa) is smaller than the S. cerevisiae (47.5kDa) and human 
(45kDa) homologues and it lacks the C-terminal hydrophobic domain which is 
thought to be involved in attaching these other GPI8 proteins to the lumenal 
membrane of the ER. Another integral membrane protein may be required to attach 
LMGPI8 to the ER membrane. Such a protein could be part of the transamidase 
complex, required for enzymatic activity or could be an accessory protein. One such 
a protein has already been identified in yeast. Gaalp is an integral membrane protein
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of the ER which appears to be an essential component of the yeast GPI: protein 
transamidase (Hamburger et al., 1995). This protein has been identified in humans 
(Hiroi et al., 1998) but has not yet been shown to be present in parasitic protozoa.
The secretory pathway of trypanosomatids, particularly African trypanosomes, has 
been studied extensively in recent years. The use of fluorescent markers such as 
green fluorescent protein (GFP) fused to a protein of interest such as the major 
surface protein of procyclic African trypanosomes (procyclic acidic repetitive protein, 
or PARP) has allowed the trafficking to the cell surface to be measured in live cells 
(Bangs, 1998). Eukaryotic proteins that enter the secretory pathway are generally 
targeted to the ER by means of a hydrophobic, N-terminal signal peptide that is 
removed upon entry to the ER lumen (Walter et a l, 1984). But what governs the 
retention of ER proteins? There is evidence to suggest that retention of some 
proteins is facilitated by a C-terminal tetrapeptide; these proteins are still able to exit 
the ER, however specific receptors in a later compartment in the secretory pathway 
bind these proteins facilitating return to the ER by retrograde transport (Pelham, 
1991; Bangs, 1998). The C-terminal tetrapeptide in LMGPI8 (YDLE) resembles the 
classical ER-retention motif described in both mammals and yeast (KDEL and HDEL 
respectively) (Pelham et al., 1988; Munro and Pelham, 1987) and may be significant 
in keeping soluble GPI8 in the ER, where it can interact with the other membrane- 
bound components of the transamidase complex. BiP, the ER molecular chaperone 
protein of T. brucei (Bangs et al., 1993) also possesses such a motif (MDDL) and 
deletion of the BiP tetrapeptide results in secretion of the protein (Bangs et al., 
1996).
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To begin further analyses of LMGPI8, overexpression of the protein for antibody 
production was necessary. The most common method for providing large amounts of 
recombinant protein is to use E. coli. E. coli often cannot express proteins in their 
correctly folded, soluble form and produce insoluble inclusion bodies containing the 
overexpressed protein. For example the cysteine proteinase cathepsin B of mammals 
(Kuhelj et al., 1995) and one of the cysteine proteinases (CPB2.8) encoded by the 
CPB array of/,, mexicana (Sanderson et al., 1999) were both expressed in E. coli as 
insoluble inclusion bodies. It may be possible to refold the purified protein artificially 
during the removal of the denaturants in which the protein was purified, as was done 
with L. mexicana CPB. Modified versions of the protein can be expressed to simplify 
purification. For example, the inclusion of a 6 x Histidine tag can be used, allowing 
the protein to be purified on a Nickel column. Ni2+ ions coordinate strongly with the 
histidine residues that act as ligands due to electron donation by the amide 
components of the amino acid side chains.
It was the aim of this section to:
• Express recombinant GPI8 in E. coli
• Produce mono-specific antibodies to GPI8
• Investigate whether LMGPI8 is post-translationally modified by the addition of N- 
linked glycans.
• Attempt to establish the subcellular location of LMGPI8 by generation of a GPI8- 
GFP fusion protein with a view to providing further evidence that LMGPI8 is the 
homologue of yeast Gpi8p and a component of the GPI: protein transamidase.
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The fluorescent marker protein, GFP has also been used successfully to determine the 
subcellular location of particular proteins, by generating and expressing a fusion 
protein and detecting the GFP fluorescence in particular subcellular compartments 
(Ha et al., 1996). For example, dolichol phosphate mannose synthase (DPMS), an 
enzyme associated with GPI-anchor biosynthesis was localised to a novel tubular 
structure in L. mexicana, thought to be a subcompartment of the ER (Ilgoutz et al., 
1999b).
5.2 METHODS
5.2.1 Preparation of constructs
5.2.1.1 Generation of pQE-30/GPI8 (pGL184)
The parent plasmid chosen for expression of GPI8 in E. coli was pQE-30 (Qiagen), 
which places a 6 x His tag at the N-terminus of the protein allowing the one-step 
purification on a Ni-NTA column. It was decided not to include the hydrophobic ER 
signal sequence of GPI8 as it is probably absent from the mature protein. The 
position of the ER signal peptidase cleavage site was predicted using a programme 
called SignalP available via the EXPASY Proteomics tools web site 
(http://www.expasy.ch/tools/). PCR primers were designed accordingly (Table 5.1), 
and GPI8 was amplified and cloned into pQE-30 to produce pGL184 (Figure 5.1).
Table 5.1: Primers used to amplify GPI8 for cloning into pQE-30
1 1 1 1 1 1
OL437 CGGGATCCGGCAAGGGCCAGAGCAACAAC BamBl
OL438 CT AGT C GAC CTACTCGAGGTCGT AGCGGACGT SalI
Note that the ER signal sequence was omitted from the construct but that the naturally occurring 
stop codon (shown in bold) was retained. Restriction sites are underlined.
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pGL184 was used to transform electrocompetent M15[pRep4], AB1899F' and 
AB1899F' GroEL/ES bacterial strains by electroporation and these cells were used 
for protein overexpression.
5.2.1.2 Generation of pXG-G/YS-GFP (pGL190)
GPI8 was amplified by PCR using the primers shown in Table 5.2. Primers were 
designed to engineer a BamYR restriction site on the 3' end of GPI8, in place of the 
stop codon to allow simple cloning into pXG-GFP, such that the GFP component of 
the fusion protein is located at the C-terminus of GPI8.
Table 5.2: Primers used to amplify GPI8 for cloning into pXG-GFP
OL510 TCTAGAAAACGGCAGCTAGTGCA Xbal (natural)
OL511 CGGGATCCCTCGAGGTCGTAGCGGACGTCCA BamHl
The gene was amplified with VENT polymerase from pGL187 (Section 3.2.1.3) using 
the same conditions as the pQE-30 cloning (Section 5.2.1.1). Amplified fragments 
were digested with BamHl directly in the PCR mixture followed by 
phenol/chloroform extraction, ethanol precipitation and gel-purification. The pXG- 
GFP vector was digested with Smal and BamHl. The Smal blunt-end was ligated to 
the 5' end of the amplified fragment and the sticky-ended BamHl site at the 3' of the 
amplified gene was ligated with the similarly digested end of pXG-GFP yielding pXG- 
GPI8-GFP, designated pGL190 (Figure 5.2).
5.2.2 Expression of recombinant GPI8His
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5.2.2.1 Buffers for denaturing purification of GPI8His
Buffer A: 6M guanidine hydrochloride, O.iM NaH2PC>4, 0.01M Tris-HCl, pH 8.0. 
Store at room temperature.
Buffer B: 8M urea, 0.1M NaH2P0 4 , 0.01M Tris-HCl, pH 8.0. Store at room 
temperature.
Buffer C: Same as buffer B, but pH adjusted to 6.3 with HC1. Store at room 
temperature.
Buffer D: Same as buffer B, but pH adjusted to 5.9 with HC1. Store at room 
temperature.
Buffer E: Same as buffer B, but pH adjusted to 4.5 with HC1. Store at room 
temperature.
Buffer F: 6M guanidine hydrochloride pH7.8, 0.2M acetic acid. Store at room 
temperature.
5.2.2.2 Small scale purification
500pl of an overnight culture of M15[pRep4] [pGL184] was added to lOmls of fresh 
L-broth and incubated for about 60-90 minutes at 37°C with shaking until the optical 
density (600nm) reached 0.7 to 0.9. IPTG (2mM final concentration) was added to 
induce the expression of GPI8His. IPTG binds to the repressor protein (which is 
expressed from the pRep4 plasmid), preventing it from binding to pGL184 and
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expression occurs. 1ml samples were taken at 0, 1, 2, 3 and 4 hours after the addition 
of IPTG. Cells were pelleted and lysed in 150pl of the denaturing Buffer A for 1 
hour at RT with agitation. Ni-NTA beads were added to bind any GPI8His and after 
30 minutes, beads were pelleted, washed with 1ml of Buffer B and 3 x 1ml of Buffer 
C before elution in 50pl Buffer C + lOOmM EDTA.
5.2.2.3 Large scale purification
A 20ml overnight culture of M15[pRep4][pGL184] was added to 1 litre of fresh L- 
broth with lOOpg/ml ampicillin and 2 5 fig/ml kanamycin. After about 3 hours the 
O D 6oo was about 0.7 and EPTG was added to 2mM final concentration. Cells were 
incubated for 3 hours at 37°C before being harvested in 4 x 250ml aliquots. Pellets 
were stored at -70°C until required.
One pellet was lysed in 5 ml of Buffer A and sonicated (Microtip 20% amplitude with 
5 x 5  second pulses). The sample was centrifuged at 10,000 x g for 15 minutes to 
remove any unbroken cells and the supernatant was passed through a 0.4pM filter. A 
4ml Ni-NTA column was prepared according to manufacturers instructions and 
equilibriated with Buffer A and the sample loaded onto the column using a Waters 
625LC FPLC system (Millipore). Absorbance at 280nm was monitored to detect 
proteins in the flow through. Fractions were collected throughout the washing and 
elution of the column. The column was washed with Buffers B and C until no more 
protein was eluted. Buffers D, E or F would be expected to contain GPI8His. In fact 
the recorded elution profile indicated that the majority of protein was eluted from the 
column in Buffer F.
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5.2.2.4 Inclusion body purification
A second frozen pellet derived from the large-scale expression of GPI8His (previous 
section) was lysed and inclusion bodies were purified using a modified version of an 
existing method (Kuhelj et al., 1995). The cell pellet was resuspended in 3ml 50mM 
Tris-HCl, pH8.0 containing 5mM EDTA, 5% sucrose and lmg/ml lysozyme. The 
suspension was incubated for 20 minutes at 37°C for lysis then the volume was made 
up to 10ml in same buffer without lysoszyme. The lysate was subjected to two cycles 
of freezing (in dry ice/ethanol) and thawing (incubation at room temperature) then 
sonication: 6 x 10s, 200W to fragment nucleic acids. The lysate was centrifuged, 
(6000 x g, lOmins) to pellet the inclusion bodies and these were washed once in 
50mM Tris/HCl, pH8.0, 5mM EDTA, 0.1% Triton X-100 and twice in 50mM 
Tris/HCl, pH8.0, 5mM EDTA, 2mM urea. The inclusion bodies were washed in 
water and centrifuged and were solubilised in Buffer B + lOmM DTT (37°C, 1 hour, 
then 4°C, overnight).
5.2.3 Co-expression of GPI8His with the chaperonins GroEL and GroES
4.5ml of overnight cultures of AB1899F'[pGL184] and the AB1899F'GroEL/ES 
[pGL184] clones were used to inoculate 2 x 100ml of L-broth each. The flasks were 
shaken at 37°C for 2 hours (OD600 = 0.7). IPTG was added to a final concentration 
of 500pM. Note that this was less IPTG than was used with M15[pRep4] [pGL184] 
cells since expression of the chaperonin was also induced by IPTG, presumably 
allowing sufficient quantities of GroEL/ES production before GPI8His levels get too 
high to form inclusion bodies. The flasks were incubated as follows:
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Flask 1 -  AB1899F' [pGL184] -  shaken at 37°C for 3 hours 
Flask 2 -  AB1899F' [pGL184] -  shaken at 19°C for 24 hours 
Flask 3 -  GroEL/ES [pGL184] -  shaken at 37°C for 3 hours 
Flask 4 -  GroEL/ES [pGL184] -  shaken at 19°C for 24 hours 
lml samples were taken from all flasks at t=0 hours after addition of IPTG (cells were 
pelleted and frozen (-20°C) until samples from all four flasks had been collected), lml 
samples were taken from flasks 1 and 3, three hours after IPTG addition -  the 
remainder of each culture was harvested and stored at -70°C until required, lml 
samples were taken from flasks 2 and 4, 24 hours after induction and the cells were 
pelleted (the rest of each culture was also harvested and stored at -70°C).
The remainder of the 100ml GroEL/ES culture was lysed in 5ml of LS-T buffer. The 
lysate was passed through a 0.4pM filter and loaded onto the column with LS buffer, 
which was passed through the column until no more Triton X-100 or protein was 
detected in the flow through (note that Triton X-100 absorbs UV light at 280nm, 
masking the protein signal meaning that the elution profile could not be used as a 
means of detecting protein). The column was washed with high salt buffer (HS) and 
proteins were eluted in an imidazole gradient of 0-25OmM. Finally 500mM imidazole 
was passed through to remove all traces of protein. Fractions were collected 
throughout the purification and fractions 2-5, 8, 11 and 14 taken during the imidazole 
gradient were concentrated by ultrafiltration using Centricon-10 tubes, which have a 
lOkDa molecular mass cut off.
5.2.4 Antibody generation and affinity purification
172
Purified recombinant GPI8His was dialysed against PBS for two days with several 
changes of PBS. The protein, which had precipitated was diluted to 1 mg/ml as 
estimated by spectrophotometry by comparison with known concentrations of bovine 
serum albumin (BSA). This material was sent as an insoluble suspension to the 
Scottish Antibody Production Unit (SAPU) for inoculation into rabbits.
The amino acid sequence of LMGPI8 was commercially analysed by Genosys for 
identification of potential antigenic regions. A 21 amino acid GPI8 peptide 
(NFNYHPYRVEASRNRSKPAHRD) was synthesised and used to inoculate two 
rabbits. This resulted in anti-peptide GPI8 antibodies (R771 and R455)
GPI8 peptide was immobilised using the AminoLink Immobilization Kit (Pierce) 
according to manufacturer’s protocol, lml of R771 (anti-peptide GPI8) antisera was 
added directly to the immobilised epitope column and sample was mixed with the 
column resin/epitope for 1 hour at room temperature. Column was washed with 16ml 
PBS and bound proteins were eluted with IgG Elution Buffer (Pierce) and collected 
in lml fractions, which were analysed for protein by spectrophotometry (absorbance 
readings were taken at 280nm wavelength). Fractions containing protein were pooled 
and dialysed against several changes of PBS before storage at 4°C.
5.2.5 Periodate treatment
The method of Bayne and co-workers was used to periodate-treat Hybond C-blotted 
lysates (Bayne et al., 1993). Two blots were prepared and one was incubated with 
lOmM sodium metaperiodate (Sigma) whilst the other was incubated with periodate 
buffer without periodate for 60 minutes. Both blots were washed in wash buffer
173
containing glycerol followed by three rinses in the same buffer minus glycerol. 
Membranes were then blocked and exposed to antibodies as normal.
5.2.6 Trypanosoma brucei immunofluorescence with R491
Procyclic T. b. rhodesiense were fixed on slides and exposed to two primary 
antibodies simultaneously using the method of McDowell et al., (1998). One primary 
antibody was a mouse monoclonal raised against the TY epitope tag (Bastin et al., 
1996) present in QM protein and the other was R491 (rabbit anti-GPI8His). Both 
were used simultaneously at 1 in 100 dilution. Two secondary antibodies were also 
used simultaneously, anti-mouse IgG-TRITC conjugate and anti-rabbit IgG-FITC 
conjugate at 1 in 100 dilution, together with DAPI at 20jig/ml. Cells were viewed by 
immunofluorescence microscopy (a Zeiss Axioplan fluorescence microscope with a 
Hamamatsu Digital Camera using the OpenLab Software Package (Improvision, 
University of Warwick)). FITC fluorescence due to QM was observed using Zeiss 
filter set 09 whilst TRITC was observed using Zeiss filter set 15.
5.3 RESULTS
5.3.1 Expression of recombinant GPI8His in E. coli
5.3.1.1 Small-scale expression of GPI8His
To determine the time course of GPI8His expression, a small-scale expression 
experiment was carried out and hourly time points were taken. These samples were 
analysed by SDS-PAGE and the protein detected by staining with Coomassie Blue 
(Figure 5.3). Significant quantities of GPI8His were detected at all timepoints. Note 
that the purification of GPI8His was carried out under strongly denaturing conditions 
(6M guanidine hydrochloride and 8M Urea).
174
To determine if any soluble GPI8His was expressed, the induction was repeated and 
the purification was repeated under soluble conditions but no purified protein was 
detected (not shown).
5.3.1.2 Large scale expression and purification of GPI8His
Larger cultures expressing GPI8His were harvested, lysed and purified on a Ni-NTA 
column. Fractions that coincided with the protein peaks of the elution profile were 
analysed by SDS-PAGE. Note that the proteins in Buffers A and F were TCA 
precipitated and resuspended in the same volume of SDS-PAGE loading buffer prior 
to electrophoresis because 6M guanidine hydrochloride forms a precipitate.
The gel was stained with Coomassie Blue and is shown in Figure 5.4A. A protein of 
36-40kDa (approximately the size expected for GPI8His) was detected in Buffer F 
elution (Figure 5.4A -  lane 8) that was not present in the other fractions. Despite 
this, there were number of bands of higher mobility, which were presumably 
contaminating E. coli proteins or partially degraded GPI8His.
Because GPI8His is insoluble, it forms inclusion bodies in E. coli. This was exploited 
as a simple extra purification step, given that inclusion bodies could be purified 
directly from E. coli using a revised version of the method of Kuhelj et al., (1991) 
(see Section 5.2.2.4). The solubilised inclusion bodies were passed through a 0.4jiM 
filter and loaded and washed on the column. As before very little protein was 
detected in the elution profile of Buffers D and E (not shown). Most of the eluted 
protein was collected in a single Buffer F fraction and this was analysed by SDS-
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PAGE (Figure 5.4B, lane 3). Whilst bands other than GPI8His were visible, the 
sample was much cleaner than before and was used to inoculate rabbits.
5.3.1.3 Generation of antisera against GPI8His
The concentration of GPI8His was estimated by absorbance at 280nm to be 
approximately 0.75mg/ml, using known concentrations of BSA to produce a standard 
curve of A2so readings. Dialysis of GPI8His to remove Buffer F was attempted to re­
fold the protein, however it was found to consistently precipitate out of solution. 
Even gradually decreasing the amount of the denaturant over time was not effective in 
re-folding the protein and resulted in precipitation. 6ml (approximately 4.5mg) of 
GPI8His in Buffer F was dialysed against PBS (with several changes of PBS) to 
remove as much denaturant as possible. The precipitate was collected by 
centrifugation (17000xg, 30 minutes) and was resuspended at approximately 1 mg/ml 
in PBS. 8x400|il aliquots were sent to the Scottish Antibody Production Unit (SAPU) 
to be injected into two rabbits for antibody production (R491 and R492). In addition, 
a synthetic peptide (peptide sequence) of part of GPI8 was produced and used to 
produce antibodies in rabbits by Genosys (R771 and R455).
These antibodies were tested by Western blotting with purified recombinant GPI8His. 
All were found to bind readily to the recombinant protein (not shown).
5.3.1.4 Soluble expression of GPI8His in E. coli expressing the chaperonins 
GroEL/GroES
An E. coli strain (AB1899F') containing plasmid which expressed the chaperonins 
GroEL/GroES on induction with IPTG (AB1899F'GroEL/ES) were a gift from Dr.
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John Hyde of UMIST. The chaperonins GroEL and GroES are proteins that provide 
a vessel for the re-folding of non-native polypeptides (see (Ranson et al., 1998) for 
review). Co-expression of GPI8His with these chaperonins could provide folded and 
soluble GPI8. Therefore, the E. coli strain AB1899F' and AB1899F'GroEL/ES and 
were transformed with pGL184.
The four small scale GPI8His expression samples described in Section 5.2.2 were 
harvested and lysed in 50pl sonication buffer + 1 mg/ml lysozyme for 15 minutes at 
37oC followed by two freeze/thaw cycles. Lysates were mixed with SDS-PAGE 
sample buffer, boiled for 5 minutes and analysed by SDS-PAGE and Western blotting 
using affinity purified R771 peptide antibodies (Figure 5.5). At t=0, GPI8His could 
not be detected in either AB1899F'[pGL184] (Figure 5.5A -  lanes 1 and 2) or 
AB1899F'GroEL/ES[pGL184] (Figure 5.5B -  lanes 1 and 2) cells. GPI8His was 
detected in abundance in the insoluble fractions of both cell lines incubated at 37°C 
during expression (Figure 5.5A -  lane 4; Figure 5.5B -  lane 4) and a very small 
amount was detectable only in the soluble fraction of the GroEL/ES cells. 
Interestingly, when GroEL/ES cells were incubated at 19°C during expression, a 
much larger amount of GPI8His was present in the soluble fraction (Figure5.4B -  
lane 5) although a band of about the same intensity was detected in the insoluble 
fraction (lane 6). No protein was detected in the soluble fraction of AB1899F' 
incubated at 19°C (Figure 5.5- lane 5).
5.3.1.5 Large-scale purification of soluble GPI8His
2ml fractions collected from the Ni-NTA column were concentrated by ultrafiltration 
and analysed by SDS-PAGE (Coomassie-stained gel) and Western blotting with R771
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antibodies (Figure 5.6). From the Coomassie gel (Figure 5.6A) Fraction 11 (lane 6) 
was found to contain several proteins. As the major band was approximately 60kDa 
it is. likely to correspond to GroEL. There were a few higher mobility proteins, 
notably one of approximately 36-38kDa, which is the size predicted for GPI8His. 
Western analysis (Figure 5.6B) identified a single protein of 42kDa (5.6B -  lane 6), 
slightly larger than expected. The more abundant chaperonin at 60kDa was not 
recognised by this antibody. Because the band of interest was absent in fractions 8 
(Figure 5.6B -  lane 5) and 14 (Figure 5.6A -  lane 7), fractions 9, 10, 12 and 13 were 
concentrated by ultrafiltration and analysed by Western blotting (Figure 5.7). The 
42kDa band could be detected in fractions 10, 12 and, to a lesser extent, 13 (Figure 
5.7 -  lanes 2, 3 and 4 respectively). There was no detectable protein in fraction 9 
(lane 1). The reason for the lower than expected mobility of the putative GPI8His is 
not clear. To confirm that the antibodies are cross-reacting with GPI8His the protein 
could be separated by SDS-PAGE, purified and subjected to N-terminal sequencing 
to confirm its identity.
5.3.2 Western analysis of L. mexicana lysates with anti-GPI8 antibodies
Repeated efforts to detect GPI8 in L. mexicana whole cell lysates by Western blotting 
with R491 and R492 (anti-GPI8His) and R771 and R455 (anti-peptide) antibodies 
have failed. A variety of modifications of the standard technique were used, 
including:
• Different amounts of material were loaded in each lane, ranging from 106 to 2xl07 
cell-equivalents.
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• Primary antibodies were used at different concentrations. R491 and R492 anti- 
GPI8His were used at between 1 in 200 to 1 in 1500 dilutions of crude serum. 
The GPI8 peptide was immobilised on Aminolink resin and this was used to 
affinity purify R771 antibodies (Section 5.2.4). Affinity purified R771 anti­
peptide GPI8 antibody was used at between lin 20 and 1 in 200 dilution. R771 
crude serum was used at between 1 in 500 and 1 in 1500 dilution.
• Three different blocking solutions (1, 2 and 3) were used with the different 
antibody concentration described above (described in Chapter 2).
All of these antibodies detected recombinant GPI8His (not shown). The affinity- 
purified anti-peptide GPI8 antibodies were the best as they detected relatively low 
levels of soluble recombinant protein expressed in and purified from E. coli (Figure 
5.7).
GPI8 should be present in both wt and the re-expresser cell lines, but not in PIS 1. 
Thus the GPI8 null mutant serves as a negative control in Western analysis. Analysis 
of lysates of these cell lines did detect proteins, but these were in the region of 60kDa 
and were also present in GPI8 null mutants indicating that these proteins were not 
GPI8. It could be that GPI8 is present in such small amounts that this method of 
detection is not sensitive enough to detect the protein. To address this, the 
Biotin/Avidin Labelling Kit (Santa Cruz ABC Reagents) was used in conjunction with 
Western Blotting according to manufacturer’s instructions. This kit provides 
amplification of antibody binding by the use of a biotinylated secondary antibody 
(anti-rabbit IgG). Avidin possesses four binding sites for biotin, one of which is filled 
by the secondary antibody. Biotinylated-HRP when added binds to the remaining
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sites on Avidin and produces a much stronger signal with ECL. This was carried out 
with four separate blots, each of which had lysates from wt, GPI8 null mutant PI SI 
and the re-expresser cell line PlSl[pGL269]. The blots were probed with both anti- 
GPI8His antibodies (R491 and R492) and neat and affinity purified anti-peptide GPI8 
antibody R771. A large number of bands were detected, however none of these were 
absent in the null mutant but present in both wt and PlSl[pGL269] (Figure 5.8B).
5.3.2.1 Enrichment of ER proteins by purification of microsomes
In order to enrich the ER proteins in an attempt to maximise the chances of detecting 
GPI8, microsomes were purified from large, L. mexicana stationary phase cultures.
Microsomes were prepared from 109 wt, PI SI and PlSl[pGL269] promastigotes by 
lysing the cells hypotonically in lml of Microsome buffer 1 (MB1) and membranes 
were stabilised by the addition of an equal volume of Microsome buffer 2 (MB2). 
Unbroken cells and larger organelles (e.g. nuclei) were pelleted by centrifugation 
(2,100xg, 10 minutes) and the supernatant was further fractionated into medium sized 
organelles (e.g. kinetoplasts) by centrifugation (15,800xg, 10 minutes). Microsomes 
were pelleted from the remaining supernatant by ultracentrifiigation (240,000xg, 60 
minutes). The microsome pellets were re-suspended in 60p,l of 0.25M sucrose and 
analysed by SDS-PAGE Coomassie-stained gels (Figure 5.8B) and Western blotting. 
Despite the presence of microsome proteins (Figure 5.8B), Western blotting failed to 
detect GPI8 (not shown). Further experiments to detect ER marker proteins such as 
BiP, to which antibodies were available (Bangs et al., 1993; Bangs et al., 1996) 
would be required to confirm the presence of ER markers in this preparation.
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5.3.2.2 Inhibition of N-glycan attachment and further attempts to detect GPI8
Tunicamycin is a widely used antibiotic that blocks the attachment of N-glycans by 
inhibiting glycosyltransferases in the ER and Golgi (Kink and Chang, 1987). This 
inhibitor has been used successfully with Leishmania to block glycosylation of GP63 
(Funk et al., 1994). If the failure to detect GPI8 is due to extensive glycosylation, 
blockage of N-glycan may allow antibodies to bind allowing detection.
Wt promastigotes were grown in the presence of 5 fig/ml tunicamycin (Sigma) for 100 
hours using the method of Funk and co-workers (1994). After this time, the cells 
were harvested and analysed by SDS-PAGE and Western Blotting using affinity 
purified anti-peptide GPI8 antibodies. No GPI8 could be detected.
5.3.2.3 Periodate treatment of glycoproteins prior to Western blotting
As an alternative to blockage of N-glycan attachment, treatment with sodium 
metaperiodate could be used. Periodate-treatment brings about the oxidation of 
carbohydrates, causing glycan destruction perhaps making the protein component of 
the glycoprotein accessible to antibodies.
Lysates of L. mexicana wt cells were subjected to SDS-PAGE and electroblotting 
onto Hybond C. One blot was treated with periodate and the other wasn’t. Both 
blots were then blocked and exposed to the affinity purified anti-peptide GPI8 
primary antibody and anti-rabbit IgG-HRP secondary antibody. GPI8 was not 
detected.
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5.3.2.4 GPI8His antibodies can detect a protein of the expected size in T. brucei 
procyclic and bloodstream-form cell lysates
L. mexicana GPI8 was found to share a high degree of homology (>70%) with the T. 
brucei homologue over the region characterised in Chapter 3. Antibodies raised 
against LMGPI8 could potentially cross-react with TBGPI8. Pellets containing 
approximately 108 procyclic (strain EATR0795) and 108 bloodstream-form 
(laboratory cultured 427 strain) African trypanosomes were supplied by Dr. Jaap van 
Hellemond and Dr. Patricia Blundell, respectively. Lysates were analysed by SDS- 
PAGE and Western blotting (Figure 5.9). A band of approximately 38-40kDa was 
detected in both procyclic (Figure 5.9 -  lane 1) and bloodstream form (lane 2) lysates. 
There were a number of slightly higher mobility bands detectable in procyclics and 
these could be unglycosylated or partially glycosylated forms of TBGPI8.
5.3.2.5 Immunofluorescence of T. brucei rhodesiense procyclic cells with R491 
antibodies
This work was carried out with Mr. Simon Lillico (University of Glasgow) and is 
included with his permission. A gene for a T. brucei protein called QM, which is a 
potential homologue of the human and yeast ribosomal QM (Dowdy et al., 1991; 
Koller et al., 1996), was identified and isolated. The TY epitope tag (Bastin et al., 
1996) was inserted into the QM gene and expressed in procyclic trypanosomes. The 
aim of this experiment was to investigate the subcellular location of the 38-40kDa 
band, detected with anti-GPI8His antibodies in the previous section, using 
immunofluorescence.
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Fluorescence due ,to TY-tagged QM was compared to either putative TBGPI8 
fluorescence or BiP (Figure 5.10). QM (Figure 5.10, Panel B) produced a very 
scattered pattern with a clear nuclear envelope signal, which is indicative of an ER- 
associated protein (it is envisaged that many ribosomes will be associated with the 
cytoplasmic face of the ER due to the high level of expression of secretoiy 
pathway/GPI-anchored proteins). Panel C shows the fluorescence with anti-GPI8His 
antibodies. These patterns were strikingly similar and they overlapped almost 
perfectly (Panel D). However, the ER marker protein, BiP (Panel G), used by Bangs 
and co-workers (Bangs et al., 1993; Bangs et al., 1996) produced some overlap with 
QM but the signals were clearly different (Panel H). Anti-BiP antibodies were a gift 
of Dr. Jay Bangs of the University of Wisconsin.
5.3.3 The use of green fluorescent protein to investigate the subcellular 
localisation of LMGPI8
Green fluorescent protein (GFP) has been used successfully with Leishmania to 
localise LPG1, one of the proteins involved in LPG biosynthesis (Ha et al., 1996). It 
was found that if the gene was fused to GFP and expressed in LPG1-mutant cells, 
complementation of the mutant phenotype and restoration LPG surface expression 
was achieved. Fluorescence due to GFP can be visualised by microscopy in the same 
way as FITC immunofluorescence staining visualisation. The aim of this section was 
to clone GPI8 into the pXG-GFP vector (Ha et al., 1996), a gift of Dr. Steve 
Beverley (Washington University Medical School), to produce a GPI8-GFP fusion 
protein. Fusion of GFP to the C-terminus of GPI8 would allow the naturally 
occurring ER-signal sequence of GPI8 to be utilised in trafficking of the fusion
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protein. When re-introduced into L. mexicana GPI8 null mutants, the GPI8-GFP 
fusion could be tested for the ability to function as a transamidase by analysis of GP63 
processing and subsequently attempts to detect GFP fluorescence in fixed cells could 
be made.
5.3.3.1 Transfection of P1S1 null mutants with pXG-GP/tf-GFP (pGL190)
PI SI promastigotes were transfected with 15pg of pGL190. Transfected cells were 
grown on agar plates with 25pg/ml each of nourseothricin and G418 and 10|ig/ml 
puromycin. Antibiotics were sufficient to prevent growth of the control transfection 
cells. Four triple-resistant clones (GFP1, GFP2, GFP3 and GFP4) were obtained and 
these were transferred to liquid medium and grown up for analysis.
5.3.3.2 Western blot analysis of GP63 in PlSl[pGL190] cells
The first question to be addressed was whether the GPI8-GFP fusion could restore 
GPI:protein transamidase function, as seen with the wild type gene.
As shown previously, the presence of surface GP63 is an excellent marker for the 
functionality of the fusion protein in terms of its transamidation capability. Two of 
these clones (GFP2 and GFP3) together with wt, PI SI and re-expresser cell lines, 
were analysed by SDS-PAGE and electroblotting using anti-GP63 monoclonal 
antibody. The blot is shown in Figure 5.11. As found previously (Figure 4.13) GP63 
was detected in both wt and the re-expresser cell line but was absent in GPI8 null 
mutant cells (Figure 5.11 -  lanes 1, 3 and 2 respectively). In the GFP2 and GFP3 
lysates several higher mobility proteins (approximately 55-58kDa) were detected 
(5.11 -  lanes 4 and 5). These proteins appeared to be more abundant than the
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comparable proteins in wt and re-expresser lysates (lanes 1 and 3 marked by a yellow 
arrow).
This indicates that GPI8-GFP is partially rescuing the mutant phenotype as some 
GP63 is detected, however, the fusion protein appears to be insufficient to allow the 
complete processing of the surface protein. This remains to be tested by 
immunofluorescence with anti-GP63.
5.4 DISCUSSION
It was the aim of this section of work to express GPI8 in E. coli to produce sufficient 
quantities for antibody production in rabbits. This would allow further 
characterisation of GPI8 in terms of post-translational modifications such as N-linked 
glycosylation since GPI8 has three sites for potential N-glycan addition. Following 
this, experiments to elucidate the subcellular localisation of LMGPI8 were begun.
Recombinant GPI8His was expressed in E. coli in insoluble inclusion bodies. 
Purification by Ni-NTA columns was carried out under denaturing conditions leading 
to an insoluble preparation of GPI8His that was not completely pure - two other 
proteins with higher mobility on SDS-PAGE were present. These could just be 
partially degraded GPI8His but this was not investigated further. Because 
recombinant GPI8His was expressed as insoluble inclusion bodies and purification of 
inclusion bodies can result in very pure preparations of recombinant protein (Kuhelj et 
al., 1995), this step was included as an extra purification step. Ni-NTA purification 
was used as the second step in purification and resulted in a greater purity preparation 
of recombinant GPI8His. All but one of the higher mobility proteins detectable in the
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first purification attempt were absent. Attempts to refold the protein by the gradual 
removal of denaturant by dialysis failed and the protein was eventually sent to SAPU 
(for antibody production) in the form of an insoluble suspension of GPI8His in PBS. 
Anti-peptide GPI8 antibodies were also raised by the inoculation of rabbits with a 
synthetic peptide of a fragment of GPI8. Both sets of antibodies were found to detect 
purified recombinant protein, however it proved difficult to detect GPI8 in 
Leishmcmia lysates.
It would be desirable to be able to produce milligram quantities of recombinant GPI8 
for structural studies. Because the protein is expressed as insoluble protein, it would 
be necessary to develop a method of refolding the protein. Alternatively it has proved 
possible to produce low levels of soluble GPI8His by co-expression with the 
chaperonins GroEL and GroES. The technique requires refinement to maximise 
yields of GPI8His. Furthermore, a single step purification on Ni-NTA columns is 
insufficient to remove the chaperonin GroEL, which is the most abundant protein in 
the fractions eluted from the column. Further purification steps, for example anion 
exchange, may allow purification of GPI8 to homogeneity if the recombinant protein 
is capable of remaining soluble without association with the chaperonin. The purified 
GPI8 could then be used for studies of the activity of the transamidase. A cell-free 
assay system has recently been developed for T. brucei GPI-anchor addition involving 
the use of purified microsomes to study the release of radiolabelled VSG from 
membranes with the nucleophile hydrazine replacing the role of the GPI-anchor 
(Sharma et al., 1999a). These membranes could be subject to alkaline wash to 
remove soluble components of the ER lumen, as was done previously with yeast 
(Vidugiriene and Menon, 1995) and the soluble protein, assuming it has folded
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correctly, could be added back to this system. This, of course, assumes that the T. 
brucei homologue of GPI8 is not membrane bound, like the human and yeast 
homologues.
Detection of GPI8 in L. mexicana cell lysates with these antibodies has not proved 
possible to date. Enrichment of ER proteins by microsome purification did not alter 
this, although the “microsome” sample was not checked for the presence of ER- 
marker proteins such as BiP, to confirm the nature of the purified fraction. It is 
possible that all of the potential GPI8 glycosylation sites have been used and that the 
protein is extensively glycosylated. As a result, the epitopes recognised by the 
antibodies available may be blocked by glycans. The peptide used to produce R771 
anti-peptide antibodies, which was designed against the predicted sequence derived 
from the gene, contains one of the potential N-glycosylation sites. Attempts to inhibit 
N-glycosylation, using the antibiotic tunicamycin, were made. This antibiotic has 
already been used successfully with Leishmania in the inhibition of GP63 
glycosylation (Funk et al., 1994), however it did not appear to have any effect on 
allowing the detection of GPI8. It could be that the concentration of tunicamycin 
used was too low and on this occasion, no positive controls were used in the 
experiment. When the experiment is repeated, tunicamycin will be used at different 
concentrations and GP63 glycosylation will be assessed as a positive control for the 
blockage of glycosylation.
Treatment of blotted lysates with sodium metaperiodate to oxidise carbohydrates also 
had no effect in allowing the detection of GPI8. A further approach to remove 
glycans attached to GPI8 is the enzymatic removal of N-glycans with enzymes such as
petide N-glycosidase A, or endoglycosidase F must be performed. Only then, if GPI8 
remains undetectable will it be certain that attached glycans do not block the epitopes 
recognised by GPI8 antibodies. Episomal expression of modified GPI8 could be 
attempted. Epitope tags such as the TY tag, which are oligonucleotide sequences 
encoding a short stretch of 10 amino acids to which monoclonal antibodies are 
available, could be inserted into the GPI8 ORF and expressed in Leishmcmia. The 
GPI:protein transamidase activity of the GPI8-TY protein could be assessed by 
detection of GP63 using Western Blotting and/or immunofluorescence. The 
detection of GPI8-TY with anti-TY monoclonal antibodies could allow subsequent 
analysis of its post-translational modifications. Clearly the GPI8 gene must be 
expressed (it cannot be a pseudogene) because deletion of the gene causes 
phenotypes associated with a defective GPI:protein transamidase and these are 
reversed by the episomal re-expression of the gene (see Chapter 4). Both sets of 
antibodies recognise the recombinant GPI8His therefore it should be possible to 
detect the native protein. Further studies are required to pursue this.
The anti-leishmanial GPI8 antibody detects a 38-40kDa protein in both procyclic and 
bloodstream form lysates of T. brucei. This is about the size expected for GPI8 if it 
was not heavily glycosylated; yeast Gpi8p is a 44kDa protein and 46, 48 and 50kDa 
forms are detected by Western analysis (Benghezal et al., 1996). Treatment of yeast 
Gpi8p with endoglycosidase H results in detection of just the 44kDa protein 
indicating the protein is N-glycosylated. Immunofluorescence of T. brucei 
rhodesiense procyclic cells detects a pattern reminiscent of ER and which almost 
perfectly matches that of a ribosomal protein called QM. We would expect the 
greatest concentration of ribosomes to be on the rough endoplasmic reticulum. Since
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these are the sites of protein synthesis and entry of nascent polypeptides into the ER, 
we might predict that the transamidase will be closely associated with these regions, 
but on the other side of the ER membrane. It is strange that the antibodies seem to 
recognise trypanosome but not leishmanial GPI8. Again, this may be due to 
differences in glycosylation between the species. Another possibility could be that 
another antibody found in R471 serum could be cross-reacting with a ribosomal 
protein because the immunofluorescence pattern differs significantly from that of BiP, 
a widely used ER marker protein. When the expression of soluble GPI8His has been 
refined, the GPI8 antibodies could be affinity purified by the immobilisation of 
GPI8His onto Aminolink . resin (Pierce), as was done with the anti-peptide GPI8 
antibodies. The affinity-purified antibodies (if they still detect the 38-40kDa band) 
could then be incubated with an excess of recombinant GPI8 before Western blotting 
as a control. If the putative TBGPI8 protein is absent then this would be good 
evidence that the antibodies are detecting the actual T. brucei homologue. Attempts 
are underway to determine if the affinity-purified R771 (peptide) antibodies are able 
to detect proteins in T. brucei lysates. If they do, then this experiment can be carried 
out using these antibodies.
In an attempt to determine the subcellular location of LMGPI8, the gene was cloned 
into pXG-GFP (Ha. et al., 1996) such that the expressed protein would be a fusion 
with GFP fused to the C-terminus of GPI8 allowing detection in the cell by UV 
fluorescence microscopy. Fusion of GFP has been used successfully by Ilgoutz and 
co-workers (1999b) to demonstrate the subcellular location of DPMS to a 
subcompartment of the ER. It was found that, when this protein was expressed in 
GPI8 null mutant cell line PI SI, rescue of the loss of GP63 was partially restored.
189
The mature 63kDa protein corresponding to GPI-anchored GP63 was not present in 
GFP2 and GFP3 cell lines. A higher mobility protein (56-58kDa) that was absent in 
PI SI lysates but was barely detectable in both wt and re-expresser lysates, was 
recognised by anti-GP63 antibodies in pXG-GPI8-GFP cell lines. Further studies are 
required to determine what this protein could be. One possibility is that GPI8-GFP 
has partial activity and has processed the C-terminal GPI signal sequence, but has not 
added a GPI-anchor. This would affect its forward trafficking -  the protein could 
remain within the ER and possibly associated with the GPI:protein transamidase. If 
trafficking is disrupted then glycosylation may be blocked resulting in a lower 
molecular weight form. As a comparison, an L. major GP63 (accession CAA68673) 
would have a molecular weight of approximately 57.5kDa after removal of both the 
ER and the GPI-anchor signal sequences (prior to glycosylation or GPI-anchor 
addition (Voth et al., 1998)) as estimated from the primary structure using the protein 
analysis tools at the Expasy Proteomics Website (http://www.expasy.ch/tools). This 
size would not increase drastically after anchor addition since the L. major GP63 
anchor is simple, having no branching side chains (Schneider et al., 1990). PI-PLC 
treatment and Triton X-114 extraction could determine if the GP63 detected in the 
GPI8-GFP expressing cell lines has a GPI-anchor attached. If the protein is found in 
the aqueous phase after enzyme treatment but in the detergent phase without enzyme 
treatment then it is clear that it has been GPI-anchored (Taguchi et al., 1985; Koch et 
al., 1986). Alternatively, detection of [3H]ethanolamine incorporation of the high 
mobility GP63 species would indicate the presence of an anchor. Whatever the case, 
GPI8-GFP is incapable of completely rescuing the mutant phenotype. This means 
that this fusion protein cannot be used reliably to determine the subcellular location. 
GFP is a large protein and may be interfering with the binding of other components of
the transamidase complex (e.g. GAA1). Because the putative ER tetrapeptide at the 
carboxyl terminus of GPI8 is fused to GFP, retention of the fusion protein in the ER 
may be blocked. The generation of other GPI8-GFP fusion proteins such as GFP at 
the N-terminus of GPI8, carboxyl to the ER signal sequence may prove to be active. 
Until effective GPI8 antibodies are available, the epitope-tagged GPI8 could be 
expressed in the null mutant and detection of the protein by immunofluorescence, 
using antibodies that recognise the tag, can be used to determine localisation.
These experiments represent the early stages of the analysis of GPI8, in terms of its 
structure, location and activity. There are many questions still to be answered and 
these form the basis of research that will take place in the near future.
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6xHis Tag
BamYU
pGL184
4370 bp
GP18
Sal I
Figure 5.1: Construct for expression of recombinant GPI8 with a 6xHistidine tag.
The gene was amplified by PCR using primers with engineered BamWl and Sail sites on 
the 5' and 3' ends respectively with VENT polymerase.
94°C 4 minutes xl
94°C, 30 seconds'^
55°C, 30 seconds p>- xl5 
72°C, 2 minutes 
72°C, 4 minutes xl
A-overhangs were added to the PCR product, which was cloned into pGEM-T. The 
gene was excised from this construct by restriction digest with BamHl and Sail and 
subcloned into the similarly digested pQE-30 vector (Qiagen). Successful cloning was 
determined by PCR screening, restriction digest and sequencing (not shown).
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Figure 5.2: Ligation of GPI8 into pXG-GFP vector to allow expression of a 
GPI8-GFP fusion protein. GPI8 was amplified by PCR as described in the text. 
The BamHl digested PCR product was ligated into a Small BamHl digested pXG-GFP 
vector and used to transform E. coli. The new vector, designated pGL190 was 
isolated and sequenced (using primer OL462, see Chapter 3) across the new junction 
between GPI8 and GFP to confirm that cloning had taken place correctly and that the 
fusion protein would be expressed correctly.
ATGI____
SmaI BamHl
GFP •n
ZtamHI
CP/# PCR
Sm all BamHl digest
digest |
ATG
IGATCCGP18 PCR
Ligation and transformation
V
ATG
pGL190
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Figure 5.3: Expression of recombinant GPI8His in E. coli -  SDS-PAGE and 
Coomassie staining of E. coli cell lysates selected with Ni-NTA. Cells were 
grown up for expression as described in the text and induced with 2mM IPTG for 
four hours. The time-course of rGPI8 expression was monitored by harvesting lml 
o f cells at 0, 1, 2, 3 and 4 hours after IPTG addition. Cells were lysed in 150jul of 
Buffer A for 1 hour with stirring and were incubated with 35pl o f Ni-NTA beads for 
a further 30 minutes. Beads were washed with lml o f Buffer B and 3x1 ml of Buffer 
C before elution in 50pl o f Buffer C + lOOmM EDTA. Samples were mixed with 
SDS-PAGE loading buffer and electrophoresed as follows:
Lane 1 -  Oh 
Lane 2 -  lh 
Lane 3 -  2h 
Lane 4 -  3h 
Lane 5 -  4h
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Figure 5.4: Large scale purification of GPI8His on a Ni-NTA column.
(A) An E. coli pellet was lysed directly in denaturing Buffer A for 1 hour (stirred) and 
filter-sterilised before passing through a 4ml Ni-NTA (Qiagen) column (pre- 
equilibriated with Buffer A). The column was washed with buffers B and C until no 
more protein could be detected (OD280). Bound proteins were then eluted in Buffers D, 
E and F. Fractions were collected and analysed by SDS-PAGE. Gels were stained with 
Coomassie-blue.
Lane 1 -  Buffer A flow through 
Lane 2 -  Buffer B wash 
Lane 3 -  Buffer C wash 
Lane 4 -  Buffer D elution 
Lane 5 -  Buffer E elution 
Lane 6 -  Buffer F elution.
(B) Insoluble inclusion bodies were purified as described in the text and were solubilised 
in Buffer B and filtered. This was loaded onto a Ni-NTA column (pre-equilibriated with 
Buffer B) and the column was washed with Buffer B and C as before. Elution was also 
performed as before (in Buffers D, E and F and fractions were collected. SDS-PAGE 
and staining with Coomassie-blue was used to analyse the samples.
Lane 1 -  Sample loaded onto column
Lane 2 -  Buffer B flow through
Lane 3 -  Buffer F elution containing GPI8His.
A1 2 3 4 5 6
kDa
w
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Figure 5.5: Western blot analysis of small-scale expression of GPI8His in E. coli 
expressing the chaperonins GroEL and GroES. E. coli AB1899F'[pGL184] and 
AB1899F'GroEL/ES [pGL184] were grown at 37°C for 3 hours and 19°C for 24 hours 
after addition of 500mM IPTG. lml samples collected at t = 0, t = 3 (for 37°C 
expression) and t = 24 (for 19°C expression) were lysed in 50pl sonication 
buffer/1 mg/ml lysozyme and incubated at 37°C for 15 minutes before three freeze-thaw 
cycles. Soluble and insoluble material was separated by centrifugation (15,000xg, 10 
minutes). The insoluble fraction was resuspended in 50pl of denaturing Buffer C and 
was mixed with Laemmli sample buffer. Soluble fractions were also mixed with 
Laemmli buffer and boiled prior to SDS-PAGE. Gels were electroblotted and exposed 
to R771 (peptide) anti-GPI8 antibodies at 1 in 50 dilution for 1 hour. Secondary 
antibody was used at 1 in 5000 dilution and the blot was incubated with ECL reagents 
(Pierce).
(A) AB1899FTpGL1841 
Lane 1 - 1 = 0, Soluble 
Lane 2 - 1 = 0, Insoluble 
Lane 3 - 1 = 3, (37°C) soluble 
Lane 4 - 1 = 3, (37°C) insoluble 
Lane 5 - 1 = 24, (19°C) soluble 
Lane 6 - 1 = 24, (19°C) insoluble
(B) AB1899F GroEL/ESrpGL1841 
Lane 1 - 1 = 0, Soluble 
Lane 2 - 1 = 0, Insoluble 
Lane 3 - 1 = 3, (37°C) soluble 
Lane 4 - 1 = 3, (37°C) insoluble 
Lane 5 - 1 = 24, (19°C) soluble 
Lane 6 - 1 = 24, (19°C) insoluble
A1 2 3 4 5 6
kDa
- 4 2  
- 3 0
B
kDa
— 42
— 30
1%
Figure 5.6: Large-scale expression of soluble recombinant GPI8His.
The proteins eluted from the Ni-NTA column were collected and fractions representing a 
cross-section of the purification were selected and concentrated using Centricon-10 
ultrafiltration columns. Fractions were denatured with Laemmli reducing sample buffer, 
incubated at 37°C for 10 minutes and electrophoresed on a 10% SDS-PAGE gel. One 
gel was stained for protein with Coomassie-blue (A) and the other was electroblotted 
and exposed to affinity purified anti-peptide GPI8 antibodies (B).
Lane 1 -  Fraction 2 
Lane 2 -  Fraction 3 
Lane 3 -  Fraction 4 
Lane 4 -  Fraction 5 
Lane 5 -  Fraction 8 
Lane 6 -  Fraction 11 
Lane 7 -  Fraction 14.
The putative GPI8His is marked by a yellow arrow on the Coomassie gel (A) based on 
the size of the band detected by Western blotting (B).
A1 2 3 4 5 6 7
kDa
B
kDa
- 6 0  
- 4 2
- 3 0
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Figure 5.7: Western analysis of purified soluble GPI8His.
Fractions 9, 10, i2 and 13 from the large scale purification of soluble GPISHis were 
concentrated by ultrafiltration (Centricon-10) before SDS-PAGE and electroblotting. 
Blots were exposed to R771 antibodies as described in Figure 5.6.
Lane 1 -  Fraction 9 
Lane 2 -  Fraction 10 
Lane 3 -  Fraction 12 
Lane 4 -  Fraction 13
Lane 5 -  Soluble fraction prior to purification
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Figure 5.8: Attempts to detect LMGPI8 in cell lysates using the Biotin/Avidin 
Labelling kit and enrichment of ER proteins by preparation of microsomes. Ceil 
lysates from wild type, PI SI and PlSl[pGL269] were electrophoresed and blotted 
onto Hybond C. This was done four times for each lysate (A).
Blot 1; R491 anti-GPI8His antibodies 
Blot 2; R492 anti-GPI8His antibodies 
Blot 3; R771 anti-GPI8 peptide antibodies 
Blot 4; R771 affinity purified antibodies
The detection of antibody binding was amplified using the Biotin/Avidin Labelling 
Kit (Santa Cruz ABC Reagents).
Lane 1: wild type 
Lane 2 :PISI 
Lane 3: PlSl[pGL269]
109 cells (wild type, PI SI and PlSl[pGL269] were hypotonically lysed and 
microsomes were prepared as described in the text. Microsome pellets were 
resuspended in 60jul of 0.25M sucrose. Boiled samples were electrophoresed on two 
SDS-PAGE gels. One gel was stained with Coomassie blue (B) and the other was 
electroblotted and affinity purified R771 antibodies were used to attempt to detect 
GPI8. The latter is not shown, as GPI8 was not detected.
Lane 1: wild type 
Lane 2 :P1S1 
Lane 3: PlSl[pGL269]
R491 
1 2 3
R492 
1 2 3
kDa
60
42
30
kDa
h60
•42
30
R771 R771 
(affinity purified) 
1 2 3
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Figure 5.9: Analysis of T. brucei procyclic and bloodstream stage cell lysates by 
Western blotting with anti-GPI8His (R471) antibody.
10s cells from each life cycle stage were harvested and lysed in 150pl of 0.25% Triton 
X-100 in Laemmli sample buffer. 1 8j l i 1 (1.2x107 cell equivalents) was electrophoresed
and electroblotted before exposure to R491 (anti-GPI8) antibodies. Anti-GPI8His
antibody R491 was used at 1 in 1000 dilution with anti-rabbit IgG-HRP secondary
antibody used at 1 in 5000 dilution
Lane 1: Procyclic cells 
Lane 2: Bloodstream cells
200
Figure 5.10: Detection of QM, BiP and GPI8 in T. brucei rhodesiense procyclic 
cells by immunofluorescence.
Procyclic cells were smeared on slides and fixed by immersion in methanol and 
acetone using the method of Bangs et al., (1996). Fluorescence was viewed with a 
Zeiss Axioplan microscope and images recorded and manipulated using the Openlab 
software (Improvision). Secondary antibodies used were anti-mouse IgG-FITC 
conjugated and anti-rabbit-TRITC conjugated (Sigma).
(A) Fixed cells were exposed simultaneously to mouse anti-QM (TY-tagged) 
antibodies (Panel B) and rabbit anti-LMGPI8 (R471) antibodies (Panel C). The 
images were overlaid (Panel D) and overlapping fluorescence is indicated in yellow.
(B) Cells were incubated with, in addition to the QM (TY) antibodies, rabbit anti-BiP, 
a gift of Dr. Jay Bangs, University of Wisconsin, USA. QM detection is shown in 
Panel F and BiP detection, in Panel G. Overlaid images are given in Panel H, again 
producing yellow fluorescence where the signals overlap.
Note that some cells expressing TY-tagged QM were not labelled with the anti-TY 
antibodies. A white arrow in (B) indicates such a cell.
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Figure 5.11: Analysis of GP63 in GPI8 null mutant cells expressing a GPI8-GFP 
fusion protein. Lysates were prepared from two PlSl[pGL190] clones GFP2 and 
GFP3 as well as wt, PI SI and PlSl[pGL269]. These were subjected to SDS-PAGE 
on two gels at 1.5xl07 cell equivalents per lane. One was stained with Coomassie 
blue (A) to demonstrate approximately equal lane loadings and the other was 
electroblotted onto Hybond C (B). Blots were exposed to anti-L. major GP63 
monoclonal antibodies at 1 in 25 dilution. Higher mobility bands recognised by this 
antibody in wild type and GPI8 re-expresser lysates are marked by yellow arrows.
Lane 1: wild type 
Lane 2: P1S1 
Lane 3: PlSl[pGL269]
Lane 4: GFP2 
Lane 5: GFP3
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CHAPTER 6
CONCLUSIONS
The protein GPI biosynthetic pathway contains potential targets for anti-parasite 
chemotherapy and, other than dolichol phosphate mannose synthase (Mazhari-Tabrizi 
et al., 1996; Ilgoutz et al., 1999a), none of the genes involved in this pathway have 
been identified in the trypanosomatids.
The aim of this work was to isolate GPI8 from Leishmania mexicana and to begin its 
characterisation. The gene encodes a component of the GPI:protein transamidase, 
which catalyses the terminal step in the protein GPI biosynthetic pathway, transfer of 
GPI anchors to nascent polypeptides.
Sequence analysis of the predicted L. mexicana GPI8 ORF revealed that LMGPI8 
protein shares 31% identity with both yeast and human GPI8 proteins, and 19% 
identity to legumain and schistosome haemoglobinase SM32. Several lines of 
evidence point to the GPI:protein transamidase having cysteine proteinase activity. 
The predicted mechanism of the transamidase (Figure 6.1) and evidence that the T. 
brucei reaction is sensitive to sulphydryl alkylating reagents (Sharma et al., 1999a), 
together with the sequence homology with cysteine proteinases in the C13 family 
(Barrett and Rawlings, 1996) suggests that enzyme is a novel cysteine proteinase. A 
number of conserved amino acids, that are potential cysteine proteinase active site 
residues, have been identified (His63, Cys94, His174, Cys216). Cys216 is also conserved 
in Jack Bean legumain making this residue the most likely candidate for an active site
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cysteine (see below). The L. mexicana protein lacks a C-terminal ER transmembrane 
domain found in the yeast and human proteins but does possess a putative ER 
retention motif (YDLE). Investigations as to whether this is a functional ER 
retention signal have yet to begin. Three potential N-glycosylation sites are present in 
the yeast (Benghezal et al., 1996) and L. mexicana GPI8s but it is not yet known 
whether these are utilised. In contrast, the human GPI8 lacks N-linked glycosylation 
sites (Benghezal et al., 1996; Yu et al., 1997). It also remains to be determined if 
LMGPI8 is able to replace functionally, the yeast homologue and/or vice versa. 
Temperature-sensitive yeast GPI8 mutants defective in GPI attachment (Benghezal et 
al., 1996) are available to test this (a gift of Andreas Conzelmann).
Direct evidence that LMGPI8 is the GPI:protein transamidase came from targeted 
gene replacement of GPI8 with antibiotic resistance markers and subsequent 
phenotype analysis. Failure to detect GPI8 open reading frame by Southern analysis, 
as well as the prediction of the correct size of hybridisation fragments with a number 
of other probes indicated that the GPI8 ORF had been lost. The isolation of GPI8- 
deficient promastigotes showed that the gene was not essential for viability of L. 
mexicana grown in culture and growth rates were comparable to wild type cells. The 
effect of these knockouts on GP63 was striking with the absence of GP63 on the cell 
surface, as well as the almost total loss of cell-associated GP63. [3H]ethanolamine 
incorporation into GP63 in GPI8 null mutants was undetectable indicating that GP63 
did not receive a GPI anchor. Whether this lack of anchoring extends to all GPI- 
anchored proteins, including PSA2 (or GP46) remains to be tested. The fate of GP63 
in GPI8 null mutants also remains unclear since it does not appear to be secreted and 
inhibition of the proteasome and lysosomal cysteine proteinases does not significantly
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block GP63 loss. The proteasome has been implicated in the quality control of GPI 
anchor attachment in mammalian cells (Wilboum et al., 1998). Alternatively, other 
lysosomal proteinases could be involved in degradation of unprocessed GP63. 
Further investigation of the fate GP63 will be carried out in the near future.
In vitro infection of macrophages revealed that GPI8 null mutant promastigotes could 
infect macrophages, differentiate to amastigote forms and replicate, intracellularly, to 
wild type levels. This shows that GPI anchored proteins are not required for these 
processes, which means that this step in the biosynthetic pathway is unlikely to 
provide a useful anti-leishmanial drug target. Infection of BALB/c mice by GPI8 null 
mutants and re-expresser cell lines was significantly reduced, however. This could be 
due to increased sensitivity to complement-mediated lysis of metacyclic promastigotes 
since GP63 is thought to be important here (Joshi et al., 1998). The GPI8 
heterozygote used to generate the null mutants also do not infect BALB/c mice as 
effectively as wild type cells, so it is not clear if this reduced virulence is directly 
caused by the absence of the transamidase or perhaps by loss of virulence associated 
with the transfection and selection process. To investigate this, two independent 
GPI8 heterozygote clones have been used to infect BALB/c mice but it is still too 
early to discuss their in vivo growth phenotype. The early indications from another 
ongoing experiment are that GPI8 null mutants isolated from mouse lesions have 
increased virulence. Re-expression of GPI8 in the null mutant background does not 
restore virulence to wild type levels and the reasons for this are not clear. Loss of the 
episome is one possible explanation and to address this, amastigotes could be isolated 
from lesions, differentiated to promastigotes in vitro, and analysed for GP63 
expression on the cell surface. The levels of LPG and GIPL are unaffected in GPI8
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null mutants indicating that reduced virulence is not a result of the disruption of the 
other GPI biosynthetic pathways caused by the observed buildup of complete protein 
anchors (Hilley, Zawadzki, McConville, Coombs and Mottram, manuscript 
submitted). Expression of GPI-anchored protein is maximal in promastigotes 
suggesting importance for survival in the sandfly stages. Whether these GPI8 
mutants are able to infect and survive in the sandfly will be tested in the near future.
Detection of LMGPI8 in L. mexicana cell lysates has not been possible to date, using 
the available antibodies raised against recombinant GPI8His and the anti-GPI8 
peptide antibodies. The reasons for this are not clear, although one possibility is 
extensive glycosylation of the protein preventing epitope binding. Indeed, the GPI8 
peptide used to raise antibodies includes one of the potential N-glycosylation 
attachment sites. Periodate treatment to destroy glycans, and tunicamycin treatment 
to prevent their attachment had no effect on the detection of GPI8. Enzymatic 
removal of glycans remains to be tested and production of epitope-tagged versions of 
GPI8 is under way. If the protein is heavily glycosylated then tagging the protein may 
not help. Thus, post-translational modifications of LMGPI8 have yet to be 
demonstrated. Mutant GPI8 in which the cysteine residue at position 216 was 
mutated to glycine (C216G), when re-expressed in the null mutant background did 
not restore transamidase activity, as assessed by detection of GP63 in cell lysates by 
Western blotting. This suggests that the protein is non-functional and that Cys216 may 
be the active site residue. However, the inability to detect GPI8 means that a lack of 
expression of the mutant gene could be an explanation for this father than non­
functional protein. The anti-GPI8His antibody detects a protein of 38-40kDa in T. 
brucei cell lysates and produces immunofluorescence patterns identical to those of an
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epitope-tagged ribosomal protein, QM. However it cannot be ruled out that the anti- 
GPI8His antibodies are not cross-reacting with another ribosomal protein. It is not 
clear why these antibodies would recognise GPI8 in T. brucei but not in L. mexicana, 
however a 38-40kDa protein suggests little or no glycosylation of the T. brucei 
protein and consequently no blocking of the epitopes recognised by anti-GPI8His 
antibodies.
If epitope-tagging of LMGPI8 produces detectable, functional enzyme as determined 
by GP63 cell-surface expression, then this paves the way for the localisation of this 
enzyme. It will be interesting to determine if, like the other GPI biosynthetic 
enzymes, the GPI:protein transamidase is associated with the novel dolichol 
phosphate mannose synthase (DPMS) tubule (Ilgoutz et al., 1999b) or if it remains 
within the bulk ER.
The yeast and human GPI:protein transamidase has at least two subunits but a 
homologue of GAA1 remains to be identified in trypanosomatids. Evidence discussed 
in Chapter 1 suggests that the molecular chaperone BiP may also play a role in the 
biosynthetic step, perhaps indirectly. The epitope-tag antibodies could lead to the 
identification of other components of the transamidase using similar methods to those 
of Kinoshita and coworkers who demonstrated that the mammalian GlcNAc 
transferase complex that catalyses the first step in GPI biosynthesis requires a 
complex of at least four proteins (see Watanabe et al., 1996; Watanabe et al., 1998 
and Chapter 1).
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Although attachment of GPI anchors to proteins does not appear to be an essential 
process in L. mexiccma, it is likely to be essential in other trypanosomatids such as 71 
brucei that rely heavily on such proteins in host-parasite interactions. This work has 
provided unique insights into the function of GPI anchored proteins in Leishmania as 
well as providing access to the GPI:protein transamidase of African trypanosomes for 
future study.
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Figure 6.1: Predicted mechanism of the GPI:protein transamidase.
The transamidation mechanism allows GPI8 to behave as a proteinase by using water 
(A), rather than GPI (B) as the nucleophile in the second step of the reaction. (Adapted 
from Maxwell et al., 1995a and Sharma et al., 1999a).
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APPENDIX
PI GPI8 heterozygote (puromycin-resistant) clone 1 1139/1238
P2 GPI8 heterozygote (puromycin-resistant) clone 2 1140
P3 GPI8 heterozygote (puromycin-resistant) clone 3 1141
SI GPI8 heterozygote (nourseothricin-resistant) 
clone 1
1142
P1S1 GPI8 null mutant clone 1 1234
P1S3 GPI8 null mutant clone 2 1236
PlSl[pGL269] GPI8 null mutant clone 1 re-expressing GPI8 
from an episome
1235
PlSl[pGL403] GPI8 null mutant clone 1 expressing C216G 
mutant GPI8 from an episome
1237
PlS3[pGL269] GPI8 null mutant clone 2 re-expressing GPI8 
from an episome
TBA
PlSl[pGL190] GPI8 null mutant clone 1 expressing GPI8-GFP 
fusion protein from an episome
TBA
TBA = To be assigned
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